Acinetobacter baumannii Piéchaud 5377 is an obligate aerobe, Gram-negative, rod-shaped bacterium that was isolated from cerebrospinal fluid, fatal case of meningitis.
Gram-negative rod-shaped obligate aerobe genome sequence 16S sequence Bacteria| @ref 20215 |
|
Last LPSN update
2026-02-09 11:31:46 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Moraxellaceae |
| Genus Acinetobacter |
| Species Acinetobacter baumannii |
| Full scientific name Acinetobacter baumannii Bouvet and Grimont 1986 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 24477 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 34573 | MEDIUM 3 - Columbia agar | Columbia agar (39.000 g);distilled water (1000.000 ml) | |||
| 24477 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water | ||
| 116743 | CIP Medium 3 | Medium recipe at CIP | |||
| 116743 | CIP Medium 72 | Medium recipe at CIP |
| Test 1 | |
|---|---|
| @ref | 24477 |
| Medium | Müller-Hinton Agar |
| Manual annotation | 1 |
| Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 28 |
| Ampicillin 10µg (disc) | 10 |
| Aztreonam 30µg (disc) | 16 |
| Cefiderocol 30µg (disc) | 30 |
| Cefotaxime 30µg (disc) | 20 |
| Ceftazidime 10µg (disc) | 20-22 |
| Ceftriaxone 30µg (disc) | 20 |
| Chloramphenicol 30µg (disc) | 10 |
| Ciprofloxacin 5µg (disc) | 32-34 |
| Clindamycin 10µg (disc) | 0 |
| Colistin sulphate 10µg (disc) | 16 |
| Erythromycin 15µg (disc) | 20 |
| Fosfomycin 50µg (disc) | 6 |
| Gentamicin 30µg (disc) | 24 |
| Imipenem 10µg (disc) | 40 |
| Kanamycin 30µg (disc) | 28 |
| Levofloxacin 5µg (disc) | 34 |
| Linezolid 10µg (disc) | 0 |
| Meropenem 10µg (disc) | 36 |
| Moxifloxacin 5µg (disc) | 34 |
| Nitrofurantoin 100µg (disc) | 0 |
| Ofloxacin 5µg (disc) | 32 |
| Oxacillin 5µg (disc) | 0 |
| Penicillin G 6µg (disc) | 0 |
| Piperacillin/Tazobactam 110µg (disc) | 30 |
| Polymyxin B 300Unit | 16 |
| Quinupristin/Dalfopristin 15µg (disc) | 0 |
| Rifampicin 5µg (disc) | 16 |
| Teicoplanin 30µg (disc) | 6 |
| Tetracycline 30µg (disc) | 26 |
| Ticarcillin 75µg (disc) | 28-30 |
| Tigecycline 15µg (disc) | 24 |
| Trimethoprim-sulfamethoxazole (1:19) 10µg (disc) | 16 |
| Vancomycin 30µg (disc) | 6 |
| @ref | Spore formation | Confidence | |
|---|---|---|---|
| 125438 | 93.827 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68369 | 17128 ChEBI | adipate | - | assimilation | from API 20NE |
| 68371 | 27613 ChEBI | amygdalin | - | builds acid from | from API 50CH acid |
| 68371 | 18305 ChEBI | arbutin | - | builds acid from | from API 50CH acid |
| 68369 | 29016 ChEBI | arginine | - | hydrolysis | from API 20NE |
| 68371 | 17057 ChEBI | cellobiose | - | builds acid from | from API 50CH acid |
| 68371 | 17108 ChEBI | D-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18333 ChEBI | D-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 15824 ChEBI | D-fructose | - | builds acid from | from API 50CH acid |
| 68371 | 28847 ChEBI | D-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 12936 ChEBI | D-galactose | - | builds acid from | from API 50CH acid |
| 68371 | 17634 ChEBI | D-glucose | - | builds acid from | from API 50CH acid |
| 68369 | 17634 ChEBI | D-glucose | - | assimilation | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | - | fermentation | from API 20NE |
| 68371 | 62318 ChEBI | D-lyxose | - | builds acid from | from API 50CH acid |
| 68371 | 16899 ChEBI | D-mannitol | - | builds acid from | from API 50CH acid |
| 68369 | 16899 ChEBI | D-mannitol | - | assimilation | from API 20NE |
| 68371 | 16024 ChEBI | D-mannose | - | builds acid from | from API 50CH acid |
| 68369 | 16024 ChEBI | D-mannose | - | assimilation | from API 20NE |
| 68371 | 16988 ChEBI | D-ribose | - | builds acid from | from API 50CH acid |
| 68371 | 17924 ChEBI | D-sorbitol | - | builds acid from | from API 50CH acid |
| 68371 | 16443 ChEBI | D-tagatose | - | builds acid from | from API 50CH acid |
| 68371 | 65327 ChEBI | D-xylose | - | builds acid from | from API 50CH acid |
| 68369 | 27689 ChEBI | decanoate | + | assimilation | from API 20NE |
| 68371 | 17113 ChEBI | erythritol | - | builds acid from | from API 50CH acid |
| 68371 | 4853 ChEBI | esculin | - | builds acid from | from API 50CH acid |
| 68369 | 4853 ChEBI | esculin | - | hydrolysis | from API 20NE |
| 68371 | 16813 ChEBI | galactitol | - | builds acid from | from API 50CH acid |
| 68371 | 28066 ChEBI | gentiobiose | - | builds acid from | from API 50CH acid |
| 68371 | 24265 ChEBI | gluconate | - | builds acid from | from API 50CH acid |
| 68369 | 24265 ChEBI | gluconate | + | assimilation | from API 20NE |
| 116743 | 17234 ChEBI | glucose | - | degradation | |
| 68371 | 17754 ChEBI | glycerol | - | builds acid from | from API 50CH acid |
| 68371 | 28087 ChEBI | glycogen | - | builds acid from | from API 50CH acid |
| 68371 | 15443 ChEBI | inulin | - | builds acid from | from API 50CH acid |
| 68371 | 30849 ChEBI | L-arabinose | - | builds acid from | from API 50CH acid |
| 68369 | 30849 ChEBI | L-arabinose | - | assimilation | from API 20NE |
| 68371 | 18403 ChEBI | L-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 18287 ChEBI | L-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 62345 ChEBI | L-rhamnose | - | builds acid from | from API 50CH acid |
| 68371 | 17266 ChEBI | L-sorbose | - | builds acid from | from API 50CH acid |
| 68371 | 65328 ChEBI | L-xylose | - | builds acid from | from API 50CH acid |
| 68371 | 17716 ChEBI | lactose | - | builds acid from | from API 50CH acid |
| 68369 | 25115 ChEBI | malate | + | assimilation | from API 20NE |
| 68371 | 17306 ChEBI | maltose | - | builds acid from | from API 50CH acid |
| 68369 | 17306 ChEBI | maltose | - | assimilation | from API 20NE |
| 68371 | 6731 ChEBI | melezitose | - | builds acid from | from API 50CH acid |
| 68371 | 28053 ChEBI | melibiose | - | builds acid from | from API 50CH acid |
| 68371 | 320061 ChEBI | methyl alpha-D-glucopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 43943 ChEBI | methyl alpha-D-mannoside | - | builds acid from | from API 50CH acid |
| 68371 | 74863 ChEBI | methyl beta-D-xylopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 17268 ChEBI | myo-inositol | - | builds acid from | from API 50CH acid |
| 68371 | 59640 ChEBI | N-acetylglucosamine | - | builds acid from | from API 50CH acid |
| 68369 | 59640 ChEBI | N-acetylglucosamine | - | assimilation | from API 20NE |
| 116743 | 17632 ChEBI | nitrate | - | reduction | |
| 116743 | 17632 ChEBI | nitrate | - | respiration | |
| 68369 | 17632 ChEBI | nitrate | - | reduction | from API 20NE |
| 116743 | 16301 ChEBI | nitrite | - | reduction | |
| 68371 | Potassium 2-ketogluconate | - | builds acid from | from API 50CH acid | |
| 68371 | Potassium 5-ketogluconate | - | builds acid from | from API 50CH acid | |
| 68371 | 16634 ChEBI | raffinose | - | builds acid from | from API 50CH acid |
| 68371 | 15963 ChEBI | ribitol | - | builds acid from | from API 50CH acid |
| 68371 | 17814 ChEBI | salicin | - | builds acid from | from API 50CH acid |
| 68371 | 28017 ChEBI | starch | - | builds acid from | from API 50CH acid |
| 68371 | 17992 ChEBI | sucrose | - | builds acid from | from API 50CH acid |
| 68371 | 27082 ChEBI | trehalose | - | builds acid from | from API 50CH acid |
| 68369 | 27897 ChEBI | tryptophan | - | energy source | from API 20NE |
| 68371 | 32528 ChEBI | turanose | - | builds acid from | from API 50CH acid |
| 68369 | 16199 ChEBI | urea | - | hydrolysis | from API 20NE |
| 68371 | 17151 ChEBI | xylitol | - | builds acid from | from API 50CH acid |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | Is sensitive | |
|---|---|---|---|---|---|---|
| 116743 | 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate) | |||||
| 24477 | 3745 | Clindamycin | 10 µg (disc) | from Antibiotic test | ||
| 24477 | 63607 | Linezolid | 10 µg (disc) | from Antibiotic test | ||
| 24477 | 71415 | Nitrofurantoin | 100 µg (disc) | from Antibiotic test | ||
| 24477 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | ||
| 24477 | 18208 | Penicillin G | 6 µg (disc) | from Antibiotic test | ||
| 24477 | Quinupristin/Dalfopristin | 15 µg (disc) | from Antibiotic test |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 68369 | arginine dihydrolase | - | 3.5.3.6 | from API 20NE |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 116743 | beta-galactosidase | - | 3.2.1.23 | |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68369 | beta-glucosidase | - | 3.2.1.21 | from API 20NE |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 116743 | catalase | + | 1.11.1.6 | |
| 68382 | cystine arylamidase | + | 3.4.11.3 | from API zym |
| 68369 | cytochrome oxidase | - | 1.9.3.1 | from API 20NE |
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 116743 | gamma-glutamyltransferase | + | 2.3.2.2 | |
| 116743 | gelatinase | - | ||
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 68382 | lipase (C 14) | - | from API zym | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 116743 | oxidase | - | ||
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 116743 | urease | + | 3.5.1.5 | |
| 68369 | urease | - | 3.5.1.5 | from API 20NE |
| 68382 | valine arylamidase | + | from API zym |
| @ref | ControlQ | GLY | ERY | DARA | LARA | RIB | DXYL | LXYL | ADO | MDX | GAL | GLU | FRU | MNE | SBE | RHA | DUL | INO | MAN | SOR | MDM | MDG | NAG | AMY | ARB | ESC | SAL | CEL | MAL | LAC | MEL | SAC | TRE | INU | MLZ | RAF | AMD | GLYG | XLT | GEN | TUR | LYX | TAG | DFUC | LFUC | DARL | LARL | GNT | 2KG | 5KG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116743 | not determinedn.d. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM2246713v1 assembly for Acinetobacter baumannii ATCC17978-VUB | complete | GCA_022467135   | 470.16154  | 470 | 99.18 | | |
| 66792 | ASM159342v2 assembly for Acinetobacter baumannii ATCC 17978-VU | complete | GCA_001593425 | 470.1999 | 2860756204  | 470 | 98.81 | |
| 66792 | ASM1106706v1 assembly for Acinetobacter baumannii ATCC 17978 | complete | GCA_011067065 | 470.11103 | 8008094054 | 470 | 98.7 | |
| 66792 | ASM863089v1 assembly for Acinetobacter baumannii AB043 | complete | GCA_008630895 | 470.9249 | 470 | 98.59 | | |
| 66792 | ASM1467277v1 assembly for Acinetobacter baumannii ATCC 17978 | complete | GCA_014672775 | 470.12190 | 8008090111 | 470 | 98.45 | |
| 66792 | ASM194176v1 assembly for Acinetobacter baumannii AB042 | complete | GCA_001941765 | 470.3044 | 470 | 98.44 | | |
| 66792 | ASM2616778v1 assembly for Acinetobacter baumannii ATCC 17978 | complete | GCA_026167785 | 400667 | 98.43 | | ||
| 66792 | ASM2616780v1 assembly for Acinetobacter baumannii ATCC 17978 | complete | GCA_026167805 | 400667 | 98.43 | | ||
| 66792 | ASM1337208v1 assembly for Acinetobacter baumannii ATCC 17978 | complete | GCA_013372085 | 400667.121 | 8008001286 | 400667 | 98.29 | |
| 124043 | ASM1935621v1 assembly for Acinetobacter baumannii 17978UN | complete | GCA_019356215 | 470.13902 | 470 | 98.28 | | |
| 66792 | ASM2945961v1 assembly for Acinetobacter baumannii ATCC17978 TnAraC-H0N27_12600 | complete | GCA_029459615 | 470.20803 | 470 | 98.14 | | |
| 66792 | ASM2091200v1 assembly for Acinetobacter baumannii ATCC 17978 | complete | GCA_020912005 | 470.15028 | 8008005213 | 470 | 98.06 | |
| 66792 | ASM479715v2 assembly for Acinetobacter baumannii ATCC 17978 ATCC 17978 substr. PMR-High | complete | GCA_004797155 | 400667.93 | 8008020736 | 400667 | 98.05 | |
| 66792 | ASM107767v1 assembly for Acinetobacter baumannii ATCC 17978-mff | complete | GCA_001077675 | 2671180557 | 470 | 97.38 | | |
| 66792 | ASM479427v2 assembly for Acinetobacter baumannii ATCC 17978 ATCC 17978 substr. PMR-Low | chromosome | GCA_004794275 | 400667.92 | 8008013218 | 400667 | 88.59 | |
| 66792 | ASM479423v2 assembly for Acinetobacter baumannii ATCC 17978 ATCC 17978 substr. Lab-WT | chromosome | GCA_004794235 | 400667.91 | 8008086191 | 400667 | 86.02 | |
| 66792 | Acinetobacter baumannii ATCC17978 assembly for Acinetobacter baumannii ATCC 17978 | contig | GCA_902728005 | 400667.143 | 400667 | 78.37 | | |
| 124043 | ASM4505602v1 assembly for Acinetobacter baumannii ATCC 17978 | contig | GCA_045056025 | 470 | 74.23 | | ||
| 66792 | ASM172136v1 assembly for Acinetobacter baumannii XH193 | scaffold | GCA_001721365 | 470.2652 | 470 | 69.07 | | |
| 66792 | ASM1542v1 assembly for Acinetobacter baumannii ATCC 17978 | complete | GCA_000015425 | 400667.7 | 640069301 | 400667 | 63.82 | |
| 66792 | ASM172144v1 assembly for Acinetobacter baumannii XH181 | scaffold | GCA_001721445 | 470.2656 | 470 | 57.69 | | |
| 66792 | ASM172147v1 assembly for Acinetobacter baumannii XH184 | scaffold | GCA_001721475 | 470.2659 | 470 | 55.24 | | |
| 66792 | ASM172142v1 assembly for Acinetobacter baumannii XH182 | scaffold | GCA_001721425 | 470.2655 | 470 | 52.64 | | |
| 66792 | ASM172145v1 assembly for Acinetobacter baumannii XH191 | scaffold | GCA_001721455 | 470.2657 | 470 | 44.86 | | |
| 66792 | ASM172137v1 assembly for Acinetobacter baumannii XH198 | scaffold | GCA_001721375 | 470.2653 | 470 | 40.19 | | |
| 66792 | ASM172146v1 assembly for Acinetobacter baumannii XH183 | scaffold | GCA_001721465 | 470.2658 | 470 | 32.41 | | |
| 66792 | ASM172138v1 assembly for Acinetobacter baumannii XH192 | scaffold | GCA_001721385 | 470.2654 | 470 | 17.34 | |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 124043 | Acinetobacter baumannii ATCC 17978 strain HODAZ1 16S ribosomal RNA gene, partial sequence. | EU052267 | 843 | | 400667 | |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii. | Alexander PJ, Oyama LB, Olleik H, Godoy Santos F, O'Brien S, Cookson A, Cochrane SA, Gilmore BF, Maresca M, Huws SA. | NPJ Biofilms Microbiomes | 10.1038/s41522-024-00560-2 | 2024 | | |
| A New Approach to Harness Probiotics Against Common Bacterial Skin Pathogens: Towards Living Antimicrobials. | Khalfallah G, Gartzen R, Moller M, Heine E, Lutticken R. | Probiotics Antimicrob Proteins | 10.1007/s12602-021-09783-7 | 2021 | | |
| Phage-based decontamination: Exploring resistance, disinfectant tolerance, and virulence trade-offs in Acinetobacter baumannii. | Chen YT, Chen LK, Jiang RS, Chang KC, Tseng CC. | Ecotoxicol Environ Saf | 10.1016/j.ecoenv.2025.119052 | 2025 | | |
| H2O2-Producing Electrochemical Bandages Are Active Using Off-the-Shelf Hydrogels. | Dagsuyu E, Kies P, Patel R, Beyenal H. | Wound Repair Regen | 10.1111/wrr.70092 | 2025 | | |
| Killing two birds with one stone: emergence of colistin and cefiderocol resistance in a mucoid MDR Acinetobacter baumannii under colistin pressure. | Fox V, Vrenna G, Rossitto M, Paris I, Papa R, Artini M, Selan L, Raimondi S, Tuccio Guarna Assanti V, Essa N, Lepanto MS, Cortazzo V, Agosta M, Boni A, Cristiani L, Cutrera R, Perno CF, Bernaschi P. | Front Microbiol | 10.3389/fmicb.2025.1650028 | 2025 | | |
| Carnosol attenuates Acinetobacter baumannii virulence by interfering with indole-mediated quorum sensing. | Cui B, Peng G, Wang M, Kong X, Wei H, Ling X, Wu G, Deng Y. | Virulence | 10.1080/21505594.2025.2530169 | 2025 | | |
| Susceptibility and resistance of Gram-negative bacteria to a novel antimicrobial agent TGV-49. | Tetz VV, Kardava KM, Vecherkovskaya MF, Leyn SA, Elane ML, Osterman AL, Tetz GV. | Front Antibiot | 10.3389/frabi.2025.1615821 | 2025 | | |
| Targeting carA Using Optimized Antisense Peptide Nucleic Acid-Cell-Penetrating Peptide Conjugates in Acinetobacter baumannii: A Novel Antibacterial Approach. | Seo JH, Kim YJ, Jeon WJ, Yoo JS, Moon DC. | Int J Mol Sci | 10.3390/ijms26199526 | 2025 | | |
| Antibiotic Persister Cells in Acinetobacter baumannii: Overview of Molecular Mechanisms and Removal Strategies. | Vergoz D, De E, Loutelier-Bourhis C, Alexandre S. | Environ Microbiol | 10.1111/1462-2920.70207 | 2025 | | |
| Activity of HOCl-generating e-bandage with clinically available hydrogels against Staphylococcus aureus and Acinetobacter baumannii biofilms. | Dagsuyu E, Kies P, Karau MJ, Patel R, Beyenal H. | Microbiol Spectr | 10.1128/spectrum.01762-25 | 2025 | | |
| Genotyping of Acinetobacter baumannii clinical isolates from Polish hospitals uncovers novel sequence types. | Sidor-Dzitkowska K, Marszalik A, Krasnicka A, Zalewska M, Wroblewska M, Bakula Z, Popowska M, Boguslawska J, Skirecki T, Jagielski T, Stachowiak R. | Sci Rep | 10.1038/s41598-025-23877-0 | 2025 | | |
| Exploration of Phosphoproteins in Acinetobacter baumannii. | Bremard L, Massier S, De E, Nalpas N, Hardouin J. | Pathogens | 10.3390/pathogens14080732 | 2025 | | |
| Establishment and Comparison of Fluorescence-Based T6SS Activity Detection Methods in Acinetobacter baumannii. | Yang W, Jie J, Li C, Chen D, Zhao S, Gu S, Xu J, Song L. | J Vis Exp | 10.3791/67772 | 2025 | | |
| Exploration of Phosphoproteins in Acinetobacter baumannii | Bremard L, Massier S, De E, Nalpas N, Hardouin J. | Pathogens | 2025 | | ||
| Pathogenicity | Live attenuated hfq-deleted Acinetobacter baumannii vaccine provides protection against systemic infection. | Bakht P, Hussain A, Pandey S, Pathania R. | Vaccine | 10.1016/j.vaccine.2025.127298 | 2025 | |
| DcaP-Family Porins are Required for Carboxylic Acid Catabolism in Acinetobacter baumannii | Noel H, Winkelman J, Palmer L. | bioRxiv | 2025 | | ||
| Transcriptome | Roles of GacSA and DJ41_1407 in Acinetobacter baumannii ATCC 19606. | Toh YH, Wen MY, Lin GH. | Int J Mol Sci | 10.3390/ijms262110620 | 2025 | |
| Cross resistance emergence to polymyxins in Acinetobacter baumannii exposed in vitro to an antimicrobial peptide. | Ritz E, Rossel T, Jacquier N. | NPJ Antimicrob Resist | 10.1038/s44259-025-00120-4 | 2025 | | |
| Pathogenicity | Acinetobacter baumannii OmpA hinders host autophagy via the CaMKK2-reliant AMPK-pathway. | Woo K, Kim DH, Park H-S, Oh MH, Lee JC, Choi CH. | mBio | 10.1128/mbio.03369-24 | 2025 | |
| Transcriptome | Transcriptome and interactome-based analyses to unravel crucial proteins and pathways involved in Acinetobacter baumannii pathogenesis. | Swain A, Senapati SS, Pan A. | Mol Divers | 10.1007/s11030-024-11041-1 | 2025 | |
| Reciprocal regulation between Acinetobacter baumannii and Enterobacter cloacae AdeR homologs: implications for antimicrobial resistance and pathogenesis. | Gaona M, Corral J, Sanchez Osuna M, Campoy S, Barbe J, Perez-Varela M, Aranda J. | PLoS One | 10.1371/journal.pone.0315428 | 2025 | | |
| Blue benzoquinone from scorpion venom shows bactericidal activity against drug-resistant strains of the priority pathogen Acinetobacter baumannii. | Gallegos-Monterrosa R, Cid-Uribe JI, Delgado-Prudencio G, Perez-Morales D, Banda MM, Tellez-Galvan A, Carcamo-Noriega EN, Garza-Ramos U, Zare RN, Possani LD, Bustamante VH. | J Antibiot (Tokyo) | 10.1038/s41429-025-00809-8 | 2025 | | |
| Biotechnology | Acinetobacter baumannii as a Model for the Study and Application of Gram-Negative Outer Membrane Vesicles: A Systematic Review. | Cano-Castano B, Lopez-Siles M, Nonnoi F, Perez A, Corral Lugo A, McConnell MJ. | Microb Biotechnol | 10.1111/1751-7915.70207 | 2025 | |
| AbOmpA in Acinetobacter baumannii: exploring virulence mechanisms of outer membrane-integrated and outer membrane vesicle-associated AbOmpA and developing anti-infective agents targeting AbOmpA. | Oh MH, Islam MM, Kim N, Choi CH, Shin M, Shin WS, Lee JC. | J Biomed Sci | 10.1186/s12929-025-01147-5 | 2025 | | |
| Signaling in Acinetobacter baumannii: Quorum sensing and nucleotide second messengers. | Cui B, Peng G, Wang LE, Deng Y. | Comput Struct Biotechnol J | 10.1016/j.csbj.2025.05.032 | 2025 | | |
| Outer membrane permeability of mcr-positive bacteria reveals potent synergy of colistin and macromolecular antibiotics against colistin-resistant Acinetobacter baumannii. | Li M, Ma F, Zhao H, Zhou D, Liang L, Lv R, Li J, Wang Y, Xu L, Liu C, Tian GB, Feng S, Xia Y. | Front Microbiol | 10.3389/fmicb.2024.1468682 | 2024 | | |
| Development of a new Acinetobacter baumannii pneumonia rabbit model for the preclinical evaluation of future anti-infective strategies. | Albac S, Anzala N, Bonnot D, Djama C, Chavanet P, Croisier D. | Microbiol Spectr | 10.1128/spectrum.01570-24 | 2024 | | |
| Noncytotoxic polymyxin derivatives enhance antibiotic action against multidrug-resistant Gram-negative bacteria. | Ramirez D, Ramirez DM, Arora R, Arthur G, Schweizer F. | Antimicrob Agents Chemother | 10.1128/aac.00712-25 | 2025 | | |
| The novel MFS efflux pump SxtP, regulated by the LysR-type transcriptional activator SxtR, is involved in the susceptibility to sulfamethoxazole/trimethoprim (SXT) and the pathogenesis of Acinetobacter baumannii. | Gaona M, Corral J, Campoy S, Barbe J, Perez Varela M, Aranda J. | Antimicrob Agents Chemother | 10.1128/aac.00712-24 | 2024 | | |
| Metabolism | Arginine utilization in Acinetobacter baumannii is essential for pneumonia pathogenesis and is regulated by virulence regulator GacA. | Devnath K, Pathak A, Bakht P, Pathania R. | Infect Immun | 10.1128/iai.00572-24 | 2025 | |
| Alternative lipid synthesis in response to phosphate limitation promotes antibiotic tolerance in Gram-negative ESKAPE pathogens. | Olea-Ozuna RJ, Campbell MJ, Quintanilla SY, Nandy S, Brodbelt JS, Boll JM. | PLoS Pathog | 10.1371/journal.ppat.1012933 | 2025 | | |
| Synthesis and antibacterial evaluations of novel vancomycin analogues targeting bacteria membrane to combat Gram-negative infections. | Li T, Zhang R, Gong H, Tang Z, Li X, Gong Z, Challa M, Zou C, Zhang SL, Guo J, He Y. | Eur J Med Chem | 10.1016/j.ejmech.2025.117483 | 2025 | | |
| OmpH is Involved in the Decrease of Acinetobacter baumannii Biofilm by the Antimicrobial Peptide Cec4. | Qiu Z, Ran J, Yang Y, Wang Y, Zeng Y, Jiang Y, Hu Z, Zeng Z, Peng J. | Drug Des Devel Ther | 10.2147/dddt.s481225 | 2024 | | |
| Acinetobacter baumannii represses type VI secretion system through a manganese-dependent small RNA-mediated regulation. | Bhowmik S, Pathak A, Pandey S, Devnath K, Sett A, Jyoti N, Bhando T, Akhter J, Chugh S, Singh R, Sharma TK, Pathania R. | mBio | 10.1128/mbio.03025-24 | 2025 | | |
| Electrochemical Catheter Hub Operated by a Wearable Micropotentiostat Prevents Acinetobacter baumannii Infection In Vitro. | Al-Qurahi M, Fleming D, Kim WJ, Bozyel I, Patel R, Beyenal H. | Biotechnol Bioeng | 10.1002/bit.28990 | 2025 | | |
| Pathogenicity | A decade of genomic and phenotypic adaptation of carbapenem-resistant Acinetobacter baumannii. | Tagueha AD, D'Agostini C, Scribano D, Fiorilla C, Limongi D, Fillo S, Corrent L, Lipari M, Lista F, Nencioni L, Palamara AT, Ambrosi C. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1527488 | 2025 | |
| Discovery of new antimicrobial thiophene derivatives with activity against drug-resistant Gram negative-bacteria. | Molina-Panadero I, Morales-Tenorio M, Garcia-Rubia A, Ginex T, Eskandari K, Martinez A, Gil C, Smani Y. | Front Pharmacol | 10.3389/fphar.2024.1412797 | 2024 | | |
| Genetics | Genomic characteristics of the multiresistant Acinetobacter baumannii global clone 1 reference strain A297/RUH875. | Koong J, Hall RM, Hamidian M. | J Antimicrob Chemother | 10.1093/jac/dkaf160 | 2025 | |
| The Comparative Characterization of a Hypervirulent Acinetobacter baumannii Bacteremia Clinical Isolate Reveals a Novel Mechanism of Pathogenesis. | Benyamini P. | Int J Mol Sci | 10.3390/ijms25189780 | 2024 | | |
| Inhibitory Effect of Antimicrobial Peptides Bac7(17), PAsmr5-17 and PAbetaN on Bacterial Growth and Biofilm Formation of Multidrug-Resistant Acinetobacter baumannii. | Ruhl-Teichner J, Muller D, Stamm I, Gottig S, Leidner U, Semmler T, Ewers C. | Microorganisms | 10.3390/microorganisms13030639 | 2025 | | |
| Bakuchiol kills Staphylococcus aureus persisters and potentiates colistin activity against Acinetobacter baumannii persisters. | Suh K, Lee Y, Baek S, Kim J, Seo J, Yang YH, Kim JS, Lee W, Seo EK, Kim W. | Front Pharmacol | 10.3389/fphar.2025.1592183 | 2025 | | |
| Pathogenicity | Exploration of New Drug Candidate Derived from Antioxidants of Korean Native Halophytes: Control of Acinetobacter baumannii with Antipathogenic Activity. | Lee J, Kim HS, Park JW, Yun B, Bang WY, Moon KH, Seo Y. | Antioxidants (Basel) | 10.3390/antiox13111334 | 2024 | |
| High-throughput single-cell analysis reveals fully human Omp38-specific monoclonal antibodies against Acinetobacter baumannii. | Zhang Y, Yu W, Yu P, Wang S, Dong H, Qi Y, Chen X, Zhang L, Liu Y, Mou X, Zhao T, Zhang J, Chen X, Li H, Zhou S, Wu Y, Tian Y. | BMC Microbiol | 10.1186/s12866-025-04283-y | 2025 | | |
| Characterization of OXA-1224, a novel OXA-213-like beta-lactamase encoded by the chromosome of Acinetobacter pittii. | Liu Z, Shen S, Lei J, Zhao S, Zhang X, Tang C, Wu S, Lei K, Yin J, Zhang Y, Guo Y, Geng Y, Hu F. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2025.107536 | 2025 | | |
| Genetics | Genomic and phenotypic insights into ST164 blaNDM-1-positive Acinetobacter baumannii from intestinal colonization in China. | Wang K, Zhu W, Gong L, Yang X, Ye H, Lou Z, Yang J, Jiang X, Li W, Tao F, Xu H, Zheng B, Liu W. | BMC Microbiol | 10.1186/s12866-025-03979-5 | 2025 | |
| Enzymology | Antivirulence drugs against Acinetobacter baumannii: where do they stand? | Elanany AA, Khalifa AG, Attia AS. | World J Microbiol Biotechnol | 10.1007/s11274-025-04593-3 | 2025 | |
| Rational design of indolyl acrylamides as antibacterial agents targeting multidrug-resistant Acinetobacter baumannii strains. | Dominguez-Mendez VG, Chavez-Santos RM, Carrillo-Jaimes K, Hernandez-Santoyo A, Ramirez-Carreto S, Hernandez-Garcia A, Aguayo-Ortiz R, Ceapa CD, Rivera-Chavez J, Martinez R. | RSC Med Chem | 10.1039/d5md00145e | 2025 | | |
| Deciphering meropenem persistence in Acinetobacter baumannii facilitates discovery of anti-persister activity of thymol. | Hussain A, Bhando T, Casius A, Gupta R, Pathania R. | Antimicrob Agents Chemother | 10.1128/aac.01381-24 | 2025 | | |
| Pathogenicity | High mortality of Acinetobacter baumannii infection is attributed to macrophage-mediated induction of cytokine storm but preventable by naproxen. | Wang H, Xu Q, Heng H, Zhao W, Ni H, Chen K, Wai Chan BK, Tang Y, Xie M, Peng M, Chi Chan EW, Yang G, Chen S. | EBioMedicine | 10.1016/j.ebiom.2024.105340 | 2024 | |
| Dicarboxylate and dicarboxylic acid appended supramolecular self-associating amphiphiles as antimicrobial agents against high priority bacterial pathogens. | White LJ, Streather B, Sutton JM, Rankin J, Baker J, Bennett C, Wilson HB, Hind CK, Hiscock JR. | Org Biomol Chem | 10.1039/d5ob01615k | 2025 | | |
| Human whole blood influences the expression of Acinetobacter baumannii genes related to translation and siderophore production. | Ghavanloughajar H, Elmassry MM, Brown AMV, Hamood AN. | PLoS One | 10.1371/journal.pone.0326330 | 2025 | | |
| Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against Acinetobacter baumannii-calcoaceticus complex strains isolated from respiratory and bloodstream sources: results from ACNBio study. | Buyukyanbolu E, Argotsinger J, Beck ET, Chamberland RR, Clark AE, Daniels AR, Liesman R, Fisher M, Gialanella P, Hand J, Harrington AT, Humphries RM, Huse H, Hamilton-Seth R, Hankins JD, Kufel WD, Riddell SW, Marino J, Westblade LF, Mochon AB, Narayanan N, Kirn TJ, Pierce VM, Potula R, Tekle T, Simner PJ, Tibbetts RJ, Vu C, Abbo LM, Martinez O, Dumm RE, Nicolau DP, Asempa TE, Acinetobacter baumannii Complex National Biorepository (ACNBio) Study Group. | Antimicrob Agents Chemother | 10.1128/aac.00379-25 | 2025 | | |
| Enzymology | Modular, inducible, and titratable expression systems for Escherichia coli and Acinetobacter baumannii. | Bacon EE, Tran JS, Nadig N, Peters JM. | Microbiol Spectr | 10.1128/spectrum.01306-24 | 2024 | |
| The antibacterial capabilities of alginate encapsulated lemon essential oil nanocapsules against multi-drug-resistant Acinetobacter baumannii. | Gholamhossein Tabar Valookolaei FS, Sazegar H, Rouhi L. | Sci Rep | 10.1038/s41598-024-81948-0 | 2025 | | |
| Large-scale combination screens reveal small-molecule sensitization of antibiotic-resistant gram-negative ESKAPE pathogens. | Tse MW, Zhu M, Peters B, Hamami E, Chen J, Davis KP, Nitz S, Weller J, Warrier T, Hunt DK, Morales Y, Kawate T, Gaulin JL, Come JH, Hernandez-Bird J, Huo W, Neisewander I, Yu X, Aceves-Salvador JA, Kiessling LL, Hung DT, Mecsas J, Aldridge BB, Isberg RR, Blainey PC. | Proc Natl Acad Sci U S A | 10.1073/pnas.2402017122 | 2025 | | |
| Manganese-dependent iron-superoxide dismutase drives Acinetobacter baumannii fitness during oxidative stress. | Ray AK, Bhowmik S, Saini S, Hussain A, Bakht P, Pandey S, Pathania R. | J Biol Chem | 10.1016/j.jbc.2025.110549 | 2025 | | |
| Overcoming phage resistance: efficacy of sequential phage-colistin therapy against carbapenem-resistant Acinetobacter baumannii. | Choi Y-J, Shamsuzzaman M, Park C, Kim S, Shin M, Kim J. | Microbiol Spectr | 10.1128/spectrum.00855-25 | 2025 | | |
| Molecular interplay between peptidoglycan integrity and outer membrane asymmetry in maintaining cell envelope homeostasis. | Nandy S, Tehrani AF, Hunt-Serracin AC, Biboy J, Pybus C, Vollmer W, Boll JM. | J Bacteriol | 10.1128/jb.00331-25 | 2025 | | |
| Synthesis and Evaluation of Pyridine-Based Antibacterial Agents that Inhibit ATP Synthase in Acinetobacter baumannii. | Dennison AL, Singh A, Marchlewski TA, Ghee SN, Gencel KC, Hammock AG, Liu S, Wilson S, Williams APL, Ward KT, Meigs TE, Steed PR, Wolfe AL. | ACS Omega | 10.1021/acsomega.5c06380 | 2025 | | |
| The BfmRS stress response protects Acinetobacter baumannii against defects in outer membrane lipoprotein biogenesis. | Marotta J, Zhao A, Rather PN, Grabowicz M. | J Bacteriol | 10.1128/jb.00332-24 | 2025 | | |
| Identification of EppR, a Second Repressor of Error-Prone DNA Polymerase Genes in Acinetobacter baumannii. | Nguyen B, Ching C, MacGuire A, Casula P, Newman C, Finley F, Godoy VG. | Mol Microbiol | 10.1111/mmi.15368 | 2025 | | |
| Phylogeny | Phage Therapy for Acinetobacter baumannii Infections: A Review on Advances in Classification, Applications, and Translational Roadblocks. | Wang Y, Li L, Liang Y, Xu K, Ye Y, He M. | Antibiotics (Basel) | 10.3390/antibiotics14111134 | 2025 | |
| Inter- and intra-bacterial strain diversity remains the "elephant in the (living) room". | Valcek A, Kroger C, de Dios R, McCarthy RR, Coenye T, Trent MS, Karah N, Uhlin BE, Classen AY, Higgins PG, Ebersberger I, Laaberki MH, Charpentier X, Visca P, Rather PN, Van der Henst C. | NPJ Antimicrob Resist | 10.1038/s44259-025-00138-8 | 2025 | | |
| The zinc metalloprotein MigC impacts cell wall biogenesis through interactions with an essential Mur ligase in Acinetobacter baumannii. | Critchlow JM, Rocchio JS, McKell MC, Campbell CJ, Barraza JP, Krystofiak ES, Green ER, Akizuki T, Chazin WJ, VanNieuwenhze MS, Stemmler TL, Giedroc DP, Skaar EP. | PLoS Pathog | 10.1371/journal.ppat.1013209 | 2025 | | |
| Potential of Cannabidiol (CBD) to overcome extensively drug-resistant Acinetobacter baumannii. | Yosboonruang A, Kiddee A, Siriphap A, Pook-In G, Suwancharoen C, Duangjai A, Praphasawat R, Reuk-Ngam N, Nawong S, Rawangkan A. | BMC Complement Med Ther | 10.1186/s12906-025-05056-w | 2025 | | |
| Acinetobacter baumannii transformants expressing oxacillinases and metallo-beta-lactamases that confer resistance to meropenem: new tools for anti-Acinetobacter drug development and AMR preparedness. | Dubey V, Farrington N, Harper N, Johnson A, Horner I, Stevenson A, Parkes A, Hoare L, Das S, Hope W. | Antimicrob Agents Chemother | 10.1128/aac.00222-24 | 2024 | | |
| A chionodracine-derived peptide, KHS-Cnd, as an anti-virulence agent against multidrug-resistant Acinetobacter baumannii clinical strains. | Artini M, Paris I, Imperlini E, Buonocore F, Vrenna G, Papa R, Selan L. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1526246 | 2025 | | |
| The interplay between Acinetobacter baumannii ZigA and SltB promotes zinc homeostasis and cell envelope integrity. | Critchlow JM, Barraza JP, Munneke MJ, Krystofiak E, Green ER, Skaar EP. | Infect Immun | 10.1128/iai.00422-24 | 2025 | | |
| Phylogeny | Phylogenomics, evolution and origin of multidrug-resistant Acinetobacter baumannii ST15. | Abu Sabah E, Tobin LA, Lebreton F, McGann PT, Hamidian M. | Microb Genom | 10.1099/mgen.0.001450 | 2025 | |
| Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates. | El Mrimar N, Belouad EM, Benaissa E, Bssaibis F, Jazouli M, El Alaoui MA, Maleb A, Elouennass M. | Acta Microbiol Immunol Hung | 10.1556/030.2024.02268 | 2024 | | |
| Near-infrared in vivo imaging system for dynamic visualization of lung-colonizing bacteria in mouse pneumonia. | Yamaguchi D, Kamoshida G, Kawakubo S, Azuma S, Tsuji T, Kitada N, Saito-Moriya R, Yamada N, Tanaka R, Okuda A, Ueyama K, Isaka S, Tomita M, Nakano R, Morita Y, Yano H, Maki SA, Yahiro K, Kato S. | Microbiol Spectr | 10.1128/spectrum.00828-24 | 2024 | | |
| Generation and comparison of broad-host range inducible expression vectors for use in Gram-negative bacteria including ESKAPE pathogens. | Ginde RK, Stella NA, Calvario RC, Lehner KM, Callaghan JD, Komlosi DR, Horzempa J, Shanks RMQ. | Proc W Va Acad Sci | 2025 | | ||
| New Antimicrobial Cyclodepsipeptides from a Freshwater Fungus from the Sierra Madre Oriental in Mexico. | Yeverino IR, Bocanegra Sosa TP, Aguilar-Vega L, Garcia-Contreras R, Magana-Gonzalez JL, Figueroa M. | ACS Omega | 10.1021/acsomega.4c10990 | 2025 | | |
| Amino acid competition shapes Acinetobacter baumannii gut carriage. | Ren X, Clark RM, Bansah DA, Varner EN, Tiffany CR, Jaswal K, Geary JH, Todd OA, Winkelman JD, Friedman ES, Jarrett RN, Zemel BS, Wu GD, Zackular JP, DePas WH, Behnsen J, Palmer LD. | Cell Host Microbe | 10.1016/j.chom.2025.07.003 | 2025 | | |
| PmrA Mutations in Drug-Resistant Acinetobacter baumannii Affect Sensor Kinase-Response Regulator Interaction and Phosphotransfer. | Jaimes FE, Hondros AD, Kinkead J, Milton ME, Thompson RJ, Figg AM, Melander C, Cavanagh J. | Microorganisms | 10.3390/microorganisms13112600 | 2025 | | |
| Antibiotic discovery with artificial intelligence for the treatment of Acinetobacter baumannii infections. | Boulaamane Y, Molina Panadero I, Hmadcha A, Atalaya Rey C, Baammi S, El Allali A, Maurady A, Smani Y. | mSystems | 10.1128/msystems.00325-24 | 2024 | | |
| Evolution of One Species Increases Resistance to Invasion in a Simple Synthetic Community. | de Scally SZ, McDonald MJ. | Microb Ecol | 10.1007/s00248-025-02618-w | 2025 | | |
| Genetics | Draft genome sequence of Acinetobacter baumannii Ab10, a clinical isolate from Hospital University Sains Malaysia (HUSM), Malaysia. | Nik Mohd Nazri NZH, Banga Singh KK, Ismail MI. | Microbiol Resour Announc | 10.1128/mra.01084-23 | 2024 | |
| Genetics | Characteristics of a Carbapenem-Resistant Acinetobacter baumannii Strain Causing Community-Acquired Pneumonia in a Young Healthy Women. | Chen Y, Xu L, Wang J. | Infect Drug Resist | 10.2147/idr.s439614 | 2023 | |
| High-throughput single-cell analysis reveals Omp38-specific monoclonal antibodies that protect against Acinetobacter baumannii infection. | Zhang Y, Cheng H, Yu P, Wang S, Dong H, Lu S, Yang R, Li B, Luo J, Mao R, Zhang Z, Qi Y, Chen X, Ding J, He Z, Zhang J, Zhao T, Chen X, Lin R, Li H, Tian Y, Wu Y. | Emerg Microbes Infect | 10.1080/22221751.2024.2437243 | 2025 | | |
| Resensitization to colistin results in rapid and stable recovery of adherence, serum resistance and ompW in Acinetobacter baumannii. | Boral J, Vatansever C, Ozcan G, Keske S, Menekse S, Gonen M, Can F. | PLoS One | 10.1371/journal.pone.0309307 | 2024 | | |
| Enzymology | Evolution of carbapenemase activity in the class C beta-lactamase ADC-1. | Stewart NK, Toth M, Bhattacharya M, Smith CA, Vakulenko SB. | mBio | 10.1128/mbio.00185-25 | 2025 | |
| Pathogenicity | Characterization of the Diversity in Host Range of an Extensively Drug-Resistant (XDR) Type IV Secretion System-Encoding Plasmid in Acinetobacter. | Martz K, Alomar D, Karim M, Knezevic S, D'Costa VM. | Pathogens | 10.3390/pathogens14060606 | 2025 | |
| Repression of Acinetobacter baumannii DNA damage response requires DdrR-assisted binding of UmuDAb dimers to atypical SOS box. | Candra B, Cook D, Hare J. | J Bacteriol | 10.1128/jb.00432-23 | 2024 | | |
| Genetics | Secondary bacterial infections of Carbapenem-Resistant Acinetobacter baumannii in patients with COVID-19 admitted to Chinese ICUs. | Chen F, Lin J, Yang W, Chen J, Qian X, Yan T, Liu X, Lu Y, Chen Q. | BMC Microbiol | 10.1186/s12866-025-04032-1 | 2025 | |
| Genetics | Comparative Genomic Analysis of Tigecycline Resistance Development in Clinical Acinetobacter baumannii Isolates. | Li X, Liu J, Zhang X, Li J, Xuan L, Yuan S, Li J, Sun Y, Du X. | Infect Drug Resist | 10.2147/idr.s539267 | 2025 | |
| History shapes regulatory and evolutionary responses to tigecycline in two reference strains of Acinetobacter baumannii. | Rokes AB, Santos-Lopez A, Cooper VS. | Microbiology (Reading) | 10.1099/mic.0.001570 | 2025 | | |
| Synergistic Antimicrobial Effects of Phage vB_AbaSi_W9 and Antibiotics against Acinetobacter baumannii Infection. | Choi YJ, Kim S, Shin M, Kim J. | Antibiotics (Basel) | 10.3390/antibiotics13070680 | 2024 | | |
| Prevalence and characteristics of tigecycline- and carbapenem-resistant adeN-truncated Acinetobacter baumannii: a genomic epidemiological analysis. | Zhang Y, Zhou B, Kong J, Hu P, Liu H, Zhao D, Ye J, Fu Q, Zhou T, Qian C. | Antimicrob Agents Chemother | 10.1128/aac.01843-24 | 2025 | | |
| TagP, a PAAR-domain containing protein, plays roles in the fitness and virulence of Acinetobacter baumannii. | Li Y, Cui Y, Song K, Shen L, Xiao L, Jin J, Zhao Y, Yan Y, Zhao S, Yao W, Wang S, Du Z, Yang R, Yi B, Song Y. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1379106 | 2024 | | |
| A Novel Truncated CHAP Modular Endolysin, CHAPSAP26-161, That Lyses Staphylococcus aureus, Acinetobacter baumannii, and Clostridioides difficile, and Exhibits Therapeutic Effects in a Mouse Model of A. baumannii Infection. | Choi YJ, Kim S, Dahal RH, Kim J. | J Microbiol Biotechnol | 10.4014/jmb.2402.02042 | 2024 | | |
| Genetics | Genomic characterization of multidrug-resistant clinical Acinetobacter baumannii isolates from a hospital in Paraguay. | Sanchez-Urtaza S, Alfonso-Alarcon L, Arazo Del Pino R, Burgwinkel T, Ocampo-Sosa A, Gonzalez R, Xanthopoulou K, Higgins PG, Alkorta I, Gallego L. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1620479 | 2025 | |
| Pathogenicity | Recent advances in host models in studying virulence factors and pathogenesis of Acinetobacter baumannii. | Garomsa TL, Shenkutie AM, Leung PHM. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1715193 | 2025 | |
| DNA damage response coregulator ddrR affects many cellular pathways and processes in Acinetobacter baumannii 17978. | Cook D, Flannigan MD, Chariker JH, Hare JM. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1324091 | 2023 | | |
| Indole derivatives display antimicrobial and antibiofilm effects against extensively drug-resistant Acinetobacter baumannii. | Li J, Xie L, Lin F, Ling B. | Microbiol Spectr | 10.1128/spectrum.03388-24 | 2025 | | |
| Impact of AbaI mutation on virulence, biofilm development, and antibiotic susceptibility in Acinetobacter baumannii. | Pumirat P, Santajit S, Tunyong W, Kong-Ngoen T, Tandhavanant S, Lohitthai S, Rungruengkitkun A, Chantratita N, Ampawong S, Reamtong O, Indrawattana N. | Sci Rep | 10.1038/s41598-024-72740-1 | 2024 | | |
| Acinetobacter baumannii biofilm was inhibited by tryptanthrin through disrupting its different stages and genes expression. | Guo T, Zhou N, Yang L, Wang Z, Huan C, Lin T, Bao G, Hu J, Li G. | iScience | 10.1016/j.isci.2024.109942 | 2024 | | |
| Exploring the metabolic profile of A. baumannii for antimicrobial development using genome-scale modeling. | Leonidou N, Xia Y, Friedrich L, Schutz MS, Drager A. | PLoS Pathog | 10.1371/journal.ppat.1012528 | 2024 | | |
| Genetic synergy between Acinetobacter baumannii undecaprenyl phosphate biosynthesis and the Mla system impacts cell envelope and antimicrobial resistance. | Noel HR, Keerthi S, Ren X, Winkelman JD, Troutman JM, Palmer LD. | mBio | 10.1128/mbio.02804-23 | 2024 | | |
| Isolation and Characterization of Novel Bacteriophages to Target Carbapenem-Resistant Acinetobacter baumannii. | Choi YJ, Kim S, Shin M, Kim J. | Antibiotics (Basel) | 10.3390/antibiotics13070610 | 2024 | | |
| Characterization of the Zinc Uptake Repressor (Zur) from Acinetobacter baumannii. | Kim M, Le MT, Fan L, Campbell C, Sen S, Capdevila DA, Stemmler TL, Giedroc DP. | Biochemistry | 10.1021/acs.biochem.3c00679 | 2024 | | |
| Emergence of tet(X2) in Acinetobacter pittii confers clinical resistance to tigecycline. | Qian C, Ma Z, Feng L, Guo W, Han Y, Zhang Y, Xu C, Cao J, Zhou T. | J Antimicrob Chemother | 10.1093/jac/dkad133 | 2023 | | |
| The novel polymyxin analogue SPR206 exhibits higher activity than colistin against both colistin-susceptible and colistin-resistant strains of Acinetobacter baumannii. | Outeda-Garcia M, Garcia-Pose A, Guijarro-Sanchez P, Rodriguez-Coello A, Baez-Barroso GA, Maceiras R, Alonso-Garcia I, Arca-Suarez J, Vazquez-Ucha JC, Bou G, Beceiro A, Spanish National Acinetobacter spp. 2020 Study Group. | Antimicrob Agents Chemother | 10.1128/aac.01940-24 | 2025 | | |
| Contribution of RND superfamily multidrug efflux pumps AdeABC, AdeFGH, and AdeIJK to antimicrobial resistance and virulence factors in multidrug-resistant Acinetobacter baumannii AYE. | Xie L, Li J, Peng Q, Liu X, Lin F, Dai X, Ling B. | Antimicrob Agents Chemother | 10.1128/aac.01858-24 | 2025 | | |
| Genome Sequence of Clinical Acinetobacter baumannii Strain V15. | Permingeat V, Perez Mora B, Torres Manno M, Giordano R, Arana N, Muller G, Krasauskas R, Mussi MA. | Microbiol Resour Announc | 10.1128/mra.00169-23 | 2023 | | |
| Nosocomial transmission of tet(x3), bla NDM-1 and bla OXA-97-carrying Acinetobacter baumannii conferring resistance to eravacycline and omadacycline, the Netherlands, March to August 2021. | Talsma DT, Monteiro R, Flores-Vallejo RDC, Heuvelmans M, Le TN, Hendrickx AP, Rosema S, Maat I, van Dijl JM, Bathoorn E. | Euro Surveill | 10.2807/1560-7917.es.2024.29.28.2400019 | 2024 | | |
| Genetics | Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolated from Bloodstream Infections in South Korea. | Jeon WJ, Kim YJ, Seo JH, Yoo JS, Moon DC. | Antibiotics (Basel) | 10.3390/antibiotics13121124 | 2024 | |
| Genetics | Experimental evolution under different nutritional conditions changes the genomic architecture and virulence of Acinetobacter baumannii. | Yun S, Min J, Han S, Sim HS, Kim SK, Lee JB, Yoon JW, Yeom J, Park W. | Commun Biol | 10.1038/s42003-024-06978-w | 2024 | |
| Natural peptides and their synthetic congeners acting against Acinetobacter baumannii through the membrane and cell wall: latest progress. | Kumar G. | RSC Med Chem | 10.1039/d4md00745j | 2025 | | |
| In Vitro Antibacterial Efficacy of Recombinant Phage-Derived Endolysin LysTAC1 Against Carbapenem-Resistant Acinetobacter baumannii. | Ullah I, Cui S, Yan Q, Ullah H, Sha S, Ma Y. | Antibiotics (Basel) | 10.3390/antibiotics14100975 | 2025 | | |
| The Development of a CRISPR-FnCpf1 System for Large-Fragment Deletion and Multiplex Gene Editing in Acinetobacter baumannii. | Wang S, Ding Y, Rong H, Wang Y. | Curr Issues Mol Biol | 10.3390/cimb46010037 | 2024 | | |
| Mutation in the two-component regulator BaeSR mediates cefiderocol resistance and enhances virulence in Acinetobacter baumannii. | Liu X, Chang Y, Xu Q, Zhang W, Huang Z, Zhang L, Weng S, Leptihn S, Jiang Y, Yu Y, Hua X. | mSystems | 10.1128/msystems.01291-22 | 2023 | | |
| AamA-mediated epigenetic control of genome-wide gene expression and phenotypic traits in Acinetobacter baumannii ATCC 17978. | Yang J, Son Y, Kang M, Park W. | Microb Genom | 10.1099/mgen.0.001093 | 2023 | | |
| Role of peptidoglycan recycling enzymes AmpD and AnmK in Acinetobacter baumannii virulence features. | Tajuelo A, Terron MC, Lopez-Siles M, McConnell MJ. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.1064053 | 2022 | | |
| Quinoline ATP Synthase Inhibitors with Activity Against Multidrug Resistant Acinetobacter baumannii and Pseudomonas aeruginosa. | Ward KT, Williams APL, Dennison AL, Aamir L, Allen DL, Chavez-Arellano B, Marchlewski TA, Zappia ML, Wolfe AL, Steed PR. | ChemMedChem | 10.1002/cmdc.202400952 | 2025 | | |
| Proteome | The Mechanism of Tigecycline Resistance in Acinetobacter baumannii under Sub-Minimal Inhibitory Concentrations of Tigecycline. | Liu C, Liu J, Lu Q, Wang P, Zou Q. | Int J Mol Sci | 10.3390/ijms25031819 | 2024 | |
| Hijacking the epigenetic mechanisms of A. baumannii. | Smiline Girija SA. | Mol Biol Res Commun | 10.22099/mbrc.2024.48801.1899 | 2024 | | |
| The versatile synthesis and biological evaluation of all-alkyl biscationic quaternary phosphonium compounds: atom-economical and potent disinfectants. | McDonough D, Bezold EL, Wuest WM, Minbiole KPC. | RSC Med Chem | 10.1039/d5md00660k | 2025 | | |
| Genetics | Hybrid Genome and Clinical Impact of Emerging Extensively Drug-Resistant Priority Bacterial Pathogen Acinetobacter baumannii in Saudi Arabia. | Borgio JF. | Life (Basel) | 10.3390/life15071094 | 2025 | |
| Genetics | Identification and genome-wide analysis provide insights into the genetic diversity and biotechnological potentials of novel cold-adapted Acinetobacter strain. | Kayani H, Rasheed MA, Alonazi WB, Jamil F, Hussain A, Yan C, Ahmed R, Ibrahim M. | Extremophiles | 10.1007/s00792-023-01301-7 | 2023 | |
| Unveiling the role of adhesin proteins in controlling Acinetobacter baumannii infections: a systematic review. | Pereira IL, Hartwig DD. | Infect Immun | 10.1128/iai.00348-24 | 2025 | | |
| Enzymology | Phenotypic Characterization of pilA, pilB, and pilD Mutants of Acinetobacter baumannii 5075: Impacts on Growth, Biofilm Formation, and Tazobactam Response | Salinas J, Gordesli-Duatepe F, Diaz-Sanchez A, Abu-Lail N. | Antibiotics (Basel) | 2025 | | |
| Isolation and identification of a newly discovered broad-spectrum Acinetobacter baumannii phage and therapeutic validation against pan-resistant Acinetobacter baumannii. | Lin M, Xiong L, Li W, Xiao L, Zhang W, Zhao X, Zheng Y. | Virol Sin | 10.1016/j.virs.2025.06.003 | 2025 | | |
| In Vivo Emergence of Pandrug-Resistant Acinetobacter baumannii Strain: Comprehensive Resistance Characterization and Compassionate Use of Sulbactam-Durlobactam. | VanNatta M, Grier L, Khan MH, Pinargote Cornejo P, Alam M, Moussa SH, Smith JG, Aitken SL, Malek AE. | Open Forum Infect Dis | 10.1093/ofid/ofad504 | 2023 | | |
| Lysine Trimethylation in Planktonic and Pellicle Modes of Growth in Acinetobacter baumannii. | Nalpas N, Kentache T, De E, Hardouin J. | J Proteome Res | 10.1021/acs.jproteome.3c00097 | 2023 | | |
| Genetics | Analysis of multidrug-resistant determinants of clinically isolated Acinetobacter baumannii CYZ via whole genome sequencing. | Chuai X, Zhou Y, Feng J, Yu M, Wu Y, Han L, Zhao Y, Qiao H, Gao Z, Li J, Xie L, Zhao W, Wang C. | Microbiol Immunol | 10.1111/1348-0421.13087 | 2023 | |
| Enhancing effect of natural adjuvant, panduratin A, on antibacterial activity of colistin against multidrug-resistant Acinetobacter baumannii. | Thadtapong N, Chaturongakul S, Napaswad C, Dubbs P, Soodvilai S. | Sci Rep | 10.1038/s41598-024-60627-0 | 2024 | | |
| Acinetobacter baumannii under Acidic Conditions Induces Colistin Resistance through PmrAB Activation and Lipid A Modification. | Ko SY, Kim N, Park SY, Kim SY, Shin M, Lee JC. | Antibiotics (Basel) | 10.3390/antibiotics12050813 | 2023 | | |
| Comprehensive Approaches to Combatting Acinetobacter baumannii Biofilms: From Biofilm Structure to Phage-Based Therapies. | Grygiel I, Bajrak O, Wojcicki M, Krusiec K, Jonczyk-Matysiak E, Gorski A, Majewska J, Letkiewicz S. | Antibiotics (Basel) | 10.3390/antibiotics13111064 | 2024 | | |
| Transcriptome | Hfq balances energetic efficiency and antibiotic persistence in Acinetobacter baumannii. | Sett A, Hussain A, Tomar S, Ray AK, Pathania R. | mSystems | 10.1128/msystems.00320-25 | 2025 | |
| Carbapenem Resistance in Acinetobacter baumannii: Mechanisms, Therapeutics, and Innovations. | de Souza J, D'Espindula HRS, Ribeiro IF, Goncalves GA, Pillonetto M, Faoro H. | Microorganisms | 10.3390/microorganisms13071501 | 2025 | | |
| Brevicidine acts as an effective sensitizer of outer membrane-impermeable conventional antibiotics for Acinetobacter baumannii treatment. | Zhong X, Deng K, Yang X, Song X, Zou Y, Zhou X, Tang H, Li L, Fu Y, Yin Z, Wan H, Zhao X. | Front Microbiol | 10.3389/fmicb.2023.1304198 | 2023 | | |
| Metabolism | Lactate metabolism promotes in vivo fitness during Acinetobacter baumannii infection. | Morris FC, Jiang Y, Fu Y, Kostoulias X, Murray GL, Yu Y, Peleg AY. | FEMS Microbiol Lett | 10.1093/femsle/fnae032 | 2024 | |
| Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against Acinetobacter baumannii. | Roson-Calero N, Lucas J, Gomis-Font MA, de Pedro-Jove R, Oliver A, Balleste-Delpierre C, Vila J. | Antibiotics (Basel) | 10.3390/antibiotics13121147 | 2024 | | |
| Pathogenicity and virulence of Acinetobacter baumannii: Factors contributing to the fitness in healthcare settings and the infected host. | Lucidi M, Visaggio D, Migliaccio A, Capecchi G, Visca P, Imperi F, Zarrilli R. | Virulence | 10.1080/21505594.2023.2289769 | 2024 | | |
| Light scattering-based screening method for rapid evaluating antibiotic effects on bacteria using laser speckle imaging. | Kim D, Moon S, Lee J, Cho K, Lee C, Yoon J. | J Biol Eng | 10.1186/s13036-025-00542-8 | 2025 | | |
| Biotechnology | Antimicrobial and anti-virulence activities of 4-shogaol from grains of paradise against gram-negative bacteria: Integration of experimental and computational methods. | Koshak AE, Okairy HM, Elfaky MA, Abdallah HM, Mohamed GA, Ibrahim SRM, Alzain AA, Abulfaraj M, Hegazy WAH, Nazeih SI. | J Ethnopharmacol | 10.1016/j.jep.2023.117611 | 2024 | |
| Mutations in the proximal binding site and F-loop of AdeJ confer resistance to efflux pump inhibitors. | Saral Sariyer A, Leus IV, Tambat R, Farjana M, Olvera M, Rukmani SJ, Sariyer E, Smith JC, Parks JM, Walker JK, Zgurskaya HI. | Antimicrob Agents Chemother | 10.1128/aac.00090-25 | 2025 | | |
| Genetic Characterization of Multidrug-Resistant Acinetobacter baumannii and Synergy Assessment of Antimicrobial Combinations. | Luna-De-Alba A, Flores-Trevino S, Camacho-Ortiz A, Contreras-Cordero JF, Bocanegra-Ibarias P. | Antibiotics (Basel) | 10.3390/antibiotics13111079 | 2024 | | |
| The role of Acinetobacter baumannii CarO outer membrane protein in carbapenems influx. | Sariyer E. | Res Microbiol | 10.1016/j.resmic.2022.103966 | 2022 | | |
| Collateral Changes in Cell Physiology Associated with ADC-7 beta-Lactamase Expression in Acinetobacter baumannii. | Colquhoun JM, Farokhyfar M, Anderson AC, Bethel CR, Bonomo RA, Clarke AJ, Rather PN. | Microbiol Spectr | 10.1128/spectrum.04646-22 | 2023 | | |
| Chemical genomics informs antibiotic and essential gene function in Acinetobacter baumannii. | Tran JS, Ward RD, Iruegas-Lopez R, Ebersberger I, Peters JM. | PLoS Genet | 10.1371/journal.pgen.1011642 | 2025 | | |
| A phosphorylation signal activates genome-wide transcriptional control by BfmR, the global regulator of Acinetobacter resistance and virulence. | Raustad N, Dai Y, Iinishi A, Mohapatra A, Soo MW, Hay E, Hernandez GM, Geisinger E. | Nucleic Acids Res | 10.1093/nar/gkaf063 | 2025 | | |
| The critical human pathogen Acinetobacter baumannii exhibits light-regulated circadian rhythms. | Permingeat V, Perez Mora BE, Migliori ML, Arana N, Fernandez J, Allasia MB, Lamberti ML, Di Venanzio G, Rodriguez RE, Feldman MF, Golombek DA, Mussi MA. | Commun Biol | 10.1038/s42003-025-08732-2 | 2025 | | |
| BaeR and H-NS control CRISPR-Cas-mediated immunity and virulence in Acinetobacter baumannii. | Yu T, Xie J, Huang X, Huang J, Bao G, Yuan W, Gao C, Liu C, Hu J, Yang W, Li G. | mSystems | 10.1128/msystems.01067-25 | 2025 | | |
| Vitamin D and vitamin K1 as novel inhibitors of biofilm in Gram-negative bacteria. | Lutfi LL, Shaaban MI, Elshaer SL. | BMC Microbiol | 10.1186/s12866-024-03293-6 | 2024 | | |
| Farnesol repurposing for prevention and treatment of Acinetobacter baumannii biofilms. | Tan L, Ma R, Katz AJ, Levi N. | Biofilm | 10.1016/j.bioflm.2024.100198 | 2024 | | |
| Phenotype | Phenotypic Characterization and Heterogeneity among Modern Clinical Isolates of Acinetobacter baumannii. | Valcek A, Philippe C, Whiteway C, Robino E, Nesporova K, Bove M, Coenye T, De Pooter T, De Coster W, Strazisar M, Van der Henst C. | Microbiol Spectr | 10.1128/spectrum.03061-22 | 2023 | |
| Phylogeny | Genomics of Acinetobacter baumannii iron uptake. | Artuso I, Poddar H, Evans BA, Visca P. | Microb Genom | 10.1099/mgen.0.001080 | 2023 | |
| Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in Acinetobacter baumannii. | Cho H, Sondak T, Kim KS. | Pharmaceutics | 10.3390/pharmaceutics15041251 | 2023 | | |
| Phenotype | A panel of genotypically and phenotypically diverse clinical Acinetobacter baumannii strains for novel antibiotic development. | Sun C, Zhou D, He J, Liu H, Fu Y, Zhou Z, Leptihn S, Yu Y, Hua X, Xu Q. | Microbiol Spectr | 10.1128/spectrum.00086-24 | 2024 | |
| Targeting the phosphatidylglycerol lipid: An amphiphilic dendrimer as a promising antibacterial candidate. | Zhang N, Dhumal D, Kuo SH, Lew SQ, Patil PD, Taher R, Vaidya S, Galanakou C, Elkihel A, Oh MW, Chong SY, Marson D, Zheng J, Rouvinski O, Abolarin WO, Pricl S, Lau GW, Lee LTO, Peng L. | Sci Adv | 10.1126/sciadv.adn8117 | 2024 | | |
| Acinetobacter baumannii ATCC 17978 encodes a microcin system with antimicrobial properties for contact-independent competition. | Bisaro F, Shuman HA, Feldman MF, Gebhardt MJ, Pukatzki S. | Microbiology (Reading) | 10.1099/mic.0.001346 | 2023 | | |
| Poly-beta-D-(1,6)-N-acetyl-glucosamine (PNAG) glycan vaccines with broad spectrum neutralizing activities | Liao K, Kao M, Ma T, Hsu M, Chen T, Imre B, Harris P, Shie J, Chiu C, Wu C, Hsieh Y. | Nat Commun | 2025 | | ||
| Regulation of antibiotic persistence and pathogenesis in Acinetobacter baumannii by glutamate and histidine metabolic pathways. | Sim HS, Kwon YK, Song H, Hwang GS, Yeom J. | BMC Microbiol | 10.1186/s12866-024-03654-1 | 2025 | | |
| Mystery of the Passerini Reaction for the Synthesis of the Antimicrobial Peptidomimetics against Nosocomial Pathogenic Bacteria. | Wavhal DS, Koszelewski D, Gulko C, Kowalczyk P, Brodzka A, Kramkowski K, Ostaszewski R. | Int J Mol Sci | 10.3390/ijms25158330 | 2024 | | |
| The crystal structure of Acinetobacter baumannii bacterioferritin reveals a heteropolymer of bacterioferritin and ferritin subunits. | Yao H, Alli S, Liu L, Soldano A, Cooper A, Fontenot L, Verdin D, Battaile KP, Lovell S, Rivera M. | Sci Rep | 10.1038/s41598-024-69156-2 | 2024 | | |
| Type IV Pilus-Mediated Inhibition of Acinetobacter baumannii Biofilm Formation by Phenothiazine Compounds. | Vo N, Sidner BS, Yu Y, Piepenbrink KH. | Microbiol Spectr | 10.1128/spectrum.01023-23 | 2023 | | |
| Comparative Transcriptomic Profiling of Pellicle and Planktonic Cells from Carbapenem-Resistant Acinetobacter baumannii. | Ng HK, Puah SM, Teh CSJ, Idris N, Chua KH. | Antibiotics (Basel) | 10.3390/antibiotics12071185 | 2023 | | |
| Characterizing the role of phosphatidylglycerol-phosphate phosphatases in Acinetobacter baumannii cell envelope biogenesis and antibiotic resistance. | Zang M, Ascari A, Adams FG, Alquethamy S, Eijkelkamp BA. | Cell Surf | 10.1016/j.tcsw.2022.100092 | 2023 | | |
| Antibacterial, antibiofilm and anti-quorum sensing activities of 1,2,3,5-tetrazine derivatives linked to a benzothiazole moiety | Dzoyem J, Tsemeugne J, Pone Kamdem B, Foyou Meupiap R, Kuate B, Mkounga P, Fekam Boyom F, McGaw L. | PLoS One | 2025 | | ||
| CsrA-mediated regulation of a virulence switch in Acinetobacter baumannii. | Singh R, Perez-Varela M, Colquhoun JM, Kroger C, Hamrock FJ, Shaibah A, Neidle EL, Rather PN. | mBio | 10.1128/mbio.04058-24 | 2025 | | |
| A comprehensive investigation of the anion inhibition profile of a beta-carbonic anhydrase from Acinetobacter baumannii for crafting innovative antimicrobial treatments. | De Luca V, Giovannuzzi S, Supuran CT, Capasso C. | J Enzyme Inhib Med Chem | 10.1080/14756366.2024.2372731 | 2024 | | |
| In vitro and in vivo evaluation of two combined beta-lactamase inhibitors against carbapenem-resistant Acinetobacter baumannii. | Dominguez AV, Panadero IM, Smani Y. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-023-04664-z | 2023 | | |
| Characterization of the diversity of type IV secretion system-encoding plasmids in Acinetobacter. | Nasser F, Gaudreau A, Lubega S, Zaker A, Xia X, Mer AS, D'Costa VM. | Emerg Microbes Infect | 10.1080/22221751.2024.2320929 | 2024 | | |
| Pathogenicity | Mobilizable shuttle vectors with fluorescent markers functional across different species of bacteria. | Armstrong ZR, Alonso J, Stanton V, Patel N, Zogaj X, Cocioba SS, Klose KE. | Appl Environ Microbiol | 10.1128/aem.00045-25 | 2025 | |
| Bushy-Tailed Multicationic Quaternary Phosphonium Compounds: Potent Amphiphilic Disinfectants with Promising Therapeutic Indices. | Rachii D, Bezold EL, Wuest WM, Minbiole KPC. | ChemMedChem | 10.1002/cmdc.202400546 | 2025 | | |
| Acinetobacter baumannii Clinical Isolates Resist Complement-Mediated Lysis by Inhibiting the Complement Cascade and Improperly Depositing MAC. | Magda M, Boschloo W, Bettoni S, Fairley D, Russo TA, Giske CG, Tellapragada C, Rooijakkers SHM, Riesbeck K, Blom AM. | J Innate Immun | 10.1159/000543664 | 2025 | | |
| Fibrous matrices facilitate pleurocidin killing of wound associated bacterial pathogens. | Ramos C, Lorenz K, Putrins M, Hind CK, Meos A, Laidmae I, Tenson T, Sutton JM, Mason AJ, Kogermann K. | Eur J Pharm Sci | 10.1016/j.ejps.2023.106648 | 2024 | | |
| DksA is a conserved master regulator of stress response in Acinetobacter baumannii. | Maharjan RP, Sullivan GJ, Adams FG, Shah BS, Hawkey J, Delgado N, Semenec L, Dinh H, Li L, Short FL, Parkhill J, Paulsen IT, Barquist L, Eijkelkamp BA, Cain AK. | Nucleic Acids Res | 10.1093/nar/gkad341 | 2023 | | |
| Independent component analysis reveals 49 independently modulated gene sets within the global transcriptional regulatory architecture of multidrug-resistant Acinetobacter baumannii. | Menon ND, Poudel S, Sastry AV, Rychel K, Szubin R, Dillon N, Tsunemoto H, Hirose Y, Nair BG, Kumar GB, Palsson BO, Nizet V. | mSystems | 10.1128/msystems.00606-23 | 2024 | | |
| Inhibition of biofilm formation and preformed biofilm in Acinetobacter baumannii by resveratrol, chlorhexidine and benzalkonium: modulation of efflux pump activity. | Migliaccio A, Stabile M, Triassi M, De E, De Gregorio E, Zarrilli R. | Front Microbiol | 10.3389/fmicb.2024.1494772 | 2024 | | |
| Engineering of lysin by fusion of antimicrobial peptide (cecropin A) enhances its antibacterial properties against multidrug-resistant Acinetobacter baumannii. | Islam MM, Kim D, Kim K, Park SJ, Akter S, Kim J, Bang S, Kim S, Kim J, Lee JC, Hong CW, Shin M. | Front Microbiol | 10.3389/fmicb.2022.988522 | 2022 | | |
| Synergistic Antimicrobial Effect of Colistin in Combination with Econazole against Multidrug-Resistant Acinetobacter baumannii and Its Persisters. | Xie M, Chen K, Chan EW, Chen S. | Microbiol Spectr | 10.1128/spectrum.00937-22 | 2022 | | |
| Evaluation of Antibacterial Activity against Nosocomial Pathogens of an Enzymatically Derived alpha-Aminophosphonates Possessing Coumarin Scaffold. | Kowalczyk P, Koszelewski D, Brodzka A, Kramkowski K, Ostaszewski R. | Int J Mol Sci | 10.3390/ijms241914886 | 2023 | | |
| The response to desiccation in Acinetobacter baumannii. | Lucidi M, Capecchi G, Spagnoli C, Basile A, Artuso I, Persichetti L, Fardelli E, Capellini G, Visaggio D, Imperi F, Rampioni G, Leoni L, Visca P. | Virulence | 10.1080/21505594.2025.2490209 | 2025 | | |
| In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals. | Iovleva A, McElheny CL, Fowler EL, Cober E, Herc ES, Arias CA, Hill C, Baum K, Fowler VG, Chambers HF, Greenwood-Quaintance KE, Patel R, van Duin D, Bonomo RA, Doi Y. | Antimicrob Agents Chemother | 10.1128/aac.01258-23 | 2024 | | |
| Value of T6SS Core Gene hcp in Acinetobacter baumannii Respiratory Tract Infection. | Hu YY, Chen S, Zhang YD, Lu QW, Wang F, Ren A, Liu CX. | Indian J Microbiol | 10.1007/s12088-023-01083-8 | 2023 | | |
| Loss of a Branch Sugar in the Acinetobacter baumannii K3-Type Capsular Polysaccharide Due To Frameshifts in the gtr6 Glycosyltransferase Gene Leads To Susceptibility To Phage APK37.1. | Timoshina OY, Kasimova AA, Shneider MM, Arbatsky NP, Shashkov AS, Shelenkov AA, Mikhailova YV, Popova AV, Hall RM, Knirel YA, Kenyon JJ. | Microbiol Spectr | 10.1128/spectrum.03631-22 | 2023 | | |
| Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability. | Stracquadanio S, Bonomo C, Marino A, Bongiorno D, Privitera GF, Bivona DA, Mirabile A, Bonacci PG, Stefani S. | Microbiol Spectr | 10.1128/spectrum.02347-22 | 2022 | | |
| Acinetobacter type VI secretion system comprises a non-canonical membrane complex. | Kandolo O, Cherrak Y, Filella-Merce I, Le Guenno H, Kosta A, Espinosa L, Santucci P, Verthuy C, Lebrun R, Nilges M, Pellarin R, Durand E. | PLoS Pathog | 10.1371/journal.ppat.1011687 | 2023 | | |
| Elongation factor P modulates Acinetobacter baumannii physiology and virulence as a cyclic dimeric guanosine monophosphate effector. | Guo Q, Cui B, Wang M, Li X, Tan H, Song S, Zhou J, Zhang LH, Deng Y. | Proc Natl Acad Sci U S A | 10.1073/pnas.2209838119 | 2022 | | |
| Insights into Acinetobacter baumannii AMA205's Unprecedented Antibiotic Resistance. | Traglia GM, Pasteran F, Moheb S, Akhtar U, Gonzalez S, Maldonado C, Furtado N, Mohamed A, Escalante J, Tuttobene MR, Quillen A, Fontan C, Albornoz E, Corso A, Bonomo RA, Rao GG, Tolmasky ME, Ramirez MS. | Int J Mol Sci | 10.3390/ijms252111424 | 2024 | | |
| Polymyxins retain in vitro activity and in vivo efficacy against "resistant" Acinetobacter baumannii strains when tested in physiological conditions. | Rubio J, Yan J, Miller S, Cheng J, Li R, Builta Z, Aoyagi K, Fisher M, She R, Spellberg B, Luna B. | Antimicrob Agents Chemother | 10.1128/aac.00725-24 | 2024 | | |
| Structural Basis of PER-1-Mediated Cefiderocol Resistance and Synergistic Inhibition of PER-1 by Cefiderocol in Combination with Avibactam or Durlobactam in Acinetobacter baumannii. | Liu X, Lei T, Yang Y, Zhang L, Liu H, Leptihn S, Yu Y, Hua X. | Antimicrob Agents Chemother | 10.1128/aac.00828-22 | 2022 | | |
| Resistance mechanisms for Gram-negative bacteria-specific lipopeptides, turnercyclamycins, differ from that of colistin. | Lim AL, Miller BW, Lin Z, Fisher MA, Barrows LR, Haygood MG, Schmidt EW. | Microbiol Spectr | 10.1128/spectrum.02306-23 | 2023 | | |
| Non-thermal obliteration of critically ranked carbapenem-resistant Acinetobacter baumannii and its resistance gene in a batch atmospheric plasma reactor. | Mosaka TBM, Unuofin JO, Daramola MO, Tizaoui C, Iwarere SA. | Environ Sci Pollut Res Int | 10.1007/s11356-024-34475-4 | 2024 | | |
| Two classes of DNA gyrase inhibitors elicit distinct evolutionary trajectories toward resistance in gram-negative pathogens. | Leyn SA, Kent JE, Zlamal JE, Elane ML, Vercruysse M, Osterman AL. | NPJ Antimicrob Resist | 10.1038/s44259-024-00021-y | 2024 | | |
| OXA beta-lactamases from Acinetobacter spp. are membrane bound and secreted into outer membrane vesicles. | Capodimonte L, Meireles FTP, Bahr G, Bonomo RA, Dal Peraro M, Lopez C, Vila AJ. | mBio | 10.1128/mbio.03343-24 | 2025 | | |
| Molecular Epidemiology and Genetic Characterization of Carbapenem-Resistant Acinetobacter baumannii Isolates from the ICU of a Tertiary Hospital in East China. | Liu L, Huang Y, Wang Y, Jiang Y, Liu K, Pei Z, Li Z, Zhu Y, Liu D, Li X. | Infect Drug Resist | 10.2147/idr.s491858 | 2024 | | |
| Clinical and microbiological features of a cohort of patients with Acinetobacter baumannii bloodstream infections. | Wu C, Yuan Y, Tang S, Liu C, He C. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-024-04881-0 | 2024 | | |
| Exploiting human immune repertoire transgenic mice for protective monoclonal antibodies against antimicrobial resistant Acinetobacter baumannii. | Baker S, Krishna A, Higham S, Naydenova P, O'Leary S, Scott JB, Harcourt K, Forrest S, Goulding D, Thi Nguyen TN, Toan ND, Alekseeva E, Zhou Q, Andreozzi I, Sobotic B, Craig H, Wong V, Forrest-Owen N, Sanchez DM, Pearce C, Roberts L, Watson S, Clare S, Torok ME, Dougan G, Kellam P, Tregoning JS, Reece ST. | Nat Commun | 10.1038/s41467-024-52357-8 | 2024 | | |
| Functionalised Mesoporous Silica Thin Films as ROS-Generating Antimicrobial Coatings | Laskowska M, Kowalczyk P, Karczmarska A, Pogoda K, Zubko M, Laskowski L. | Int J Mol Sci | 2025 | | ||
| A bacterial methyltransferase that initiates biotin synthesis, an attractive anti-ESKAPE druggable pathway. | Su Z, Zhang W, Shi Y, Cui T, Xu Y, Yang R, Huang M, Zhou C, Zhang H, Lu T, Qu J, He ZG, Gan J, Feng Y. | Sci Adv | 10.1126/sciadv.adp3954 | 2024 | | |
| Identification of determinants that allow maintenance of high-level fluoroquinolone resistance in Acinetobacter baumannii. | Hamami E, Huo W, Hernandez-Bird J, Castaneda A, Bai J, Syal S, Ortiz-Marquez JC, van Opijnen T, Geisinger E, Isberg RR. | mBio | 10.1128/mbio.03221-24 | 2025 | | |
| Acinetobacter baumannii Survival under Infection-Associated Stresses Depends on the Expression of Resistance-Nodulation-Division and Major Facilitator Superfamily Efflux Pumps. | Leus IV, Olvera M, Adamiak JW, Nguyen LL, Zgurskaya HI. | Antibiotics (Basel) | 10.3390/antibiotics13010007 | 2023 | | |
| Development of acute Pseudomonas aeruginosa and Acinetobacter baumannii lung mono-challenge models in mice using oropharyngeal aspiration. | Jurado-Martin I, Ma C, Rezk N, Sainz-Mejias M, Hou Y, Baugh JA, McClean S. | Access Microbiol | 10.1099/acmi.0.000860.v3 | 2024 | | |
| Synergy between Winter Flounder antimicrobial peptides. | Clarke M, Hind CK, Ferguson PM, Manzo G, Mistry B, Yue B, Romanopulos J, Clifford M, Bui TT, Drake AF, Lorenz CD, Sutton JM, Mason AJ. | NPJ Antimicrob Resist | 10.1038/s44259-023-00010-7 | 2023 | | |
| Blue Light Sensing BlsA-Mediated Modulation of Meropenem Resistance and Biofilm Formation in Acinetobacter baumannii. | Yang J, Yun S, Park W. | mSystems | 10.1128/msystems.00897-22 | 2023 | | |
| Novel antimicrobial peptides and peptide-microbiome crosstalk in Appalachian salamander skin. | Muletz-Wolz CR, Urrutia-Carter J, Osborne O, Kutos S, Meneses Montano J, Madison JD, Gratwicke B, Racharaks R, Roncal NE, Jimenez RR, Ellison A, Cleland TP. | NPJ Biofilms Microbiomes | 10.1038/s41522-025-00837-0 | 2025 | | |
| Exposure to bacterial PAMPs before RSV infection exacerbates innate inflammation and disease via IL-1alpha and TNF-alpha. | Owen AR, Farias A, Levins AM, Wang Z, Higham SL, Mack M, Tregoning JS, Johansson C. | Mucosal Immunol | 10.1016/j.mucimm.2024.08.002 | 2024 | | |
| Comparative genotypic characterization related to antibiotic resistance phenotypes of clinical carbapenem-resistant Acinetobacter baumannii MTC1106 (ST2) and MTC0619 (ST25). | Wiradiputra MRD, Thirapanmethee K, Khuntayaporn P, Wanapaisan P, Chomnawang MT. | BMC Genomics | 10.1186/s12864-023-09734-2 | 2023 | | |
| Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains. | Li FJ, Starrs L, Mathur A, Ishii H, Man SM, Burgio G. | PLoS One | 10.1371/journal.pone.0277019 | 2022 | | |
| RND pumps across the genus Acinetobacter: AdeIJK is the universal efflux pump. | Darby EM, Bavro VN, Dunn S, McNally A, Blair JMA. | Microb Genom | 10.1099/mgen.0.000964 | 2023 | | |
| Genetics | Genomic relatedness and dissemination of bla NDM-5 among Acinetobacter baumannii isolated from hospital environments and clinical specimens in Thailand. | Kitti T, Manrueang S, Leungtongkam U, Khongfak S, Thummeepak R, Thummeepak R, Wannalerdsakun S, Jindayok T, Sitthisak S. | PeerJ | 10.7717/peerj.14831 | 2023 | |
| Mucoid Acinetobacter baumannii enhances anti-phagocytosis through reducing C3b deposition. | Gong X, Zhao Q, Wu Y, Zhou H, Ding S, Zhu K. | Front Med (Lausanne) | 10.3389/fmed.2022.879361 | 2022 | | |
| Identification of the blaOXA-23 Gene in the First Mucoid XDR Acinetobacter baumannii Isolated from a Patient with Cystic Fibrosis. | Rossitto M, Vrenna G, Tuccio Guarna Assanti V, Essa N, De Santis ML, Granaglia A, Fini V, Costabile V, Onori M, Cristiani L, Boni A, Cutrera R, Perno CF, Bernaschi P. | J Clin Med | 10.3390/jcm12206582 | 2023 | | |
| What was old is new again: Phenotypic screening of a unique fungal library yields pyridoxatin, a promising lead against extensively resistant Acinetobacter baumannii (AB5075). | Winter HL, Flores-Bocanegra L, Cank KB, Crandall WJ, Rotich FC, Tillman MN, Todd DA, Graf TN, Raja HA, Pearce CJ, Oberlies NH, Cech NB. | Phytochem Lett | 10.1016/j.phytol.2023.04.002 | 2023 | | |
| Phylogeny | Predation on bacterial pathogens by predatory bacteria of sewage origin: three days prey-predator interactions. | Mohsenipour Z, Arazi P, Skurnik M, Jahanbin B, Abtahi HR, Edalatifard M, Feizabadi MM. | BMC Microbiol | 10.1186/s12866-024-03672-z | 2024 | |
| Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates. | Lu P, Alletto F, Lee B, Burk E, Martinez J, Prati F, Caselli E, Spellberg B, Luna B. | PLoS One | 10.1371/journal.pone.0287102 | 2023 | | |
| Development of Novel Membrane Disrupting Lipoguanidine Compounds Sensitizing Gram-Negative Bacteria to Antibiotics. | Kim SH, Hind CK, Fernandes GFS, Wu J, Semenya D, Clifford M, Marsh C, Anselmi S, Mason AJ, Bruce KD, Sutton JM, Castagnolo D. | ACS Med Chem Lett | 10.1021/acsmedchemlett.3c00460 | 2024 | | |
| Evidence for Rho-dependent control of a virulence switch in Acinetobacter baumannii. | Perez-Varela M, Singh R, Colquhoun JM, Starich OG, Tierney ARP, Tipton KA, Rather PN. | mBio | 10.1128/mbio.02708-23 | 2024 | | |
| Pathogenicity | The Acinetobacter baumannii model can explain the role of small non-coding RNAs as potential mediators of host-pathogen interactions. | Sarshar M, Scribano D, Palamara AT, Ambrosi C, Masotti A. | Front Mol Biosci | 10.3389/fmolb.2022.1088783 | 2022 | |
| Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK). | Miller AA, Moussa SH, McLeod SM. | Antimicrob Agents Chemother | 10.1128/aac.01698-23 | 2024 | | |
| A response regulator controls Acinetobacter baumannii virulence by acting as an indole receptor. | Cui B, Guo Q, Li X, Song S, Wang M, Wang G, Yan A, Zhou J, Deng Y. | PNAS Nexus | 10.1093/pnasnexus/pgad274 | 2023 | | |
| The DdrR Coregulator of the Acinetobacter baumannii Mutagenic DNA Damage Response Potentiates UmuDAb Repression of Error-Prone Polymerases. | Cook D, Flannigan MD, Candra BV, Compton KD, Hare JM. | J Bacteriol | 10.1128/jb.00165-22 | 2022 | | |
| Application of tobramycin benzyl ether as an antibiotic adjuvant capable of sensitizing multidrug-resistant Gram-negative bacteria to rifampicin. | Ramirez DM, Dhiman S, Mukherjee A, Wimalasekara R, Schweizer F. | RSC Med Chem | 10.1039/d3md00602f | 2024 | | |
| Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates. | Vijayakumar S, Swetha RG, Bakthavatchalam YD, Vasudevan K, Abirami Shankar B, Kirubananthan A, Walia K, Ramaiah S, Biswas I, Veeraraghavan B, Anbarasu A. | Microbiol Spectr | 10.1128/spectrum.02511-23 | 2024 | | |
| Iron Acquisition Mechanisms and Their Role in the Virulence of Acinetobacter baumannii. | Cook-Libin S, Sykes EME, Kornelsen V, Kumar A. | Infect Immun | 10.1128/iai.00223-22 | 2022 | | |
| C7-Substituted Quinolines as Potent Inhibitors of AdeG Efflux Pumps in Acinetobacter baumannii. | Zhu Y, Hind CK, Al-Adhami T, Wand ME, Clifford M, Sutton JM, Rahman KM. | ACS Infect Dis | 10.1021/acsinfecdis.4c00705 | 2025 | | |
| Structure-Activity Relationship of the Diaminobutyric Acid Residues in Polymyxins. | Ma W, Jiang X, Mu K, Tian S, Yu HH, Wickremasinghe H, Velkov T, Roberts KD, Patil NA, Li J. | JACS Au | 10.1021/jacsau.5c00587 | 2025 | | |
| BfmRS encodes a regulatory system involved in light signal transduction modulating motility and desiccation tolerance in the human pathogen Acinetobacter baumannii. | Perez Mora B, Giordano R, Permingeat V, Calderone M, Arana N, Muller G, Rodriguez RE, Krasauskas R, Mussi MA. | Sci Rep | 10.1038/s41598-022-26314-8 | 2023 | | |
| Enzymology | A series of vectors for inducible gene expression in multidrug-resistant Acinetobacter baumannii. | Intorcia V, Sava RL, Schroeder GP, Gebhardt MJ. | Appl Environ Microbiol | 10.1128/aem.00474-24 | 2024 | |
| Enzymology | The Anti-Multidrug-Resistant Acinetobacter baumannii Study on 1,3-diamino-7H-pyrrolo[3,2-f]quinazoline Compounds. | Wu H, Chen H, Zhang J, Hu X, Xie C, Cao W, Zhao Z, Xiao Z, Ren Y, Dong L, Sun P, You X, Yang X, Hong W, Wang H. | Molecules | 10.3390/molecules27238609 | 2022 | |
| Pathogenicity | Virulence Factors and Pathogenicity Mechanisms of Acinetobacter baumannii in Respiratory Infectious Diseases. | Yao Y, Chen Q, Zhou H. | Antibiotics (Basel) | 10.3390/antibiotics12121749 | 2023 | |
| A Short Peptide of Autotransporter Ata Is a Promising Protective Antigen for Vaccination Against Acinetobacter baumannii. | Sun P, Li X, Pan C, Liu Z, Wu J, Wang H, Zhu L. | Front Immunol | 10.3389/fimmu.2022.884555 | 2022 | | |
| Genetics | Genetic Diversity of Antimicrobial Resistance and Key Virulence Features in Two Extensively Drug-Resistant Acinetobacter baumannii Isolates. | Marazzato M, Scribano D, Sarshar M, Brunetti F, Fillo S, Fortunato A, Lista F, Palamara AT, Zagaglia C, Ambrosi C. | Int J Environ Res Public Health | 10.3390/ijerph19052870 | 2022 | |
| The role of universal stress protein Usp1413 in meropenem adaptive resistance and environmental stress responses in Acinetobacter baumannii. | Zhang S, Wang J, Yu R, Liu H, Liu S, Luo K, Lei J, Han B, Chen Y, Han S, Yang E, Xun M, Han L. | Curr Res Microb Sci | 10.1016/j.crmicr.2024.100332 | 2025 | | |
| Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant Acinetobacter baumannii. | Sannio F, Brizzi A, Del Prete R, Avigliano M, Simone T, Pagli C, Ferraro T, De Luca F, Paolino M, Corelli F, Mugnaini C, Docquier JD. | Antibiotics (Basel) | 10.3390/antibiotics11121832 | 2022 | | |
| Intrinsic Antibacterial Activity of Xeruborbactam In Vitro: Assessing Spectrum and Mode of Action. | Sun D, Tsivkovski R, Pogliano J, Tsunemoto H, Nelson K, Rubio-Aparicio D, Lomovskaya O. | Antimicrob Agents Chemother | 10.1128/aac.00879-22 | 2022 | | |
| Alterations in gene expression of recA and umuDC in antibiotic-resistant Acinetobacter baumannii. | Ameer NAA, Dhahi MAR. | J Med Life | 10.25122/jml-2022-0358 | 2023 | | |
| Genetics | Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii. | Kabic J, Novovic K, Kekic D, Trudic A, Opavski N, Dimkic I, Jovcic B, Gajic I. | Comput Struct Biotechnol J | 10.1016/j.csbj.2022.12.045 | 2023 | |
| Expanding the Substrate Selectivity of the Fimsbactin Biosynthetic Adenylation Domain, FbsH. | Ahmed SF, Balutowski A, Yang J, Wencewicz TA, Gulick AM. | ACS Chem Biol | 10.1021/acschembio.4c00512 | 2024 | | |
| CsrA-Controlled Proteins Reveal New Dimensions of Acinetobacter baumannii Desiccation Tolerance. | Oda Y, Shapiro MM, Lewis NM, Zhong X, Huse HK, Zhong W, Bruce JE, Manoil C, Harwood CS. | J Bacteriol | 10.1128/jb.00479-21 | 2022 | | |
| Deciphering the virulence factors, regulation, and immune response to Acinetobacter baumannii infection. | Shadan A, Pathak A, Ma Y, Pathania R, Singh RP. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1053968 | 2023 | | |
| Carboxy-Amidated AamAP1-Lys has Superior Conformational Flexibility and Accelerated Killing of Gram-Negative Bacteria. | Van Wyk RJ, Serem JC, Oosthuizen CB, Semenya D, Serian M, Lorenz CD, Mason AJ, Bester MJ, Gaspar ARM. | Biochemistry | 10.1021/acs.biochem.4c00580 | 2025 | | |
| Pathogenicity | Characterization of Amino Acid Substitutions in the Two-Component Regulatory System AdeRS Identified in Multidrug-Resistant Acinetobacter baumannii. | Lucassen K, Xanthopoulou K, Wille J, Wille T, Wen Y, Hua X, Seifert H, Higgins PG. | mSphere | 10.1128/msphere.00709-21 | 2021 | |
| Evaluation of the Effects of Heteroaryl Ethylene Molecules in Combination with Antibiotics: A Preliminary Study on Control Strains. | Bonomo C, Bonacci PG, Bivona DA, Mirabile A, Bongiorno D, Nicitra E, Marino A, Bonaccorso C, Consiglio G, Fortuna CG, Stefani S, Musso N. | Antibiotics (Basel) | 10.3390/antibiotics12081308 | 2023 | | |
| A conserved zinc-binding site in Acinetobacter baumannii PBP2 required for elongasome-directed bacterial cell shape. | Micelli C, Dai Y, Raustad N, Isberg RR, Dowson CG, Lloyd AJ, Geisinger E, Crow A, Roper DI. | Proc Natl Acad Sci U S A | 10.1073/pnas.2215237120 | 2023 | | |
| Incidence of an Intracellular Multiplication Niche among Acinetobacter baumannii Clinical Isolates. | Rubio T, Gagne S, Debruyne C, Dias C, Cluzel C, Mongellaz D, Rousselle P, Gottig S, Seifert H, Higgins PG, Salcedo SP. | mSystems | 10.1128/msystems.00488-21 | 2022 | | |
| Genetics | Whole-genome sequencing of two multidrug-resistant acinetobacter baumannii strains isolated from a neonatal intensive care unit in Egypt: a prospective cross-sectional study. | Mohamed RAE, Moustafa NM, Mahmoud FM, Elsaadawy YS, Aziz HSA, Gaber SAB, Hussin AM, Seadawy MG. | BMC Microbiol | 10.1186/s12866-024-03482-3 | 2024 | |
| Potential Activities of Centella asiatica Leaf Extract against Pathogenic Bacteria-Associated Biofilms and Its Anti-Inflammatory Effects. | Chonsut P, Romyasamit C, Konyanee A, Niyomtham N, Goodla L, Mordmuang A. | Adv Pharmacol Pharm Sci | 10.1155/2024/5959077 | 2024 | | |
| iPro-MP: a BERT-based model to predict multiple prokaryotic promoters. | Su W, Yang Y, Zhao Y, Yuan S, Xie X, Hao Y, Zhang H, Ye D, Lyu H, Lin H. | Genome Biol | 10.1186/s13059-025-03819-9 | 2025 | | |
| Enzymology | OXA-23 beta-Lactamase Overexpression in Acinetobacter baumannii Drives Physiological Changes Resulting in New Genetic Vulnerabilities. | Colquhoun JM, Farokhyfar M, Hutcheson AR, Anderson A, Bethel CR, Bonomo RA, Clarke AJ, Rather PN. | mBio | 10.1128/mbio.03137-21 | 2021 | |
| Total Synthesis of the Reported Structure of Cahuitamycin A: Insights into an Elusive Natural Product Scaffold. | Shapiro JA, Post SJ, Smith GC, Wuest WM. | Org Lett | 10.1021/acs.orglett.3c03993 | 2023 | | |
| Uncovering the Secretion Systems of Acinetobacter baumannii: Structures and Functions in Pathogenicity and Antibiotic Resistance. | Li P, Zhang S, Wang J, Al-Shamiri MM, Han B, Chen Y, Han S, Han L. | Antibiotics (Basel) | 10.3390/antibiotics12020195 | 2023 | | |
| Anti-Biofilm Activity of a Tunable Hypochlorous Acid-Generating Electrochemical Bandage Controlled By a Wearable Potentiostat. | Mohamed A, Raval YS, Gelston S, Tibbits G, Ay SU, Flurin L, Greenwood-Quaintance KE, Patel R, Beyenal H. | Adv Eng Mater | 10.1002/adem.202200792 | 2023 | | |
| Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice. | Li X, Pan C, Liu Z, Sun P, Hua X, Feng E, Yu Y, Wu J, Zhu L, Wang H. | Microb Biotechnol | 10.1111/1751-7915.13770 | 2022 | | |
| Genomic Surveillance Uncovers a 10-Year Persistence of an OXA-24/40 Acinetobacter baumannii Clone in a Tertiary Hospital in Northern Spain. | Aranzamendi M, Xanthopoulou K, Sanchez-Urtaza S, Burgwinkel T, Arazo Del Pino R, Lucassen K, Perez-Vazquez M, Oteo-Iglesias J, Sota M, Marimon JM, Seifert H, Higgins PG, Gallego L. | Int J Mol Sci | 10.3390/ijms25042333 | 2024 | | |
| Understanding the mechanisms of antimicrobial resistance and potential therapeutic approaches against the Gram-negative pathogen Acinetobacter baumannii. | Jamwal V, Palmo T, Singh K. | RSC Med Chem | 10.1039/d4md00449c | 2024 | | |
| An Explorative Review on Advanced Approaches to Overcome Bacterial Resistance by Curbing Bacterial Biofilm Formation. | Mohamad F, Alzahrani RR, Alsaadi A, Alrfaei BM, Yassin AEB, Alkhulaifi MM, Halwani M. | Infect Drug Resist | 10.2147/idr.s380883 | 2023 | | |
| Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli. | Chatupheeraphat C, Kaewsai N, Anuwongcharoen N, Phanus-Umporn C, Pornsuwan S, Eiamphungporn W. | Sci Rep | 10.1038/s41598-025-01303-9 | 2025 | | |
| The StkSR Two-Component System Influences Colistin Resistance in Acinetobacter baumannii. | Giles SK, Stroeher UH, Papudeshi B, Edwards RA, Carlson-Jones JA, Roach M, Brown MH. | Microorganisms | 10.3390/microorganisms10050985 | 2022 | | |
| Inhibitors of the Bacterioferritin Ferredoxin Complex Dysregulate Iron Homeostasis and Kill Acinetobacter baumannii and Biofilm-Embedded Pseudomonas aeruginosa Cells. | Behm AM, Yao H, Eze EC, Alli SA, Baugh SDP, Ametsetor E, Powell KM, Battaile KP, Seibold S, Lovell S, Bunce RA, Reitz AB, Rivera M. | ACS Infect Dis | 10.1021/acsinfecdis.5c00209 | 2025 | | |
| AadT, a new weapon in Acinetobacter's fight against antibiotics. | Naidu V, Shah B, Maher C, Paulsen IT, Hassan KA. | Microbiology (Reading) | 10.1099/mic.0.001341 | 2023 | | |
| Peptaibol Analogs Show Potent Antibacterial Activity against Multidrug Resistant Opportunistic Pathogens. | Dalla Torre C, Sannio F, Battistella M, Docquier JD, De Zotti M. | Int J Mol Sci | 10.3390/ijms24097997 | 2023 | | |
| Exploring Roles of the Polysaccharide Capsule in Pathogenesis of Hypervirulent Acinetobacter baumannii Clinical Isolate Lac-4. | Bjanes E, Koh T, Qayum T, Zurich R, McCabe S, Hampel K, Cartwright L, Nizet V. | Antibiotics (Basel) | 10.3390/antibiotics13010010 | 2023 | | |
| Pathogenicity | Galleria mellonella as a Good Model to Study Acinetobacter baumannii Pathogenesis. | Tao Y, Duma L, Rossez Y. | Pathogens | 10.3390/pathogens10111483 | 2021 | |
| Transcriptome | LeuO, a LysR-Type Transcriptional Regulator, Is Involved in Biofilm Formation and Virulence of Acinetobacter baumannii. | Islam MM, Kim K, Lee JC, Shin M. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.738706 | 2021 | |
| MacAB-TolC Contributes to the Development of Acinetobacter baumannii Biofilm at the Solid-Liquid Interface. | Robin B, Nicol M, Le H, Tahrioui A, Schaumann A, Vuillemenot JB, Vergoz D, Lesouhaitier O, Jouenne T, Hardouin J, Potron A, Perrot V, De E. | Front Microbiol | 10.3389/fmicb.2021.785161 | 2021 | | |
| Chimeric Amphiphilic Disinfectants: Quaternary Ammonium/Quaternary Phosphonium Hybrid Structures. | Leatherbury MS, Thierer LM, Sanchez CA, Vargas-Cuebas GG, Petersen AA, Amoo LE, Bezold EL, Washington KC, Mistrot MB, Zdilla MJ, Wuest WM, Minbiole KPC. | ChemMedChem | 10.1002/cmdc.202300718 | 2024 | | |
| Enhancement of beta-Lactam-Mediated Killing of Gram-Negative Bacteria by Lysine Hydrochloride. | Hong S, Su S, Gao Q, Chen M, Xiao L, Cui R, Guo Y, Xue Y, Wang D, Niu J, Huang H, Zhao X. | Microbiol Spectr | 10.1128/spectrum.01198-23 | 2023 | | |
| A unique cell division protein critical for the assembly of the bacterial divisome. | Chu X, Wang L, Zhu Y, Feng Z, Guan Q, Song L, Luo Z. | Elife | 10.7554/elife.87922 | 2024 | | |
| Synthesis, Antimicrobial Activity, and Tyrosinase Inhibition by Multifunctional 3,4-Dihydroxy-Phenyl Peptidomimetics. | Wavhal DS, Koszelewski D, Kowalczyk P, Brodzka A, Ostaszewski R. | Int J Mol Sci | 10.3390/ijms26041702 | 2025 | | |
| Inhibition of LpxC Increases the Activity of Iron Chelators and Gallium Nitrate in Multidrug-Resistant Acinetobacter baumannii. | Vinuesa V, Cruces R, Nonnoi F, McConnell MJ. | Antibiotics (Basel) | 10.3390/antibiotics10050609 | 2021 | | |
| Novel Genes Required for Surface-Associated Motility in Acinetobacter baumannii. | Blaschke U, Skiebe E, Wilharm G. | Curr Microbiol | 10.1007/s00284-021-02407-x | 2021 | | |
| Genotypic and Phenotypic Characterization of Novel Sequence Types of Carbapenem-Resistant Acinetobacter baumannii, With Heterogeneous Resistance Determinants and Targeted Variations in Efflux Operons. | Bharathi SV, Venkataramaiah M, Rajamohan G. | Front Microbiol | 10.3389/fmicb.2021.738371 | 2021 | | |
| Characterisation of pellicle-forming ability in clinical carbapenem-resistant Acinetobacter baumannii. | Ng HK, Puah SM, Teh CSJ, Idris N, Chua KH. | PeerJ | 10.7717/peerj.15304 | 2023 | | |
| Metabolism | The Membrane Composition Defines the Spatial Organization and Function of a Major Acinetobacter baumannii Drug Efflux System. | Zang M, MacDermott-Opeskin H, Adams FG, Naidu V, Waters JK, Carey AB, Ashenden A, McLean KT, Brazel EB, Jiang JH, Panizza A, Trappetti C, Paton JC, Peleg AY, Koper I, Paulsen IT, Hassan KA, O'Mara ML, Eijkelkamp BA. | mBio | 10.1128/mbio.01070-21 | 2021 | |
| The effects of sequencing strategies on Metagenomic pathogen detection using bronchoalveolar lavage fluid samples. | Li Z, Guo Z, Wu W, Tan L, Long Q, Xia H, Hu M. | Heliyon | 10.1016/j.heliyon.2024.e33429 | 2024 | | |
| Genetics | Diverse Repertoire and Relationship of Exopolysaccharide Genes in Cold-Adapted Acinetobacter sp. CUI-P1 Revealed by Comparative Genome Analysis. | Ferheen I, Ahmed Z, Alonazi WB, Pessina A, Ibrahim M, Pucciarelli S, Bokhari H. | Microorganisms | 10.3390/microorganisms11040885 | 2023 | |
| Bicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens. | Wang W, Zhu X, Luo H, Wang Z, Hong A, Zeng J, Li L, Wang D, Deng X, Zhao X. | Microbiol Spectr | 10.1128/spectrum.03790-22 | 2023 | | |
| Research progress on bacterial outer membrane vesicles in antibiotic resistance and clinical anti-infective therapy. | Lu Y, Wen Z, Liu X, Zhang T, Liu M, Zhang L, Qiu J, Wang M. | Front Microbiol | 10.3389/fmicb.2025.1670307 | 2025 | | |
| The Molecular Basis of Acinetobacter baumannii Cadmium Toxicity and Resistance. | Alquethamy SF, Adams FG, Maharjan R, Delgado NN, Zang M, Ganio K, Paton JC, Hassan KA, Paulsen IT, McDevitt CA, Cain AK, Eijkelkamp BA. | Appl Environ Microbiol | 10.1128/aem.01718-21 | 2021 | | |
| Peptidoglycan Recycling Promotes Outer Membrane Integrity and Carbapenem Tolerance in Acinetobacter baumannii. | Islam N, Kazi MI, Kang KN, Biboy J, Gray J, Ahmed F, Schargel RD, Boutte CC, Dorr T, Vollmer W, Boll JM. | mBio | 10.1128/mbio.01001-22 | 2022 | | |
| The evolutionary tale of eight novel plasmids in a colistin-resistant environmental Acinetobacter baumannii isolate. | Prity FT, Tobin LA, Maharajan R, Paulsen IT, Cain AK, Hamidian M. | Microb Genom | 10.1099/mgen.0.001010 | 2023 | | |
| Capsule carbohydrate structure determines virulence in Acinetobacter baumannii. | Talyansky Y, Nielsen TB, Yan J, Carlino-Macdonald U, Di Venanzio G, Chakravorty S, Ulhaq A, Feldman MF, Russo TA, Vinogradov E, Luna B, Wright MS, Adams MD, Spellberg B. | PLoS Pathog | 10.1371/journal.ppat.1009291 | 2021 | | |
| Genetics | Whole-Genome Analysis of Acinetobacter baumannii Strain AB43 Containing a Type I-Fb CRISPR-Cas System: Insights into the Relationship with Drug Resistance. | Guo T, Yang J, Sun X, Wang Y, Yang L, Kong G, Jiao H, Bao G, Li G. | Molecules | 10.3390/molecules27175665 | 2022 | |
| Computer-Based Identification of Potential Druggable Targets in Multidrug-Resistant Acinetobacter baumannii: A Combined In Silico, In Vitro and In Vivo Study. | Badie OH, Basyony AF, Samir R. | Microorganisms | 10.3390/microorganisms10101973 | 2022 | | |
| Heteroaryl-Ethylenes as New Effective Agents for High Priority Gram-Positive and Gram-Negative Bacterial Clinical Isolates. | Bivona DA, Mirabile A, Bonomo C, Bonacci PG, Stracquadanio S, Marino A, Campanile F, Bonaccorso C, Fortuna CG, Stefani S, Musso N, Bongiorno D. | Antibiotics (Basel) | 10.3390/antibiotics11060767 | 2022 | | |
| Enzymology | Discovery of GuaB inhibitors with efficacy against Acinetobacter baumannii infection. | Kofoed EM, Aliagas I, Crawford T, Mao J, Harris SF, Xu M, Wang S, Wu P, Ma F, Clark K, Sims J, Xu Y, Peng Y, Skippington E, Yang Y, Reeder J, Ubhayakar S, Baumgardner M, Yan Z, Chen J, Park S, Zhang H, Yen C-W, Lorenzo M, Skelton N, Liang X, Chen L, Hoag B, Li CS, Liu Z, Wai J, Liu X, Liang J, Tan MW. | mBio | 10.1128/mbio.00897-24 | 2024 | |
| Constitutive Phenotypic Modification of Lipid A in Clinical Acinetobacter baumannii Isolates. | Kim SH, Yun S, Park W. | Microbiol Spectr | 10.1128/spectrum.01295-22 | 2022 | | |
| Testing the Luedemann hypothesis: the discovery of novel antimicrobials from slow-growing microbes from nutrient-limited environments. | Lin B, Woo S, Philbrick A, Bacsa J, Laskey E, Mehra N, Gondil VS, Mei JA, Jones G, Pavelka MS, Dziejman M, Shutter DA, Melander C, Perritt AM, Jakober R, Shen Y, Chang W-C, Quave CL, Dunman PM, Luedemann G. | mSphere | 10.1128/msphere.00367-25 | 2025 | | |
| Supercharged precision killers: Genetically engineered biomimetic drugs of screened metalloantibiotics against Acinetobacter baumanni. | Wei X, Xue B, Ruan S, Guo J, Huang Y, Geng X, Wang D, Zhou C, Zheng J, Yuan Z. | Sci Adv | 10.1126/sciadv.adk6331 | 2024 | | |
| The association between Acinetobacter baumannii infections and the COVID-19 pandemic in an intensive care unit. | Boral J, Genc Z, Pinarlik F, Ekinci G, Kuskucu MA, Irkoren P, Kapmaz M, Tekin S, Cakar N, Senturk E, Yurdakul F, Dikenelli B, Can F, Ergonul O. | Sci Rep | 10.1038/s41598-022-25493-8 | 2022 | | |
| Phylogeny | Genomic and phenotypic analyses of diverse non-clinical Acinetobacter baumannii strains reveals strain-specific virulence and resistance capacity. | Hamidian M, Maharjan RP, Farrugia DN, Delgado NN, Dinh H, Short FL, Kostoulias X, Peleg AY, Paulsen IT, Cain AK. | Microb Genom | 10.1099/mgen.0.000765 | 2022 | |
| Antibacterial activity and mechanism of X33 antimicrobial oligopeptide against Acinetobacter baumannii. | Lu Q, Wu X, Fang Y, Wang Y, Zhang B. | Synth Syst Biotechnol | 10.1016/j.synbio.2024.03.002 | 2024 | | |
| Genetics | Co-Existence of blaNDM-1, blaOXA-23, blaOXA-64, blaPER-7 and blaADC-57 in a Clinical Isolate of Acinetobacter baumannii from Alexandria, Egypt. | Sanchez-Urtaza S, Ocampo-Sosa A, Molins-Bengoetxea A, Rodriguez-Grande J, El-Kholy MA, Hernandez M, Abad D, Shawky SM, Alkorta I, Gallego L. | Int J Mol Sci | 10.3390/ijms241512515 | 2023 | |
| Acinetobacter baumannii Global Clone-Specific Resistomes Explored in Clinical Isolates Recovered from Egypt. | Hamed SM, Elkhatib WF, Brangsch H, Gesraha AS, Moustafa S, Khater DF, Pletz MW, Sprague LD, Neubauer H, Wareth G. | Antibiotics (Basel) | 10.3390/antibiotics12071149 | 2023 | | |
| Sulfonamidoboronic Acids as "Cross-Class" Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii. | Introvigne ML, Beardsley TJ, Fernando MC, Leonard DA, Wallar BJ, Rudin SD, Taracila MA, Rather PN, Colquhoun JM, Song S, Fini F, Hujer KM, Hujer AM, Prati F, Powers RA, Bonomo RA, Caselli E. | Antibiotics (Basel) | 10.3390/antibiotics12040644 | 2023 | | |
| IITR00803: a benzoxazole-nitrothiophene small molecule with broad-spectrum antibacterial potential. | Gupta R, Gaurav A, Pathania R. | Microbiol Spectr | 10.1128/spectrum.01144-25 | 2025 | | |
| Transcriptome | The abaI/abaR Quorum Sensing System Effects on Pathogenicity in Acinetobacter baumannii. | Sun X, Ni Z, Tang J, Ding Y, Wang X, Li F. | Front Microbiol | 10.3389/fmicb.2021.679241 | 2021 | |
| "In vitro antimicrobial and synergistic effect of fermented Indian zebu (Sahiwal) cow colostrum whey derived peptides with Lactobacillus rhamnosus against pathogenic bacteria". | Iram D, Sansi MS, Meena S, Puniya AK, Vij S. | J Food Sci Technol | 10.1007/s13197-023-05776-2 | 2023 | | |
| The Fsr transporter of Sinorhizobium meliloti contributes to antimicrobial resistance and symbiosis with alfalfa. | Chavez-Jacobo VM, Reyes-Gonzalez AR, Girard L, Dunn MF. | Microbiology (Reading) | 10.1099/mic.0.001566 | 2025 | | |
| Enzymology | PYED-1 Overcomes Colistin Resistance in Acinetobacter baumannii. | Stabile M, Esposito A, Iula VD, Guaragna A, De Gregorio E. | Pathogens | 10.3390/pathogens12111323 | 2023 | |
| The molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units. | Farajnia S, Lotfi F, Dehnad A, Shojaie M, Raisi R, Rahbarnia L, Bazmani A, Naghili B, Shiry S. | Iran J Microbiol | 10.18502/ijm.v14i3.9768 | 2022 | | |
| PmrAB, the two-component system of Acinetobacter baumannii, controls the phosphoethanolamine modification of lipooligosaccharide in response to metal ions. | Yamada N, Kamoshida G, Shiraishi T, Yamaguchi D, Matsuoka M, Yamauchi R, Kanda N, Kamioka R, Takemoto N, Morita Y, Fujimuro M, Yokota S-i, Yahiro K. | J Bacteriol | 10.1128/jb.00435-23 | 2024 | | |
| Whole-genome sequencing for the characterization of resistance mechanisms and epidemiology of colistin-resistant Acinetobacter baumannii. | Hahm C, Chung HS, Lee M. | PLoS One | 10.1371/journal.pone.0264335 | 2022 | | |
| Identification of a Novel Ciprofloxacin Tolerance Gene, aciT, Which Contributes to Filamentation in Acinetobacter baumannii. | Naidu V, Shah B, Kamath KS, Chien A, Nagy S, Pokhrel A, Molloy M, Hassan KA, Paulsen IT. | Antimicrob Agents Chemother | 10.1128/aac.01400-20 | 2021 | | |
| Insights Into Mechanisms of Biofilm Formation in Acinetobacter baumannii and Implications for Uropathogenesis. | Colquhoun JM, Rather PN. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.00253 | 2020 | | |
| Pathogenicity | 'GGFGGQ' repeats in Hfq of Acinetobacter baumannii are essential for nutrient utilization and virulence. | Sett A, Maiti PK, Garg K, Hussain A, Saini S, Pandey S, Pathania R. | J Biol Chem | 10.1016/j.jbc.2024.107895 | 2024 | |
| Blue light directly modulates the quorum network in the human pathogen Acinetobacter baumannii. | Tuttobene MR, Muller GL, Blasco L, Arana N, Hourcade M, Diacovich L, Cribb P, Tomas M, Nieto-Penalver CG, Mussi MA. | Sci Rep | 10.1038/s41598-021-92845-1 | 2021 | | |
| Pathogenicity | LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity. | Kim S, Jin JS, Choi YJ, Kim J. | Viruses | 10.3390/v12111340 | 2020 | |
| Pathogenicity | Rapid Killing and Biofilm Inhibition of Multidrug-Resistant Acinetobacter baumannii Strains and Other Microbes by Iodoindoles. | Raorane CJ, Lee JH, Lee J. | Biomolecules | 10.3390/biom10081186 | 2020 | |
| Genomic Diversity, Antimicrobial Susceptibility, and Biofilm Formation of Clinical Acinetobacter baumannii Isolates from Horses. | Ruhl-Teichner J, Jacobmeyer L, Leidner U, Semmler T, Ewers C. | Microorganisms | 10.3390/microorganisms11030556 | 2023 | | |
| Controlling drug-resistant bacteria in Arabian horses: bacteriophage cocktails for treating wound infections. | Khalid E, Tartor YH, Ammar AM, Abdelaziz R, Mahmmod Y, Abdelkhalek A. | Front Vet Sci | 10.3389/fvets.2025.1609955 | 2025 | | |
| Genetics | Galaxy ASIST: A web-based platform for mapping and assessment of global standards of antimicrobial susceptibility: A case study in Acinetobacter baumannii genomes. | Sharma T, Kumar R, Kalra JS, Singh S, Bhalla GS, Bhardwaj A. | Front Microbiol | 10.3389/fmicb.2022.1041847 | 2022 | |
| Immunosuppression broadens evolutionary pathways to drug resistance and treatment failure during Acinetobacter baumannii pneumonia in mice. | Huo W, Busch LM, Hernandez-Bird J, Hamami E, Marshall CW, Geisinger E, Cooper VS, van Opijnen T, Rosch JW, Isberg RR. | Nat Microbiol | 10.1038/s41564-022-01126-8 | 2022 | | |
| Delivery determinants of an Acinetobacter baumannii type VI secretion system bifunctional peptidoglycan hydrolase. | Bezkorovayna V, Hayes BK, Gillett FN, Wright A, Roper DI, Harper M, McGowan S, Boyce JD. | mBio | 10.1128/mbio.02627-24 | 2025 | | |
| An update to the database for Acinetobacter baumannii capsular polysaccharide locus typing extends the extensive and diverse repertoire of genes found at and outside the K locus. | Cahill SM, Hall RM, Kenyon JJ. | Microb Genom | 10.1099/mgen.0.000878 | 2022 | | |
| High-Resolution Bacterial Cytological Profiling Reveals Intrapopulation Morphological Variations upon Antibiotic Exposure. | Samernate T, Htoo HH, Sugie J, Chavasiri W, Pogliano J, Chaikeeratisak V, Nonejuie P. | Antimicrob Agents Chemother | 10.1128/aac.01307-22 | 2023 | | |
| In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii. | Abdul-Mutakabbir JC, Yim J, Nguyen L, Maassen PT, Stamper K, Shiekh Z, Kebriaei R, Shields RK, Castanheira M, Kaye KS, Rybak MJ. | Antibiotics (Basel) | 10.3390/antibiotics10070880 | 2021 | | |
| Polymyxin B in Combination with Glycerol Monolaurate Exerts Synergistic Killing against Gram-Negative Pathogens. | Zheng Y, Yang N, Ding Y, Li J, Liu Y, Chen H, Li J. | Pathogens | 10.3390/pathogens11080874 | 2022 | | |
| Enhanced Antibacterial Activity of Substituted Derivatives of NCR169C Peptide. | Howan DHO, Jenei S, Szolomajer J, Endre G, Kondorosi E, Toth GK. | Int J Mol Sci | 10.3390/ijms24032694 | 2023 | | |
| Dioctanoyl Ultrashort Tetrabasic beta-Peptides Sensitize Multidrug-Resistant Gram-Negative Bacteria to Novobiocin and Rifampicin. | Ramirez D, Berry L, Domalaon R, Li Y, Arthur G, Kumar A, Schweizer F. | Front Microbiol | 10.3389/fmicb.2021.803309 | 2021 | | |
| Characterization of BLUF-photoreceptors present in Acinetobacter nosocomialis. | Abatedaga I, Perez Mora B, Tuttobene M, Muller G, Biancotti D, Borsarelli CD, Valle L, Mussi MA. | PLoS One | 10.1371/journal.pone.0254291 | 2022 | | |
| Genomic Analysis of Acinetobacter baumannii Isolates Carrying OXA-23 and OXA-58 Genes from Animals Reveals ST1 and ST25 as Major Clonal Lineages. | Jacobmeyer L, Semmler T, Stamm I, Ewers C. | Antibiotics (Basel) | 10.3390/antibiotics11081045 | 2022 | | |
| Metabolism | Septal Class A Penicillin-Binding Protein Activity and ld-Transpeptidases Mediate Selection of Colistin-Resistant Lipooligosaccharide-Deficient Acinetobacter baumannii. | Kang KN, Kazi MI, Biboy J, Gray J, Bovermann H, Ausman J, Boutte CC, Vollmer W, Boll JM. | mBio | 10.1128/mbio.02185-20 | 2021 | |
| InvL, an Invasin-Like Adhesin, Is a Type II Secretion System Substrate Required for Acinetobacter baumannii Uropathogenesis. | Jackson-Litteken CD, Di Venanzio G, Le NH, Scott NE, Djahanschiri B, Distel JS, Pardue EJ, Ebersberger I, Feldman MF. | mBio | 10.1128/mbio.00258-22 | 2022 | | |
| UTILITY OF STREM-1 BIOMARKER AND HCP GENE FOR IDENTIFICATION OF ACINETOBACTER BAUMANNII COLONIZATION AND INFECTION IN LUNG. | Wang X, Jiang J, Wei C, Yang W, Chen J, Dong X, Wan H, Yu D. | Shock | 10.1097/shk.0000000000002175 | 2023 | | |
| Aromatic hydrazides: A potential solution for Acinetobacter baumannii infections. | Green KD, Thamban Chandrika N, Vu LY, Pang AH, Tsodikov OV, Garneau-Tsodikova S. | Eur J Med Chem | 10.1016/j.ejmech.2023.115165 | 2023 | | |
| Metabolism | Virulence role of the outer membrane protein CarO in carbapenem-resistant Acinetobacter baumannii. | Labrador-Herrera G, Perez-Pulido AJ, Alvarez-Marin R, Casimiro-Soriguer CS, Cebrero-Cangueiro T, Moran-Barrio J, Pachon J, Viale AM, Pachon-Ibanez ME. | Virulence | 10.1080/21505594.2020.1855912 | 2020 | |
| Isolation of Bioactive Metabolites from Soil Derived Fungus-Aspergillus fumigatus. | Gill H, Sykes EME, Kumar A, Sorensen JL. | Microorganisms | 10.3390/microorganisms11030590 | 2023 | | |
| Heterocyclic Diaryliodonium-Based Inhibitors of Carbapenem-Resistant Acinetobacter baumannii. | Kumari P, Kaul G, Kumar TA, Akhir A, Shukla M, Sharma S, Kamat SS, Chopra S, Chakrapani H. | Microbiol Spectr | 10.1128/spectrum.04773-22 | 2023 | | |
| Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies. | Mendes SG, Combo SI, Allain T, Domingues S, Buret AG, Da Silva GJ. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-023-04677-8 | 2023 | | |
| Bolaamphiphile Analogues of 12-bis-THA Cl2 Are Potent Antimicrobial Therapeutics with Distinct Mechanisms of Action against Bacterial, Mycobacterial, and Fungal Pathogens. | Di Blasio S, Clarke M, Hind CK, Asai M, Laurence L, Benvenuti A, Hassan M, Semenya D, Man DK, Horrocks V, Manzo G, Van Der Lith S, Lam C, Gentile E, Annette C, Bosse J, Li Y, Panaretou B, Langford PR, Robertson BD, Lam JKW, Sutton JM, McArthur M, Mason AJ. | mSphere | 10.1128/msphere.00508-22 | 2023 | | |
| Acinetobactin-Mediated Inhibition of Commensal Bacteria by Acinetobacter baumannii. | Knauf GA, Powers MJ, Herrera CM, Trent MS, Davies BW. | mSphere | 10.1128/msphere.00016-22 | 2022 | | |
| Isolation and Characterization of a Phapecoctavirus Infecting Multidrug-Resistant Acinetobacter baumannii in A549 Alveolar Epithelial Cells. | Wintachai P, Surachat K, Chaimaha G, Septama AW, Smith DR. | Viruses | 10.3390/v14112561 | 2022 | | |
| Recent Advances in Phage-Based Therapeutics for Multi-Drug Resistant Acinetobacter baumannii. | Tan Y, Su J, Fu M, Zhang H, Zeng H. | Bioengineering (Basel) | 10.3390/bioengineering10010035 | 2022 | | |
| Genetic Determinants of Acinetobacter baumannii Serum-Associated Adaptive Efflux-Mediated Antibiotic Resistance. | Young M, Chojnacki M, Blanchard C, Cao X, Johnson WL, Flaherty D, Dunman PM. | Antibiotics (Basel) | 10.3390/antibiotics12071173 | 2023 | | |
| Metabolism | Insights into Acinetobacter baumannii fatty acid synthesis 3-oxoacyl-ACP reductases. | Cross EM, Adams FG, Waters JK, Aragao D, Eijkelkamp BA, Forwood JK. | Sci Rep | 10.1038/s41598-021-86400-1 | 2021 | |
| Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of Acinetobacter baumannii. | Moussa SH, Shapiro AB, McLeod SM, Iyer R, Carter NM, Tsai Y-K, Siu LK, Miller AA. | Antimicrob Agents Chemother | 10.1128/aac.00665-23 | 2023 | | |
| The aryl hydrocarbon receptor and FOS mediate cytotoxicity induced by Acinetobacter baumannii. | Kew C, Prieto-Garcia C, Bhattacharya A, Tietgen M, MacNair CR, Carfrae LA, Mello-Vieira J, Klatt S, Cheng YL, Rathore R, Gradhand E, Fleming I, Tan MW, Gottig S, Kempf VAJ, Dikic I. | Nat Commun | 10.1038/s41467-024-52118-7 | 2024 | | |
| Metabolism | Acinetobacter Metabolism in Infection and Antimicrobial Resistance. | Ren X, Palmer LD. | Infect Immun | 10.1128/iai.00433-22 | 2023 | |
| Characterization of Virulent T4-Like Acinetobacter baumannii Bacteriophages DLP1 and DLP2. | Peters DL, Davis CM, Harris G, Zhou H, Rather PN, Hrapovic S, Lam E, Dennis JJ, Chen W. | Viruses | 10.3390/v15030739 | 2023 | | |
| Biosynthesized Silver Nanoparticles Using Morus alba (White Mulberry) Leaf Extract as Potential Antibacterial and Anticancer Agents. | Kumkoon T, Srisaisap M, Boonserm P. | Molecules | 10.3390/molecules28031213 | 2023 | | |
| Double BAC and Triple BAC: A Systematic Analysis of the Disinfectant Properties of Multicationic Derivatives of Benzalkonium Chloride (BAC). | Toles ZEA, Wu A, Sanchez CA, Michaud ME, Thierer LM, Wuest WM, Minbiole KPC. | ChemMedChem | 10.1002/cmdc.202300018 | 2023 | | |
| Pathogenicity | A novel decoy strategy for polymyxin resistance in Acinetobacter baumannii. | Park J, Kim M, Shin B, Kang M, Yang J, Lee TK, Park W. | Elife | 10.7554/elife.66988 | 2021 | |
| Complete genome of the extensively antibiotic-resistant GC1 Acinetobacter baumannii isolate MRSN 56 reveals a novel route to fluoroquinolone resistance. | Harmer CJ, Lebreton F, Stam J, McGann PT, Hall RM. | J Antimicrob Chemother | 10.1093/jac/dkac115 | 2022 | | |
| Nonadditive functional interactions between ligand-binding sites of the multidrug efflux pump AdeB from Acinetobacter baumannii. | Leus IV, Roberts SR, Trinh A, W Yu E, Zgurskaya HI. | J Bacteriol | 10.1128/jb.00217-23 | 2024 | | |
| Antarctic Marine Bacteria as a Source of Anti-Biofilm Molecules to Combat ESKAPE Pathogens. | Artini M, Papa R, Vrenna G, Trecca M, Paris I, D'Angelo C, Tutino ML, Parrilli E, Selan L. | Antibiotics (Basel) | 10.3390/antibiotics12101556 | 2023 | | |
| Nomogram for predicting 90-day mortality in patients with Acinetobacter baumannii-caused hospital-acquired and ventilator-associated pneumonia in the respiratory intensive care unit. | Pei Y, Huang Y, Pan X, Yao Z, Chen C, Zhong A, Xing Y, Qian B, Minhua S, Zhou T. | J Int Med Res | 10.1177/03000605231161481 | 2023 | | |
| Exploring the principles behind antibiotics with limited resistance. | Maharramov E, Czikkely MS, Szili P, Farkas Z, Grezal G, Daruka L, Kurko E, Meszaros L, Daraba A, Kovacs T, Bognar B, Juhasz S, Papp B, Lazar V, Pal C. | Nat Commun | 10.1038/s41467-025-56934-3 | 2025 | | |
| Transcriptomic analysis reveals the regulatory role of quorum sensing in the Acinetobacter baumannii ATCC 19606 via RNA-seq. | Xiong L, Yi F, Yu Q, Huang X, Ao K, Wang Y, Xie Y. | BMC Microbiol | 10.1186/s12866-022-02612-z | 2022 | | |
| A novel antibiotic class targeting the lipopolysaccharide transporter. | Zampaloni C, Mattei P, Bleicher K, Winther L, Thate C, Bucher C, Adam JM, Alanine A, Amrein KE, Baidin V, Bieniossek C, Bissantz C, Boess F, Cantrill C, Clairfeuille T, Dey F, Di Giorgio P, du Castel P, Dylus D, Dzygiel P, Felici A, Garcia-Alcalde F, Haldimann A, Leipner M, Leyn S, Louvel S, Misson P, Osterman A, Pahil K, Rigo S, Schaublin A, Scharf S, Schmitz P, Stoll T, Trauner A, Zoffmann S, Kahne D, Young JAT, Lobritz MA, Bradley KA. | Nature | 10.1038/s41586-023-06873-0 | 2024 | | |
| Fitness Costs of Tigecycline Resistance in Acinetobacter baumannii and the Resistance Mechanism Revealed by a Transposon Mutation Library. | Wang P, Wang H, Liu C, Feng C, Lu Q, Zou Q. | Antibiotics (Basel) | 10.3390/antibiotics11101379 | 2022 | | |
| Metabolism | CsrA Coordinates Compatible Solute Synthesis in Acinetobacter baumannii and Facilitates Growth in Human Urine. | Hubloher JJ, Schabacker K, Muller V, Averhoff B. | Microbiol Spectr | 10.1128/spectrum.01296-21 | 2021 | |
| Multidrug resistance in Pseudomonas aeruginosa: genetic control mechanisms and therapeutic advances. | Zhao Y, Xu H, Wang H, Wang P, Chen S. | Mol Biomed | 10.1186/s43556-024-00221-y | 2024 | | |
| Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin-sulbactam combination therapy. | Srisakul S, Wannigama DL, Higgins PG, Hurst C, Abe S, Hongsing P, Saethang T, Luk-In S, Liao T, Kueakulpattana N, Shein AMS, Gan L, Kupwiwat R, Tanasatitchai C, Wapeesittipan P, Phattharapornjaroen P, Badavath VN, Leelahavanichkul A, Chatsuwan T. | Sci Rep | 10.1038/s41598-022-15386-1 | 2022 | | |
| Genetics | Insights from the revised complete genome sequences of Acinetobacter baumannii strains AB307-0294 and ACICU belonging to global clones 1 and 2. | Hamidian M, Wick RR, Hartstein RM, Judd LM, Holt KE, Hall RM. | Microb Genom | 10.1099/mgen.0.000298 | 2019 | |
| Acinetobacter baumannii Catabolizes Ethanolamine in the Absence of a Metabolosome and Converts Cobinamide into Adenosylated Cobamides. | Villa EA, Escalante-Semerena JC. | mBio | 10.1128/mbio.01793-22 | 2022 | | |
| Lipocalin-2 is an essential component of the innate immune response to Acinetobacter baumannii infection. | Sheldon JR, Himmel LE, Kunkle DE, Monteith AJ, Maloney KN, Skaar EP. | PLoS Pathog | 10.1371/journal.ppat.1010809 | 2022 | | |
| A subtractive proteomics approach for the identification of immunodominant Acinetobacter baumannii vaccine candidate proteins. | Acar MB, Ayaz-Guner S, Guner H, Dinc G, Ulu Kilic A, Doganay M, Ozcan S. | Front Immunol | 10.3389/fimmu.2022.1001633 | 2022 | | |
| Copper-coated hospital surfaces: reduction of total bacterial loads and resistant Acinetobacter spp. | Blehm CJ, Monteiro MSG, Bessa MC, Leyser M, Dias AS, Sumienski J, Gallo SW, da Silva AB, Barros A, Marco R, Preve CP, Ferreira CAS, Ramos F, de Oliveira SD. | AMB Express | 10.1186/s13568-022-01491-x | 2022 | | |
| Metabolism | Acinetobacter baumannii can use multiple siderophores for iron acquisition, but only acinetobactin is required for virulence. | Sheldon JR, Skaar EP. | PLoS Pathog | 10.1371/journal.ppat.1008995 | 2020 | |
| Pathogenicity | Antibiotic-Resistant Acinetobacter baumannii Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI In Vitro and in Experimental Pneumonia in Mice. | Parquet MDC, Savage KA, Allan DS, Ang MTC, Chen W, Logan SM, Holbein BE. | Antimicrob Agents Chemother | 10.1128/aac.00855-19 | 2019 | |
| Pathogenicity | Shared and Unique Evolutionary Trajectories to Ciprofloxacin Resistance in Gram-Negative Bacterial Pathogens. | Zlamal JE, Leyn SA, Iyer M, Elane ML, Wong NA, Wamsley JW, Vercruysse M, Garcia-Alcalde F, Osterman AL. | mBio | 10.1128/mbio.00987-21 | 2021 | |
| Comparison of available methods to evaluate cefiderocol susceptibility in Acinetobacter spp. | Pasteran F, Wong O, Mezcord V, Lopez C, Georgeos N, Fua V, Ozuna A, Ramlaoui D, Sanchez C, Marchetti P, Corso A, Tolmasky ME, Bonomo RA, Ramirez MS. | J Microbiol Methods | 10.1016/j.mimet.2024.106972 | 2024 | | |
| Genome Sequences for Two Acinetobacter baumannii Strains Obtained Using the Unicycler Hybrid Assembly Pipeline. | Farrow JM, Pesci EC, Slade DJ. | Microbiol Resour Announc | 10.1128/mra.00017-21 | 2021 | | |
| Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli. | Miro-Canturri A, Ayerbe-Algaba R, Vila-Dominguez A, Jimenez-Mejias ME, Pachon J, Smani Y. | Antibiotics (Basel) | 10.3390/antibiotics10030336 | 2021 | | |
| Identification of Potential Virulence Factors in the Model Strain Acinetobacter baumannii A118. | Ramirez MS, Penwell WF, Traglia GM, Zimbler DL, Gaddy JA, Nikolaidis N, Arivett BA, Adams MD, Bonomo RA, Actis LA, Tolmasky ME. | Front Microbiol | 10.3389/fmicb.2019.01599 | 2019 | | |
| Identification of further variation at the lipooligosaccharide outer core locus in Acinetobacter baumannii genomes and extension of the OCL reference sequence database for Kaptive. | Sorbello BM, Cahill SM, Kenyon JJ. | Microb Genom | 10.1099/mgen.0.001042 | 2023 | | |
| Pathogenicity | Antigen Epitope Developed Based on Acinetobacter baumannii MacB Protein Can Provide Partial Immune Protection in Mice. | Song X, Zhao G, Ding M. | Biomed Res Int | 10.1155/2020/1975875 | 2020 | |
| Contribution of RND-Type Efflux Pumps in Reduced Susceptibility to Biocides in Acinetobacter baumannii. | Meyer C, Lucaben K, Gerson S, Xanthopoulou K, Wille T, Seifert H, Higgins PG. | Antibiotics (Basel) | 10.3390/antibiotics11111635 | 2022 | | |
| Guanidinylated Polymyxins as Outer Membrane Permeabilizers Capable of Potentiating Rifampicin, Erythromycin, Ceftazidime and Aztreonam against Gram-Negative Bacteria. | Ramirez DM, Ramirez D, Arthur G, Zhanel G, Schweizer F. | Antibiotics (Basel) | 10.3390/antibiotics11101277 | 2022 | | |
| Global emergence of a hypervirulent carbapenem-resistant Escherichia coli ST410 clone. | Ba X, Guo Y, Moran RA, Doughty EL, Liu B, Yao L, Li J, He N, Shen S, Li Y, van Schaik W, McNally A, Holmes MA, Zhuo C. | Nat Commun | 10.1038/s41467-023-43854-3 | 2024 | | |
| Proteomics Profiling of S-sulfurated Proteins in Acinetobacter baumannii. | Walsh BJC, Giedroc DP. | Bio Protoc | 10.21769/bioprotoc.4000 | 2021 | | |
| Genetics | Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons. | Zafer MM, Hussein AFA, Al-Agamy MH, Radwan HH, Hamed SM. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1229473 | 2023 | |
| Development of triplex assay for simultaneous detection of Escherichia coli, methicillin resistant and sensitive Staphylococcus aureus in raw pork samples of retail markets. | Parihar R, Deb R, Niharika J, Thakur P, Pegu SR, Sengar GS, Sonowal J, Das PJ, Rajkhowa S, Raj A, Gupta VK. | J Food Sci Technol | 10.1007/s13197-023-05917-7 | 2024 | | |
| Molecular epidemiology and carbapenem resistance characteristics of Acinetobacter baumannii causing bloodstream infection from 2009 to 2018 in northwest China. | Gu Y, Zhang W, Lei J, Zhang L, Hou X, Tao J, Wang H, Deng M, Zhou M, Weng R, Xu J. | Front Microbiol | 10.3389/fmicb.2022.983963 | 2022 | | |
| Genetics | Molecular characterization of multidrug resistant Acinetobacter baumannii clinical isolates from Alexandria, Egypt. | Sanchez-Urtaza S, Ocampo-Sosa A, Molins-Bengoetxea A, El-Kholy MA, Hernandez M, Abad D, Shawky SM, Alkorta I, Gallego L. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1208046 | 2023 | |
| Enzymology | Next Generation of Tn7-Based Single-Copy Insertion Elements for Use in Multi- and Pan-Drug-Resistant Strains of Acinetobacter baumannii. | Ducas-Mowchun K, De Silva PM, Crisostomo L, Fernando DM, Chao TC, Pelka P, Schweizer HP, Kumar A. | Appl Environ Microbiol | 10.1128/aem.00066-19 | 2019 | |
| Isolation and characterization of a VHH targeting the Acinetobacter baumannii cell surface protein CsuA/B. | Lei EK, Ryan S, van Faassen H, Foss M, Robotham A, Baltat I, Fulton K, Henry KA, Chen W, Hussack G. | Appl Microbiol Biotechnol | 10.1007/s00253-023-12594-1 | 2023 | | |
| Illuminating microflora: shedding light on the potential of blue light to modulate the cutaneous microbiome. | Serrage HJ, O' Neill CA, Uzunbajakava NE. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1307374 | 2024 | | |
| Analysis of Bacterial Phosphorylcholine-Related Genes Reveals an Association between Type-Specific Biosynthesis Pathways and Biomolecules Targeted for Phosphorylcholine Modification. | Zhang Y, Jen FE, Edwards JL, Jennings MP. | Microbiol Spectr | 10.1128/spectrum.01583-23 | 2023 | | |
| Biofilms preserve the transmissibility of a multi-drug resistance plasmid. | Metzger GA, Ridenhour BJ, France M, Gliniewicz K, Millstein J, Settles ML, Forney LJ, Stalder T, Top EM. | NPJ Biofilms Microbiomes | 10.1038/s41522-022-00357-1 | 2022 | | |
| Antibiofilm and Antivirulence Efficacies of Flavonoids and Curcumin Against Acinetobacter baumannii. | Raorane CJ, Lee JH, Kim YG, Rajasekharan SK, Garcia-Contreras R, Lee J. | Front Microbiol | 10.3389/fmicb.2019.00990 | 2019 | | |
| Genomics-guided identification of a conserved CptBA-like toxin-antitoxin system in Acinetobacter baumannii. | ElBanna SA, Moneib NA, Aziz RK, Samir R. | J Adv Res | 10.1016/j.jare.2020.11.007 | 2021 | | |
| Transcriptional Regulation of the Outer Membrane Protein A in Acinetobacter baumannii. | Oh KW, Kim K, Islam MM, Jung HW, Lim D, Lee JC, Shin M. | Microorganisms | 10.3390/microorganisms8050706 | 2020 | | |
| Molecular characterisation of Acinetobacter baumannii isolates from bloodstream infections in a tertiary-level hospital in South Africa. | Lowe M, Singh-Moodley A, Ismail H, Thomas T, Chibabhai V, Nana T, Lowman W, Ismail A, Chan WY, Perovic O. | Front Microbiol | 10.3389/fmicb.2022.863129 | 2022 | | |
| Metabolism | Functional Characterization of AbaQ, a Novel Efflux Pump Mediating Quinolone Resistance in Acinetobacter baumannii. | Perez-Varela M, Corral J, Aranda J, Barbe J. | Antimicrob Agents Chemother | 10.1128/aac.00906-18 | 2018 | |
| Cyclic AMP is a global virulence regulator governing inter and intrabacterial signalling in Acinetobacter baumannii. | Harkova LG, de Dios R, Rubio-Valle A, Perez-Pulido AJ, McCarthy RR. | PLoS Pathog | 10.1371/journal.ppat.1012529 | 2024 | | |
| A set of shuttle plasmids for gene expression in Acinetobacter baumannii. | Jie J, Chu X, Li D, Luo Z. | PLoS One | 10.1371/journal.pone.0246918 | 2021 | | |
| Characterization of Three Different Endolysins Effective against Gram-Negative Bacteria. | Jeong TH, Hong HW, Kim MS, Song M, Myung H. | Viruses | 10.3390/v15030679 | 2023 | | |
| Genomic and phenotypic characterization of Pseudomonas sp. GOM7, a novel marine bacterial species with antimicrobial activity against multidrug-resistant Staphylococcus aureus. | Romero-Gonzalez LE, Rojas-Vargas J, Muriel-Millan LF, Bustos-Martinez J, Bustamante VH, Pardo-Lopez L. | PLoS One | 10.1371/journal.pone.0288504 | 2023 | | |
| Emergence and Evolution of OXA-23-Producing ST46Pas-ST462Oxf-KL28-OCL1 Carbapenem-Resistant Acinetobacter baumannii Mediated by a Novel ISAba1-Based Tn7534 Transposon. | Liu H, Liu X, He J, Zhang L, Zhao F, Zhou Z, Hua X, Yu Y. | Antibiotics (Basel) | 10.3390/antibiotics12020396 | 2023 | | |
| BlsA Is a Low to Moderate Temperature Blue Light Photoreceptor in the Human Pathogen Acinetobacter baumannii. | Golic AE, Valle L, Jaime PC, Alvarez CE, Parodi C, Borsarelli CD, Abatedaga I, Mussi MA. | Front Microbiol | 10.3389/fmicb.2019.01925 | 2019 | | |
| Proteome | The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis. | Liu C, Wang L, Wang P, Xiao D, Zou Q. | Int J Mol Sci | 10.3390/ijms24108652 | 2023 | |
| Effect of traditional Chinese medicine monomers interfering with quorum-sensing on virulence factors of extensively drug-resistant Acinetobacter baumannii. | Zeng L, Lin F, Ling B. | Front Pharmacol | 10.3389/fphar.2023.1135180 | 2023 | | |
| A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii. | Chen SP, Chen EH, Yang SY, Kuo PS, Jan HM, Yang TC, Hsieh MY, Lee KT, Lin CH, Chen RP. | Front Microbiol | 10.3389/fmicb.2021.678330 | 2021 | | |
| Effects of Inactivation of d,d-Transpeptidases of Acinetobacter baumannii on Bacterial Growth and Susceptibility to beta-Lactam Antibiotics. | Toth M, Lee M, Stewart NK, Vakulenko SB. | Antimicrob Agents Chemother | 10.1128/aac.01729-21 | 2022 | | |
| Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria. | Vila Dominguez A, Ayerbe Algaba R, Miro Canturri A, Rodriguez Villodres A, Smani Y. | Antibiotics (Basel) | 10.3390/antibiotics9010036 | 2020 | | |
| Genome-wide phage susceptibility analysis in Acinetobacter baumannii reveals capsule modulation strategies that determine phage infectivity. | Bai J, Raustad N, Denoncourt J, van Opijnen T, Geisinger E. | PLoS Pathog | 10.1371/journal.ppat.1010928 | 2023 | | |
| Metabolism | The type VI secretion system protein AsaA in Acinetobacter baumannii is a periplasmic protein physically interacting with TssM and required for T6SS assembly. | Li L, Wang YN, Jia HB, Wang P, Dong JF, Deng J, Lu FM, Zou QH. | Sci Rep | 10.1038/s41598-019-45875-9 | 2019 | |
| Novel Penicillin-Based Sulfone-Siderophore Conjugates for Restoring beta-Lactam Antibiotic Efficacy. | Rodriguez D, Lence E, Vazquez-Ucha JC, Beceiro A, Gonzalez-Bello C. | ACS Omega | 10.1021/acsomega.4c02984 | 2024 | | |
| Pathogenicity | Bacterial Cytological Profiling as a Tool To Study Mechanisms of Action of Antibiotics That Are Active against Acinetobacter baumannii. | Htoo HH, Brumage L, Chaikeeratisak V, Tsunemoto H, Sugie J, Tribuddharat C, Pogliano J, Nonejuie P. | Antimicrob Agents Chemother | 10.1128/aac.02310-18 | 2019 | |
| Pathogenicity | Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates. | Trebosc V, Gartenmann S, Totzl M, Lucchini V, Schellhorn B, Pieren M, Lociuro S, Gitzinger M, Tigges M, Bumann D, Kemmer C. | mBio | 10.1128/mbio.01083-19 | 2019 | |
| Pathogenicity | The investigation of adrenal involvement in carbapenem resistant Acinetobacter baumannii sepsis: experimental mouse model | Eryilmaz-Eren E, Dinc G, Kontas O, Alp E, Doganay M. | Turk J Med Sci | 10.3906/sag-2001-163 | 2021 | |
| Hybrid antigens expressing surface loops of BauA from Acinetobacter baumannii are capable of inducing protection against infection. | Chaudhuri S, Rasooli I, Oskouei RH, Pishgahi M, Jahangir A, Andisi VF, Schryvers AB. | Front Immunol | 10.3389/fimmu.2022.933445 | 2022 | | |
| Metabolism | Histidine Utilization Is a Critical Determinant of Acinetobacter Pathogenesis. | Lonergan ZR, Palmer LD, Skaar EP. | Infect Immun | 10.1128/iai.00118-20 | 2020 | |
| Pathogenicity | Bacterial membrane vesicles from Acinetobacter baumannii induced by ceftazidime are more virulent than those induced by imipenem. | Chiu CH, Lee YT, Lin YC, Kuo SC, Yang YS, Wang YC, Liu YH, Lin JC, Chang FY, Chen TL. | Virulence | 10.1080/21505594.2020.1726593 | 2020 | |
| Bacterial hydrophilins promote pathogen desiccation tolerance. | Green ER, Fakhoury JN, Monteith AJ, Pi H, Giedroc DP, Skaar EP. | Cell Host Microbe | 10.1016/j.chom.2022.03.019 | 2022 | | |
| Metabolism | 2-Hydroxylation of Acinetobacter baumannii Lipid A Contributes to Virulence. | Bartholomew TL, Kidd TJ, Sa Pessoa J, Conde Alvarez R, Bengoechea JA. | Infect Immun | 10.1128/iai.00066-19 | 2019 | |
| Pathogenicity | Infection of Endothelial Cells with Acinetobacter baumannii Reveals Remodelling of Mitochondrial Protein Complexes. | Leukert L, Tietgen M, Krause FF, Schultze TG, Fuhrmann DC, Debruyne C, Salcedo SP, Visekruna A, Wittig L, Gottig S. | Microbiol Spectr | 10.1128/spectrum.05174-22 | 2023 | |
| Metabolism | Biochemical characterization of a recombinant acid phosphatase from Acinetobacter baumannii. | Smiley-Moreno E, Smith D, Yu JJ, Cao P, Arulanandam BP, Chambers JP. | PLoS One | 10.1371/journal.pone.0252377 | 2021 | |
| Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli. | Miro-Canturri A, Ayerbe-Algaba R, Del Toro R, Mejias ME, Pachon J, Smani Y. | Pharmaceuticals (Basel) | 10.3390/ph14060507 | 2021 | | |
| New N-phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity. | Cotman AE, Fulgheri F, Piga M, Persolja P, Tiz DB, Skok Z, Durcik M, Sterle M, Dernovsek J, Cruz CD, Tammela P, Szili PE, Daruka L, Pal C, Zega A, Masic LP, Ilas J, Tomasic T, Kikelj D, Zidar N. | RSC Adv | 10.1039/d4ra04802d | 2024 | | |
| Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates From Greece. | Petropoulou D, Siopi M, Vourli S, Pournaras S. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.814530 | 2021 | | |
| Antibacterial and antibiofilm activities of ZIF-67. | Gallegos-Monterrosa R, Mendiola RO, Nunez Y, Auvynet C, Kumar KM, Tang B, Ruiz-Ortega LI, Bustamante VH. | J Antibiot (Tokyo) | 10.1038/s41429-023-00637-8 | 2023 | | |
| Biosurfactant from Nile Papyrus endophyte with potential antibiofilm activity against global clones of Acinetobacter baumannii. | Amer MA, Wasfi R, Hamed SM. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1210195 | 2023 | | |
| New Genetically Engineered Derivatives of Antibacterial Darobactins Underpin Their Potential for Antibiotic Development. | Seyfert CE, Muller AV, Walsh DJ, Birkelbach J, Kany AM, Porten C, Yuan B, Krug D, Herrmann J, Marlovits TC, Hirsch AKH, Muller R. | J Med Chem | 10.1021/acs.jmedchem.3c01660 | 2023 | | |
| A high-efficiency scar-free genome-editing toolkit for Acinetobacter baumannii. | de Dios R, Gadar K, McCarthy RR. | J Antimicrob Chemother | 10.1093/jac/dkac328 | 2022 | | |
| Inhibitor of Chromosome Segregation in Pseudomonas aeruginosa from Fungal Extracts. | Zhao H, Peramuna T, Ajmal S, Wendt KL, Petrushenko ZM, Premachandra K, Cichewicz RH, Rybenkov VV. | ACS Chem Biol | 10.1021/acschembio.4c00264 | 2024 | | |
| Metal retention and replacement in QueD2 protect queuosine-tRNA biosynthesis in metal-starved Acinetobacter baumannii. | Jordan MR, Gonzalez-Gutierrez G, Trinidad JC, Giedroc DP. | Proc Natl Acad Sci U S A | 10.1073/pnas.2213630119 | 2022 | | |
| Pathogenicity | Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae. | Ayerbe-Algaba R, Gil-Marques ML, Jimenez-Mejias ME, Sanchez-Encinales V, Parra-Millan R, Pachon-Ibanez ME, Pachon J, Smani Y. | Front Cell Infect Microbiol | 10.3389/fcimb.2018.00348 | 2018 | |
| Light Regulates Acinetobacter baumannii Chromosomal and pAB3 Plasmid Genes at 37°C. | Squire MS, Townsend HA, Islam A, Actis LA. | J Bacteriol | 10.1128/jb.00032-22 | 2022 | | |
| Quorum Sensing Inhibition or Quenching in Acinetobacter baumannii: The Novel Therapeutic Strategies for New Drug Development. | Zhong S, He S. | Front Microbiol | 10.3389/fmicb.2021.558003 | 2021 | | |
| Total Synthesis of a Pentasaccharide O-Glycan from Acinetobacter baumannii. | Njeri DK, Ragains JR. | European J Org Chem | 10.1002/ejoc.202201261 | 2022 | | |
| Effect of Hypoxia on the Pathogenesis of Acinetobacter baumannii and Pseudomonas aeruginosa In Vitro and in Murine Experimental Models of Infection. | Gil-Marques ML, Pachon-Ibanez ME, Pachon J, Smani Y. | Infect Immun | 10.1128/iai.00543-18 | 2018 | | |
| Pathogenicity | The effect of sub-inhibitory concentrations of antibiotics on natural transformation in Acinetobacter baumannii. | Quinn B, Martinez J, Liu C, Nguyen M, Ramirez MS. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2018.01.026 | 2018 | |
| Rigidity-Activity Relationships of bisQPC Scaffolds against Pathogenic Bacteria. | Spahr AC, Michaud ME, Amoo LE, Sanchez CA, Hogue CE, Thierer LM, Gau MR, Wuest WM, Minbiole KPC. | ChemMedChem | 10.1002/cmdc.202200224 | 2022 | | |
| Development of a Magnetic Bead-Based Method for Specific Detection of Enterococcus faecalis Using C-Terminal Domain of ECP3 Phage Endolysin. | Choi YJ, Kim S, Kim J. | J Microbiol Biotechnol | 10.4014/jmb.2302.02033 | 2023 | | |
| Metabolism | CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII. | Waack U, Warnock M, Yee A, Huttinger Z, Smith S, Kumar A, Deroux A, Ginsburg D, Mobley HLT, Lawrence DA, Sandkvist M. | mBio | 10.1128/mbio.01606-18 | 2018 | |
| Antibacterial Effects of Recombinant Endolysins in Disinfecting Medical Equipment: A Pilot Study. | Choi YJ, Kim S, Bae S, Kim Y, Chang HH, Kim J. | Front Microbiol | 10.3389/fmicb.2021.773640 | 2021 | | |
| Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: Comparison between intranasal inoculation, intratracheal instillation and oropharyngeal aspiration techniques. | Bergamini G, Perico ME, Di Palma S, Sabatini D, Andreetta F, Defazio R, Felici A, Ferrari L. | PLoS One | 10.1371/journal.pone.0260627 | 2021 | | |
| Contribution of the AbaI/AbaR Quorum Sensing System to Resistance and Virulence of Acinetobacter baumannii Clinical Strains. | Tang J, Chen Y, Wang X, Ding Y, Sun X, Ni Z. | Infect Drug Resist | 10.2147/idr.s276970 | 2020 | | |
| Proline-Hinged alpha-Helical Peptides Sensitize Gram-Positive Antibiotics, Expanding Their Physicochemical Properties to Be Used as Gram-Negative Antibiotics. | Choi Y, Choe HW, Kook M, Choo S, Park TW, Bae S, Kim H, Yang J, Jeong WS, Yu J, Lee KR, Kim YS, Yu J. | J Med Chem | 10.1021/acs.jmedchem.3c01473 | 2024 | | |
| Profiling Antibiotic Resistance in Acinetobacter calcoaceticus. | Glover JS, Ticer TD, Engevik MA. | Antibiotics (Basel) | 10.3390/antibiotics11070978 | 2022 | | |
| Pathogenicity | Outer Membrane Interaction Kinetics of New Polymyxin B Analogs in Gram-Negative Bacilli. | Akhoundsadegh N, Belanger CR, Hancock REW. | Antimicrob Agents Chemother | 10.1128/aac.00935-19 | 2019 | |
| Overexpression of a DNA Methyltransferase Increases Persister Cell Formation in Acinetobacter baumannii. | Kim H, Kim JH, Cho H, Ko KS. | Microbiol Spectr | 10.1128/spectrum.02655-22 | 2022 | | |
| Cl415, a carbapenem-resistant Acinetobacter baumannii isolate containing four AbaR4 and a new variant of AbGRI2, represents a novel global clone 2 strain. | Liepa R, Mann R, Osman M, Hamze M, Gunawan C, Hamidian M. | J Antimicrob Chemother | 10.1093/jac/dkab399 | 2022 | | |
| CRISPR-Cas in Acinetobacter baumannii Contributes to Antibiotic Susceptibility by Targeting Endogenous AbaI. | Wang Y, Yang J, Sun X, Li M, Zhang P, Zhu Z, Jiao H, Guo T, Li G. | Microbiol Spectr | 10.1128/spectrum.00829-22 | 2022 | | |
| Characterization of a novel and active temperate phage vB_AbaM_ABMM1 with antibacterial activity against Acinetobacter baumannii infection. | Mardiana M, Teh SH, Tsai YC, Yang HH, Lin LC, Lin NT. | Sci Rep | 10.1038/s41598-023-38453-7 | 2023 | | |
| When Combined with Colistin, an Otherwise Ineffective Rifampicin-Linezolid Combination Becomes Active in Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii. | Armengol E, Asuncion T, Vinas M, Sierra JM. | Microorganisms | 10.3390/microorganisms8010086 | 2020 | | |
| Metabolism | Intracellular Trafficking and Persistence of Acinetobacter baumannii Requires Transcription Factor EB. | Parra-Millan R, Guerrero-Gomez D, Ayerbe-Algaba R, Pachon-Ibanez ME, Miranda-Vizuete A, Pachon J, Smani Y. | mSphere | 10.1128/msphere.00106-18 | 2018 | |
| Pathogenicity | In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae. | Lee B, Yan J, Ulhaq A, Miller S, Seo W, Lu P, She R, Spellberg B, Luna B. | mSphere | 10.1128/msphere.00920-21 | 2021 | |
| Genomic Characterization of Mobile Genetic Elements Associated With Carbapenem Resistance of Acinetobacter baumannii From India. | Vijayakumar S, Jacob JJ, Vasudevan K, Mathur P, Ray P, Neeravi A, Baskaran A, Kirubananthan A, Anandan S, Biswas I, Walia K, Veeraraghavan B. | Front Microbiol | 10.3389/fmicb.2022.869653 | 2022 | | |
| Endophytic bacteria of Fagonia indica Burm. f revealed to harbour rich secondary antibacterial metabolites. | Rahman L, Mukhtar A, Ahmad S, Rahman L, Ali M, Saeed M, Shinwari ZK. | PLoS One | 10.1371/journal.pone.0277825 | 2022 | | |
| Metabolism | Role of EmaSR in Ethanol Metabolism by Acinetobacter baumannii. | Shu HY, Huang YW, Tsai PY, Hsieh KS, Lin GH. | Int J Mol Sci | 10.3390/ijms232012606 | 2022 | |
| Characterization of a small plasmid carrying the carbapenem resistance gene bla OXA-72 from community-acquired Acinetobacter baumannii sequence type 880 in China. | Jia H, Sun Q, Ruan Z, Xie X. | Infect Drug Resist | 10.2147/idr.s202803 | 2019 | | |
| Emergence of high colistin resistance in carbapenem resistant Acinetobacter baumannii in Pakistan and its potential management through immunomodulatory effect of an extract from Saussurea lappa. | Ahsan U, Mushtaq F, Saleem S, Malik A, Sarfaraz H, Shahzad M, Uhlin BE, Ahmad I. | Front Pharmacol | 10.3389/fphar.2022.986802 | 2022 | | |
| Development of naphthalimide hydrazide derivatives as potent antibacterial agents against carbapenem-resistant A. baumannii. | Rana P, Maitra R, Saxena D, Akhir A, Vadakattu M, Kalam A, Joshi SV, Parupalli R, Bhandari V, Madhavi YV, Dasgupta A, Chopra S, Nanduri S. | RSC Med Chem | 10.1039/d4md00368c | 2024 | | |
| Differential Binding of Carbapenems with the AdeABC Efflux Pump and Modulation of the Expression of AdeB Linked to Novel Mutations within Two-Component System AdeRS in Carbapenem-Resistant Acinetobacter baumannii. | Roy S, Junghare V, Dutta S, Hazra S, Basu S. | mSystems | 10.1128/msystems.00217-22 | 2022 | | |
| Metabolism | Description of a Rare Pyomelanin-Producing Carbapenem-Resistant Acinetobacter baumannii Strain Coharboring Chromosomal OXA-23 and NDM-1. | Zhao F, Liu H, Yao Y, Zhang L, Zhou Z, Leptihn S, Yu Y, Hua X, Fu Y. | Microbiol Spectr | 10.1128/spectrum.02144-22 | 2022 | |
| Pathogenicity | Pentagalloyl glucose from Schinus terebinthifolia inhibits growth of carbapenem-resistant Acinetobacter baumannii. | Dettweiler M, Marquez L, Lin M, Sweeney-Jones AM, Chhetri BK, Zurawski DV, Kubanek J, Quave CL. | Sci Rep | 10.1038/s41598-020-72331-w | 2020 | |
| Pathogenicity | Effect of Host Human Products on Natural Transformation in Acinetobacter baumannii. | Quinn B, Traglia GM, Nguyen M, Martinez J, Liu C, Fernandez JS, Ramirez MS. | Curr Microbiol | 10.1007/s00284-017-1417-5 | 2019 | |
| Genetics | Analysis of Complete Genome Sequence of Acinetobacter baumannii Strain ATCC 19606 Reveals Novel Mobile Genetic Elements and Novel Prophage. | Hamidian M, Blasco L, Tillman LN, To J, Tomas M, Myers GSA. | Microorganisms | 10.3390/microorganisms8121851 | 2020 | |
| Isolation, Characterization, and Anti-Biofilm Activity of a Novel Kaypoctavirus Against K24 Capsular Type, Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates. | Wintachai P, Santini JM, Thonguppatham R, Stroyakovski M, Surachat K, Atipairin A. | Antibiotics (Basel) | 10.3390/antibiotics14020157 | 2025 | | |
| The Cell-Cell Communication Signal Indole Controls the Physiology and Interspecies Communication of Acinetobacter baumannii. | Cui B, Chen X, Guo Q, Song S, Wang M, Liu J, Deng Y. | Microbiol Spectr | 10.1128/spectrum.01027-22 | 2022 | | |
| Sequential Hypertonic-Hypotonic Treatment Enhances Efficacy of Antibiotic against Acinetobacter baumannii Biofilm Communities. | Falghoush A, Beyenal H, Call DR. | Antibiotics (Basel) | 10.3390/antibiotics9110832 | 2020 | | |
| Francisella tularensis universal stress protein contributes to persistence during growth arrest and paraquat-induced superoxide stress. | Girardo B, Yue Y, Lockridge O, Bartling AM, Schopfer LM, Augusto L, Larson MA. | J Bacteriol | 10.1128/jb.00377-24 | 2025 | | |
| Antibiofilm and Antimicrobial Activities of Chloroindoles Against Uropathogenic Escherichia coli. | Boya BR, Lee JH, Lee J. | Front Microbiol | 10.3389/fmicb.2022.872943 | 2022 | | |
| Disulfiram inhibits bacterial growth by inducing zinc-dependent reactive oxygen species. | Luo Q, Wu Z, Pan Y, Zhang Y. | Front Microbiol | 10.3389/fmicb.2025.1619416 | 2025 | | |
| Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing. | Kazi MI, Schargel RD, Boll JM. | J Vis Exp | 10.3791/61612 | 2020 | | |
| Electrical Broth Micro-Dilution for Rapid Antibiotic Resistance Testing. | Spencer D, Li Y, Zhu Y, Sutton JM, Morgan H. | ACS Sens | 10.1021/acssensors.2c02166 | 2023 | | |
| In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms. | Trebosc V, Schellhorn B, Schill J, Lucchini V, Buhler J, Bourotte M, Butcher JJ, Gitzinger M, Lociuro S, Kemmer C, Dale GE. | J Antimicrob Chemother | 10.1093/jac/dkaa370 | 2020 | | |
| Biotechnology | Assessing the antibacterial potential of 6-gingerol: Combined experimental and computational approaches. | Elfaky MA, Okairy HM, Abdallah HM, Koshak AE, Mohamed GA, Ibrahim SRM, Alzain AA, Hegazy WAH, Khafagy ES, Seleem NM. | Saudi Pharm J | 10.1016/j.jsps.2024.102041 | 2024 | |
| Targeting Protein Disorder for the Remediation of Antimicrobial Resistance. | Callaghan JO, Ryan MP, Hudson S, Thompson D. | ACS Omega | 10.1021/acsomega.4c08427 | 2024 | | |
| Overexpression of Efflux Pumps, Mutations in the Pumps' Regulators, Chromosomal Mutations, and AAC(6')-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic Acinetobacter baumannii: A 7-Year Single Center Study. | Roy S, Chatterjee S, Bhattacharjee A, Chattopadhyay P, Saha B, Dutta S, Basu S. | Front Microbiol | 10.3389/fmicb.2021.602724 | 2021 | | |
| Metabolism | The Acinetobacter baumannii Znu System Overcomes Host-Imposed Nutrient Zinc Limitation. | Hesse LE, Lonergan ZR, Beavers WN, Skaar EP. | Infect Immun | 10.1128/iai.00746-19 | 2019 | |
| Disrupting quorum sensing as a strategy to inhibit bacterial virulence in human, animal, and plant pathogens. | Gonzales M, Kergaravat B, Jacquet P, Billot R, Grizard D, Chabriere E, Plener L, Daude D. | Pathog Dis | 10.1093/femspd/ftae009 | 2024 | | |
| Atom Economical QPCs: Phenyl-Free Biscationic Quaternary Phosphonium Compounds as Potent Disinfectants. | Thierer LM, Petersen AA, Michaud ME, Sanchez CA, Brayton SR, Wuest WM, Minbiole KPC. | ACS Infect Dis | 10.1021/acsinfecdis.2c00575 | 2023 | | |
| Pathogenicity | Vaccination induces rapid protection against bacterial pneumonia via training alveolar macrophage in mice. | Gu H, Zeng X, Peng L, Xiang C, Zhou Y, Zhang X, Zhang J, Wang N, Guo G, Li Y, Liu K, Gu J, Zeng H, Zhuang Y, Li H, Zhang J, Zhang W, Zou Q, Shi Y. | Elife | 10.7554/elife.69951 | 2021 | |
| Screen of Unfocused Libraries Identified Compounds with Direct or Synergistic Antibacterial Activity. | Mugnaini C, Sannio F, Brizzi A, Del Prete R, Simone T, Ferraro T, De Luca F, Corelli F, Docquier JD. | ACS Med Chem Lett | 10.1021/acsmedchemlett.9b00674 | 2020 | | |
| Pathogenicity | Antimicrobial Resistance Profile of Acinetobacter spp. Isolates from Retail Meat Samples under Campylobacter-Selective Conditions. | Cha MH, Kim SH, Kim S, Lee W, Kwak HS, Chi YM, Woo GJ. | J Microbiol Biotechnol | 10.4014/jmb.2102.02027 | 2021 | |
| Enzymology | Widespread detoxifying NO reductases impart a distinct isotopic fingerprint on N2O under anoxia. | Wang RZ, Lonergan ZR, Wilbert SA, Eiler JM, Newman DK. | Proc Natl Acad Sci U S A | 10.1073/pnas.2319960121 | 2024 | |
| Molecular Characterization of Carbapenem/Colistin-Resistant Acinetobacter baumannii Clinical Isolates from Egypt by Whole-Genome Sequencing. | Fam NS, Gamal D, Mohamed SH, Wasfy RM, Soliman MS, El-Kholy AA, Higgins PG. | Infect Drug Resist | 10.2147/idr.s288865 | 2020 | | |
| Trimeric Tobramycin/Nebramine Synergizes beta-Lactam Antibiotics against Pseudomonas aeruginosa. | Dhiman S, Ramirez D, Arora R, Gandhi K, Wimalasekara R, Arthur G, Kumar A, Schweizer F. | ACS Omega | 10.1021/acsomega.3c02810 | 2023 | | |
| SSNOMBACTER: A collection of scattering-type scanning near-field optical microscopy and atomic force microscopy images of bacterial cells. | Lucidi M, Tranca DE, Nichele L, Unay D, Stanciu GA, Visca P, Holban AM, Hristu R, Cincotti G, Stanciu SG. | Gigascience | 10.1093/gigascience/giaa129 | 2020 | | |
| Pathogenicity | Rescued chlorhexidine activity by resveratrol against carbapenem-resistant Acinetobacter baumannii via down-regulation of AdeB efflux pump. | Singkham-In U, Higgins PG, Wannigama DL, Hongsing P, Chatsuwan T. | PLoS One | 10.1371/journal.pone.0243082 | 2020 | |
| Development of xanthone derivatives as effective broad-spectrum antimicrobials: Disrupting cell wall and inhibiting DNA synthesis. | Li H, Kang WT, Zheng Y, He Y, Zhong R, Fang S, Wen W, Liu S, Lin S. | Sci Adv | 10.1126/sciadv.adt4723 | 2025 | | |
| Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens. | Lei EK, Azmat A, Henry KA, Hussack G. | Appl Microbiol Biotechnol | 10.1007/s00253-024-13033-5 | 2024 | | |
| Genetics | Acinetobacter baumannii NCIMB8209: a Rare Environmental Strain Displaying Extensive Insertion Sequence-Mediated Genome Remodeling Resulting in the Loss of Exposed Cell Structures and Defensive Mechanisms. | Repizo GD, Espariz M, Seravalle JL, Diaz Miloslavich JI, Steimbruch BA, Shuman HA, Viale AM. | mSphere | 10.1128/msphere.00404-20 | 2020 | |
| Identification of the Acinetobacter baumannii Ribonuclease P Catalytic Subunit: Cleavage of a Target mRNA in the Presence of an External Guide Sequence. | Davies-Sala C, Jani S, Zorreguieta A, Tolmasky ME. | Front Microbiol | 10.3389/fmicb.2018.02408 | 2018 | | |
| PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens. | Euler CW, Raz A, Hernandez A, Serrano A, Xu S, Andersson M, Zou G, Zhang Y, Fischetti VA, Li J. | Antimicrob Agents Chemother | 10.1128/aac.01519-22 | 2023 | | |
| Metabolism | Role of Iron-Containing Alcohol Dehydrogenases in Acinetobacter baumannii ATCC 19606 Stress Resistance and Virulence. | Lin GH, Hsieh MC, Shu HY. | Int J Mol Sci | 10.3390/ijms22189921 | 2021 | |
| An insight into the emergence of Acinetobacter baumannii as an oro-dental pathogen and its drug resistance gene profile - An in silico approach. | Vijayashree Priyadharsini J, Smiline Girija AS, Paramasivam A. | Heliyon | 10.1016/j.heliyon.2018.e01051 | 2018 | | |
| Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It. | Ma C, McClean S. | Vaccines (Basel) | 10.3390/vaccines9060570 | 2021 | | |
| Complete Genome Sequence of Collection Strain Acinetobacter baumannii ATCC BAA-1790, Used as a Model To Study the Antibiotic Resistance Reversion Induced by Iodine-Containing Complexes. | Korotetskiy IS, Joubert M, Magabotha SM, Jumagaziyeva AB, Shilov SV, Suldina NA, Kenesheva ST, Yssel A, Reva ON, Ilin AI. | Microbiol Resour Announc | 10.1128/mra.01467-19 | 2020 | | |
| Homodimerization and heterodimerization requirements of Acinetobacter baumannii SOS response coregulators UmuDAb and DdrR revealed by two-hybrid analyses. | Cook D, Carrington J, Johnson K, Hare J. | Can J Microbiol | 10.1139/cjm-2020-0219 | 2021 | | |
| Genomic surveillance of Acinetobacter baumannii in the Philippines, 2013-2014. | Chilam J, Argimon S, Limas MT, Masim ML, Gayeta JM, Lagrada ML, Olorosa AM, Cohen V, Hernandez LT, Jeffrey B, Abudahab K, Hufano CM, Sia SB, Holden MTG, Stelling J, Aanensen DM, Carlos CC, Philippines Antimicrobial Resistance Surveillance Program. | Western Pac Surveill Response J | 10.5365/wpsar.2021.12.4.863 | 2021 | | |
| Genetics | Characterization of multidrug-resistant Acinetobacter baumannii strain ATCC BAA1605 using whole-genome sequencing. | Ten KE, Md Zoqratt MZH, Ayub Q, Tan HS. | BMC Res Notes | 10.1186/s13104-021-05493-z | 2021 | |
| Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study. | Tran TB, Bergen PJ, Creek DJ, Velkov T, Li J. | Front Pharmacol | 10.3389/fphar.2018.00359 | 2018 | | |
| Detection of Antimicrobial Resistance Genes Associated with Carbapenem Resistance from the Whole-Genome Sequence of Acinetobacter baumannii Isolates from Malaysia. | Rao M, Rashid FA, Shukor S, Hashim R, Ahmad N. | Can J Infect Dis Med Microbiol | 10.1155/2020/5021064 | 2020 | | |
| An Update on the Therapeutic Potential of Antimicrobial Peptides against Acinetobacter baumannii Infections. | Rangel K, Lechuga GC, Provance DW, Morel CM, De Simone SG. | Pharmaceuticals (Basel) | 10.3390/ph16091281 | 2023 | | |
| Importance of twitching and surface-associated motility in the virulence of Acinetobacter baumannii. | Corral J, Perez-Varela M, Sanchez-Osuna M, Cortes P, Barbe J, Aranda J. | Virulence | 10.1080/21505594.2021.1950268 | 2021 | | |
| Pathogenicity | Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis. | Nielsen TB, Pantapalangkoor P, Luna BM, Bruhn KW, Yan J, Dekitani K, Hsieh S, Yeshoua B, Pascual B, Vinogradov E, Hujer KM, Domitrovic TN, Bonomo RA, Russo TA, Lesczcyniecka M, Schneider T, Spellberg B. | J Infect Dis | 10.1093/infdis/jix315 | 2017 | |
| Bushy-Tailed QACs: The Development of Multicationic Quaternary Ammonium Compounds with a High Degree of Alkyl Chain Substitution. | Toles ZEA, Thierer LM, Wu A, Bezold EL, Rachii D, Sanchez CA, Vargas-Cuebas GG, Keller TM, Carroll PJ, Wuest WM, Minbiole KPC. | ChemMedChem | 10.1002/cmdc.202400301 | 2024 | | |
| Synthesis and Characterization of Paclitaxel-Loaded Silver Nanoparticles: Evaluation of Cytotoxic Effects and Antimicrobial Activity. | Tunc T, Hepokur C, Kari Per A. | Bioinorg Chem Appl | 10.1155/2024/9916187 | 2024 | | |
| Metabolism | Structural Characterization of TssL from Acinetobacter baumannii: a Key Component of the Type VI Secretion System. | Ruiz FM, Lopez J, Ferrara CG, Santillana E, Espinosa YR, Feldman MF, Romero A. | J Bacteriol | 10.1128/jb.00210-20 | 2020 | |
| Genetics | Genomic Characterization of Extensively Drug-Resistant NDM-Producing Acinetobacter baumannii Clinical Isolates With the Emergence of Novel bla ADC-257. | Zafer MM, Hussein AFA, Al-Agamy MH, Radwan HH, Hamed SM. | Front Microbiol | 10.3389/fmicb.2021.736982 | 2021 | |
| Metabolism | Histone-like nucleoid-structuring protein (H-NS) regulatory role in antibiotic resistance in Acinetobacter baumannii. | Rodgers D, Le C, Pimentel C, Tuttobene MR, Subils T, Escalante J, Nishimura B, Vescovi EG, Sieira R, Bonomo RA, Tolmasky ME, Ramirez MS. | Sci Rep | 10.1038/s41598-021-98101-w | 2021 | |
| Pathogenicity | Enhanced antibacterial effect of a novel Friunavirus phage vWU2001 in combination with colistin against carbapenem-resistant Acinetobacter baumannii. | Wintachai P, Phaonakrop N, Roytrakul S, Naknaen A, Pomwised R, Voravuthikunchai SP, Surachat K, Smith DR. | Sci Rep | 10.1038/s41598-022-06582-0 | 2022 | |
| Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens. | Hussein M, Hu X, Paulin OKA, Crawford S, Tony Zhou Q, Baker M, Schneider-Futschik EK, Zhu Y, Li J, Velkov T. | Comput Struct Biotechnol J | 10.1016/j.csbj.2020.08.008 | 2020 | | |
| Genetics | GR13-type plasmids in Acinetobacter potentiate the accumulation and horizontal transfer of diverse accessory genes. | Moran RA, Liu H, Doughty EL, Hua X, Cummins EA, Liveikis T, McNally A, Zhou Z, van Schaik W, Yu Y. | Microb Genom | 10.1099/mgen.0.000840 | 2022 | |
| Antibiotics Combinations and Chitosan Nanoparticles for Combating Multidrug Resistance Acinetobacter baumannii. | Banoub NG, Saleh SE, Helal HS, Aboshanab KM, Aboshanab KM. | Infect Drug Resist | 10.2147/idr.s328788 | 2021 | | |
| Analysis of pCl107 a large plasmid carried by an ST25 Acinetobacter baumannii strain reveals a complex evolutionary history and links to multiple antibiotic resistance and metabolic pathways. | Rafei R, Koong J, Osman M, Al Atrouni A, Hamze M, Hamidian M. | FEMS Microbes | 10.1093/femsmc/xtac027 | 2022 | | |
| Identification of Promoter Region Markers Associated With Altered Expression of Resistance-Nodulation-Division Antibiotic Efflux Pumps in Acinetobacter baumannii. | Lopez-Siles M, McConnell MJ, Martin-Galiano AJ. | Front Microbiol | 10.3389/fmicb.2022.869208 | 2022 | | |
| Phylogeny | Nonclassical Biofilms Induced by DNA Breaks in Klebsiella pneumoniae. | Liu Y, Pan C, Ye L, Si Y, Bi C, Hua X, Yu Y, Zhu L, Wang H. | mSphere | 10.1128/msphere.00336-20 | 2020 | |
| ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro. | Daruka L, Czikkely MS, Szili P, Farkas Z, Balogh D, Grezal G, Maharramov E, Vu TH, Sipos L, Juhasz S, Dunai A, Daraba A, Szamel M, Sari T, Stirling T, Vasarhelyi BM, Ari E, Christodoulou C, Manczinger M, Enyedi MZ, Jaksa G, Kovacs K, van Houte S, Pursey E, Pinter L, Haracska L, Kintses B, Papp B, Pal C. | Nat Microbiol | 10.1038/s41564-024-01891-8 | 2025 | | |
| Acinetobacter baumannii Regulates Its Stress Responses via the BfmRS Two-Component Regulatory System. | Palethorpe S, Farrow JM, Wells G, Milton ME, Actis LA, Cavanagh J, Pesci EC. | J Bacteriol | 10.1128/jb.00494-21 | 2022 | | |
| Non-antibiotic prevention and treatment against Acinetobacter baumannii infection: Are vaccines and adjuvants effective strategies? | Hu Y, Zhang X, Deng S, Yue C, Jia X, Lyu Y. | Front Microbiol | 10.3389/fmicb.2023.1049917 | 2023 | | |
| Targeting virulence regulation to disarm Acinetobacter baumannii pathogenesis. | Trebosc V, Lucchini V, Narwal M, Wicki B, Gartenmann S, Schellhorn B, Schill J, Bourotte M, Frey D, Grunberg J, Trauner A, Ferrari L, Felici A, Champion OL, Gitzinger M, Lociuro S, Kammerer RA, Kemmer C, Pieren M. | Virulence | 10.1080/21505594.2022.2135273 | 2022 | | |
| Metabolism | Stereochemical Trajectories of a Two-Component Regulatory System PmrA/B in a Colistin-Resistant Acinetobacter baumannii Clinical Isolate. | Kandehkar Ghahraman MR, Hosseini-Nave H, Azizi O, Shakibaie MR, Mollaie HR, Shakibaie S. | Iran Biomed J | 10.29252/ibj.25.3.157 | 2021 | |
| Exploring the repository of de novo-designed bifunctional antimicrobial peptides through deep learning. | Dong R, Liu R, Liu Z, Liu Y, Zhao G, Li H, Hou S, Ma X, Kang H, Liu J, Guo F, Zhao P, Wang J, Wang C, Wu X, Ye S, Zhu C. | Elife | 10.7554/elife.97330 | 2025 | | |
| Complete Nucleotide Sequences of mcr-4.3-Carrying Plasmids in Acinetobacter baumannii Sequence Type 345 of Human and Food Origin from the Czech Republic, the First Case in Europe. | Bitar I, Medvecky M, Gelbicova T, Jakubu V, Hrabak J, Zemlickova H, Karpiskova R, Dolejska M. | Antimicrob Agents Chemother | 10.1128/aac.01166-19 | 2019 | | |
| Enzymology | Assessing Boron-Pleuromutilin AN11251 for the Development of Antibacterial Agents. | Han MJ, Pan M, Xiao G, Yuan Y, Chen S, Zou Z. | Molecules | 10.3390/molecules28124628 | 2023 | |
| Involvement of a Phage-Encoded Wzy Protein in the Polymerization of K127 Units To Form the Capsular Polysaccharide of Acinetobacter baumannii Isolate 36-1454. | Arbatsky NP, Kasimova AA, Shashkov AS, Shneider MM, Popova AV, Shagin DA, Shelenkov AA, Mikhailova YV, Yanushevich YG, Hall RM, Knirel YA, Kenyon JJ. | Microbiol Spectr | 10.1128/spectrum.01503-21 | 2022 | | |
| In vitro antibacterial activity of antiretroviral drugs on key commensal bacteria from the human microbiota. | Rubio-Garcia E, Ferrando N, Martin N, Balleste-Delpierre C, Miro JM, Paredes R, Casals-Pascual C, Vila J. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1306430 | 2023 | | |
| RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity. | Green AB, Chiaraviglio L, Truelson KA, Zulauf KE, Cui M, Zhang Z, Ware MP, Flegel WA, Haspel RL, Yu EW, Kirby JE. | mSphere | 10.1128/msphere.00673-22 | 2023 | | |
| Genetics | Towards the complete proteinaceous regulome of Acinetobacter baumannii. | Casella LG, Weiss A, Perez-Rueda E, Antonio Ibarra J, Shaw LN. | Microb Genom | 10.1099/mgen.0.000107 | 2017 | |
| Antibiotic susceptibility signatures identify potential antimicrobial targets in the Acinetobacter baumannii cell envelope. | Geisinger E, Mortman NJ, Dai Y, Cokol M, Syal S, Farinha A, Fisher DG, Tang AY, Lazinski DW, Wood S, Anthony J, van Opijnen T, Isberg RR. | Nat Commun | 10.1038/s41467-020-18301-2 | 2020 | | |
| Acinetobacter baumannii: Its Clinical Significance in Human and Veterinary Medicine. | Nocera FP, Attili AR, De Martino L. | Pathogens | 10.3390/pathogens10020127 | 2021 | | |
| Pathogenicity | OMN6 a novel bioengineered peptide for the treatment of multidrug resistant Gram negative bacteria. | Mandel S, Michaeli J, Nur N, Erbetti I, Zazoun J, Ferrari L, Felici A, Cohen-Kutner M, Bachnoff N. | Sci Rep | 10.1038/s41598-021-86155-9 | 2021 | |
| Structural and Biochemical Characterization of the Flavin-Dependent Siderophore-Interacting Protein from Acinetobacter baumannii. | Valentino H, Korasick DA, Bohac TJ, Shapiro JA, Wencewicz TA, Tanner JJ, Sobrado P. | ACS Omega | 10.1021/acsomega.1c03047 | 2021 | | |
| Pathogenicity | The Acinetobacter trimeric autotransporter adhesin Ata controls key virulence traits of Acinetobacter baumannii. | Weidensdorfer M, Ishikawa M, Hori K, Linke D, Djahanschiri B, Iruegas R, Ebersberger I, Riedel-Christ S, Enders G, Leukert L, Kraiczy P, Rothweiler F, Cinatl J, Berger J, Hipp K, Kempf VAJ, Gottig S. | Virulence | 10.1080/21505594.2018.1558693 | 2019 | |
| adeABC efflux gene in Acinetobacter baumannii. | Xu C, Bilya SR, Xu W. | New Microbes New Infect | 10.1016/j.nmni.2019.100549 | 2019 | | |
| Multidrug-Resistant Acinetobacter baumannii Genetic Characterization and Spread in Lithuania in 2014, 2016, and 2018. | Kirtikliene T, Mierauskaite A, Razmiene I, Kuisiene N. | Life (Basel) | 10.3390/life11020151 | 2021 | | |
| Native Pig Neutrophil Products: Insights into Their Antimicrobial Activity. | Fernandez-De La Cruz E, Wessely-Szponder J, Vinas M, Vinuesa T, Merlos A, Jorba M, Espinal P, Fuste E. | Microorganisms | 10.3390/microorganisms11082119 | 2023 | | |
| Metabolism | The Acinetobacter baumannii Mla system and glycerophospholipid transport to the outer membrane. | Kamischke C, Fan J, Bergeron J, Kulasekara HD, Dalebroux ZD, Burrell A, Kollman JM, Miller SI. | Elife | 10.7554/elife.40171 | 2019 | |
| Pathogenicity | In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms. | Pollini S, Boncompagni S, Di Maggio T, Di Pilato V, Spanu T, Fiori B, Blasi F, Aliberti S, Sergio F, Rossolini GM, Pallecchi L. | J Antimicrob Chemother | 10.1093/jac/dky185 | 2018 | |
| Conjugation of Aztreonam, a Synthetic Monocyclic beta-Lactam Antibiotic, to a Siderophore Mimetic Significantly Expands Activity Against Gram-Negative Bacteria. | Liu R, Miller PA, Miller MJ. | ACS Infect Dis | 10.1021/acsinfecdis.1c00458 | 2021 | | |
| Comprehensive Analysis of Antimicrobial, Heavy Metal, and Pesticide Residues in Commercial Organic Fertilizers and Their Correlation with Tigecycline-Resistant tet(X)-Variant Genes. | He T, Li J, Gong L, Wang Y, Li R, Ji X, Luan F, Tang M, Zhu L, Wei R, Wang R. | Microbiol Spectr | 10.1128/spectrum.04251-22 | 2023 | | |
| Metabolism | Insights into the Periplasmic Proteins of Acinetobacter baumannii AB5075 and the Impact of Imipenem Exposure: A Proteomic Approach. | Scribano D, Marzano V, Levi Mortera S, Sarshar M, Vernocchi P, Zagaglia C, Putignani L, Palamara AT, Ambrosi C. | Int J Mol Sci | 10.3390/ijms20143451 | 2019 | |
| Enzymology | In vivo efficacy of enmetazobactam combined with cefepime in a murine pneumonia model induced by OXA-48-producing Klebsiella pneumoniae. | Albac S, Anzala N, Chavanet P, Dunkel N, Quevedo J, Santerre Henriksen A, Croisier D. | Microbiol Spectr | 10.1128/spectrum.02345-24 | 2024 | |
| Inhibition of AdeB, AceI, and AmvA Efflux Pumps Restores Chlorhexidine and Benzalkonium Susceptibility in Acinetobacter baumannii ATCC 19606. | Migliaccio A, Esposito EP, Bagattini M, Berisio R, Triassi M, De Gregorio E, Zarrilli R. | Front Microbiol | 10.3389/fmicb.2021.790263 | 2021 | | |
| Genetics | First Report of New Delhi Metallo-beta-Lactamase-6 (NDM-6) in a Clinical Acinetobacter baumannii Isolate From Northern Spain. | Xanthopoulou K, Urrutikoetxea-Gutierrez M, Vidal-Garcia M, Diaz de Tuesta Del Arco JL, Sanchez-Urtaza S, Wille J, Seifert H, Higgins PG, Gallego L. | Front Microbiol | 10.3389/fmicb.2020.589253 | 2020 | |
| The Small DdrR Protein Directly Interacts with the UmuDAb Regulator of the Mutagenic DNA Damage Response in Acinetobacter baumannii. | Pavlin A, Bajc G, Fornelos N, Browning DF, Butala M. | J Bacteriol | 10.1128/jb.00601-21 | 2022 | | |
| The antimicrobial activity of silver acetate against Acinetobacter baumannii in a Galleria mellonella infection model. | Mannix-Fisher E, McLean S. | PeerJ | 10.7717/peerj.11196 | 2021 | | |
| Genome Sequence of a Clinical Strain of Acinetobacter baumannii Belonging to the ST79/PFGE-HUI-1 Clone Lacking the AdeABC (Resistance-Nodulation-Cell Division-Type) Efflux Pump. | Lopez M, Alvarez-Fraga L, Gato E, Blasco L, Poza M, Fernandez-Garcia L, Bou G, Tomas M. | Genome Announc | 10.1128/genomea.00962-16 | 2016 | | |
| Transcriptome | Transcriptomic Analysis of Drug-Resistance Acinetobacter baumannii under the Stress Condition Caused by Litsea cubeba L. Essential Oil via RNA Sequencing. | Yang Y, Hao K, Jiang M, Memon FU, Guo L, Zhang G, Liu T, Wu X, Si H. | Genes (Basel) | 10.3390/genes12071003 | 2021 | |
| Antibiotic treatment modulates protein components of cytotoxic outer membrane vesicles of multidrug-resistant clinical strain, Acinetobacter baumannii DU202. | Yun SH, Park EC, Lee SY, Lee H, Choi CW, Yi YS, Ro HJ, Lee JC, Jun S, Kim HY, Kim GH, Kim SI. | Clin Proteomics | 10.1186/s12014-018-9204-2 | 2018 | | |
| Pathogenicity | Role of Capsule in Resistance to Disinfectants, Host Antimicrobials, and Desiccation in Acinetobacter baumannii. | Tipton KA, Chin CY, Farokhyfar M, Weiss DS, Rather PN. | Antimicrob Agents Chemother | 10.1128/aac.01188-18 | 2018 | |
| Highly Effective Biocides against Pseudomonas aeruginosa Reveal New Mechanistic Insights Across Gram-Negative Bacteria. | Sanchez CA, Vargas-Cuebas GG, Michaud ME, Allen RA, Morrison-Lewis KR, Siddiqui S, Minbiole KPC, Wuest WM. | ACS Infect Dis | 10.1021/acsinfecdis.4c00433 | 2024 | | |
| Relationship between the Biofilm-Forming Capacity and Antimicrobial Resistance in Clinical Acinetobacter baumannii Isolates: Results from a Laboratory-Based In Vitro Study. | Donadu MG, Mazzarello V, Cappuccinelli P, Zanetti S, Madlena M, Nagy AL, Stajer A, Burian K, Gajdacs M. | Microorganisms | 10.3390/microorganisms9112384 | 2021 | | |
| Metabolism | Plasmid-Encoded H-NS Controls Extracellular Matrix Composition in a Modern Acinetobacter baumannii Urinary Isolate. | Benomar S, Di Venanzio G, Feldman MF. | J Bacteriol | 10.1128/jb.00277-21 | 2021 | |
| Essential Metabolic Routes as a Way to ESKAPE From Antibiotic Resistance. | Barra ALC, Dantas LOC, Morao LG, Gutierrez RF, Polikarpov I, Wrenger C, Nascimento AS. | Front Public Health | 10.3389/fpubh.2020.00026 | 2020 | | |
| Discovery and Derivatization of Tridecaptin Antibiotics with Altered Host Specificity and Enhanced Bioactivity. | Machushynets NV, Al Ayed K, Terlouw BR, Du C, Buijs NP, Willemse J, Elsayed SS, Schill J, Trebosc V, Pieren M, Alexander FM, Cochrane SA, Liles MR, Medema MH, Martin NI, van Wezel GP. | ACS Chem Biol | 10.1021/acschembio.4c00034 | 2024 | | |
| Genetics | Virulent Epidemic Pneumonia in Sheep Caused by the Human Pathogen Acinetobacter baumannii. | Linz B, Mukhtar N, Shabbir MZ, Rivera I, Ivanov YV, Tahir Z, Yaqub T, Harvill ET. | Front Microbiol | 10.3389/fmicb.2018.02616 | 2018 | |
| Pathogenicity | Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS. | Deveson Lucas D, Crane B, Wright A, Han ML, Moffatt J, Bulach D, Gladman SL, Powell D, Aranda J, Seemann T, Machado D, Pacheco T, Marques T, Viveiros M, Nation R, Li J, Harper M, Boyce JD. | Antimicrob Agents Chemother | 10.1128/aac.02442-17 | 2018 | |
| A Phenome-Wide Association Study Uncovers a Pathological Role of Coagulation Factor X during Acinetobacter baumannii Infection. | Choby JE, Monteith AJ, Himmel LE, Margaritis P, Shirey-Rice JK, Pruijssers A, Jerome RN, Pulley J, Skaar EP. | Infect Immun | 10.1128/iai.00031-19 | 2019 | | |
| An Update on the Acinetobacter baumannii Regulatory Circuitry. | Wood CR, Mack LE, Actis LA. | Trends Microbiol | 10.1016/j.tim.2018.05.005 | 2018 | | |
| Mechanisms Underlying Synergistic Killing of Polymyxin B in Combination with Cannabidiol against Acinetobacter baumannii: A Metabolomic Study. | Hussein M, Allobawi R, Levou I, Blaskovich MAT, Rao GG, Li J, Velkov T. | Pharmaceutics | 10.3390/pharmaceutics14040786 | 2022 | | |
| Pathogenicity | A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii. | Luna B, Trebosc V, Lee B, Bakowski M, Ulhaq A, Yan J, Lu P, Cheng J, Nielsen T, Lim J, Ketphan W, Eoh H, McNamara C, Skandalis N, She R, Kemmer C, Lociuro S, Dale GE, Spellberg B. | Nat Microbiol | 10.1038/s41564-020-0737-6 | 2020 | |
| Transcript Profiling of Nitroxoline-Treated Biofilms Shows Rapid Up-regulation of Iron Acquisition Gene Clusters. | Liu K, Abouelhassan Y, Zhang Y, Jin S, Huigens Iii RW. | ACS Infect Dis | 10.1021/acsinfecdis.2c00206 | 2022 | | |
| Early Molecular Insights into Thanatin Analogues Binding to A. baumannii LptA. | Oi KK, Moehle K, Schuster M, Zerbe O. | Molecules | 10.3390/molecules28114335 | 2023 | | |
| The l,d-Transpeptidase LdtAb from Acinetobacter baumannii Is Poorly Inhibited by Carbapenems and Has a Unique Structural Architecture. | Toth M, Stewart NK, Smith CA, Lee M, Vakulenko SB. | ACS Infect Dis | 10.1021/acsinfecdis.2c00321 | 2022 | | |
| Identification of a Specific Biomarker of Acinetobacter baumannii Global Clone 1 by Machine Learning and PCR Related to Metabolic Fitness of ESKAPE Pathogens. | Alvarez VE, Quiroga MP, Centron D. | mSystems | 10.1128/msystems.00734-22 | 2023 | | |
| The Accurate and Exclusive Quantification of Somatic Cells in Raw Milk with an OPD-Cu2+ System-Based Colorimetric Method. | Xie M, Wang M, Liu S, Liu Y, Wang Z, Zhou G, Sui Z. | Foods | 10.3390/foods13182890 | 2024 | | |
| Enzymology | Activity of the beta-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D beta-Lactamases from Acinetobacter baumannii. | Vazquez-Ucha JC, Maneiro M, Martinez-Guitian M, Buynak J, Bethel CR, Bonomo RA, Bou G, Poza M, Gonzalez-Bello C, Beceiro A. | Antimicrob Agents Chemother | 10.1128/aac.01172-17 | 2017 | |
| AdeR-AdeS mutations & overexpression of the AdeABC efflux system in ciprofloxacin-resistant Acinetobacter baumannii clinical isolates. | Lari AR, Ardebili A, Hashemi A. | Indian J Med Res | 10.4103/ijmr.ijmr_644_16 | 2018 | | |
| Pathogenicity | Small molecule adjuvants that suppress both chromosomal and mcr-1 encoded colistin-resistance and amplify colistin efficacy in polymyxin-susceptible bacteria. | Barker WT, Martin SE, Chandler CE, Nguyen TV, Harris TL, Goodell C, Melander RJ, Doi Y, Ernst RK, Melander C. | Bioorg Med Chem | 10.1016/j.bmc.2017.08.055 | 2017 | |
| Pathogenicity | Characterization of carbapenem-resistant hypervirulent Acinetobacter baumannii strains isolated from hospitalized patients in the mid-south region of China. | Li J, Yu T, Luo Y, Peng JY, Li YJ, Tao XY, Hu YM, Wang HC, Zou MX. | BMC Microbiol | 10.1186/s12866-020-01957-7 | 2020 | |
| Genetics | CRISPR-Based Gene Editing in Acinetobacter baumannii to Combat Antimicrobial Resistance. | Junaid M, Thirapanmethee K, Khuntayaporn P, Chomnawang MT. | Pharmaceuticals (Basel) | 10.3390/ph16070920 | 2023 | |
| Enzymology | Lon Protease Has Multifaceted Biological Functions in Acinetobacter baumannii. | Ching C, Yang B, Onwubueke C, Lazinski D, Camilli A, Godoy VG. | J Bacteriol | 10.1128/jb.00536-18 | 2019 | |
| Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery. | Armengol E, Domenech O, Fuste E, Perez-Guillen I, Borrell JH, Sierra JM, Vinas M. | Infect Drug Resist | 10.2147/idr.s207844 | 2019 | | |
| Pathogenicity | Miltefosine Reduces the Cytolytic Activity and Virulence of Acinetobacter baumannii. | Fiester SE, Arivett BA, Beckett AC, Wagner BR, Ohneck EJ, Schmidt RE, Grier JT, Actis LA. | Antimicrob Agents Chemother | 10.1128/aac.01409-18 | 2019 | |
| Pathogenicity | A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii. | Boll JM, Crofts AA, Peters K, Cattoir V, Vollmer W, Davies BW, Trent MS. | Proc Natl Acad Sci U S A | 10.1073/pnas.1611594113 | 2016 | |
| Inactivation of Acinetobacter baumannii Biofilms on Polystyrene, Stainless Steel, and Urinary Catheters by Octenidine Dihydrochloride. | Narayanan A, Nair MS, Karumathil DP, Baskaran SA, Venkitanarayanan K, Amalaradjou MA. | Front Microbiol | 10.3389/fmicb.2016.00847 | 2016 | | |
| Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens. | Shah S, Das R, Chavan B, Bajpai U, Hanif S, Ahmed S. | Front Microbiol | 10.3389/fmicb.2023.1170418 | 2023 | | |
| Diversity and Function of Capsular Polysaccharide in Acinetobacter baumannii. | Singh JK, Adams FG, Brown MH. | Front Microbiol | 10.3389/fmicb.2018.03301 | 2018 | | |
| 4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infections. | Barbieri F, Carlen V, Martina MG, Sannio F, Cancade S, Perini C, Restori M, Crespan E, Maga G, Docquier JD, Cagno V, Radi M. | RSC Med Chem | 10.1039/d3md00686g | 2024 | | |
| Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in Acinetobacter baumannii. | Huang KJ, Pantua H, Diao J, Skippington E, Volny M, Sandoval W, Tiku V, Peng Y, Sagolla M, Yan D, Kang J, Katakam AK, Michaelian N, Reichelt M, Tan MW, Austin CD, Xu M, Hanan E, Kapadia SB. | Proc Natl Acad Sci U S A | 10.1073/pnas.2123117119 | 2022 | | |
| A novel chemical biology and computational approach to expedite the discovery of new-generation polymyxins against life-threatening Acinetobacter baumannii. | Jiang X, Patil NA, Azad MAK, Wickremasinghe H, Yu H, Zhao J, Zhang X, Li M, Gong B, Wan L, Ma W, Thompson PE, Yang K, Yuan B, Schreiber F, Wang L, Velkov T, Roberts KD, Li J. | Chem Sci | 10.1039/d1sc03460j | 2021 | | |
| AssessORF: combining evolutionary conservation and proteomics to assess prokaryotic gene predictions. | Korandla DR, Wozniak JM, Campeau A, Gonzalez DJ, Wright ES. | Bioinformatics | 10.1093/bioinformatics/btz714 | 2020 | | |
| NetGenes: A Database of Essential Genes Predicted Using Features From Interaction Networks. | Senthamizhan V, Ravindran B, Raman K. | Front Genet | 10.3389/fgene.2021.722198 | 2021 | | |
| Spectrum of activity of Salmonella anti-biofilm compounds: Evaluation of activity against biofilm-forming ESKAPE pathogens. | Bennett AN, Woolard KJ, Sorge A, Melander C, Gunn JS. | Biofilm | 10.1016/j.bioflm.2023.100158 | 2023 | | |
| Pathogenicity | Novobiocin Inhibits the Antimicrobial Resistance Acquired through DNA Damage-Induced Mutagenesis in Acinetobacter baumannii. | Jara LM, Perez-Varela M, Corral J, Arch M, Cortes P, Bou G, Aranda J, Barbe J. | Antimicrob Agents Chemother | 10.1128/aac.01810-15 | 2016 | |
| Genetics | Genomic Analysis of Two Novel Bacteriophages Infecting Acinetobacter beijerinckii and halotolerans Species. | Gomes M, Domingues R, Turner D, Oliveira H. | Viruses | 10.3390/v15030643 | 2023 | |
| Enzymology | Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment. | Park YJ, Hong DJ, Yoon EJ, Kim D, Choi MH, Hong JS, Lee H, Yong D, Jeong SH. | Ann Lab Med | 10.3343/alm.2018.38.6.545 | 2018 | |
| DEG 15, an update of the Database of Essential Genes that includes built-in analysis tools. | Luo H, Lin Y, Liu T, Lai FL, Zhang CT, Gao F, Zhang R. | Nucleic Acids Res | 10.1093/nar/gkaa917 | 2021 | | |
| Pathogenicity | Regulatory networks important for survival of Acinetobacter baumannii within the host. | Allen JL, Tomlinson BR, Casella LG, Shaw LN. | Curr Opin Microbiol | 10.1016/j.mib.2020.03.001 | 2020 | |
| New Auranofin Analogs with Antibacterial Properties against Burkholderia Clinical Isolates. | Maydaniuk D, Wu B, Truong D, Liyanage SH, Hogan AM, Yap ZL, Yan M, Cardona ST. | Antibiotics (Basel) | 10.3390/antibiotics10121443 | 2021 | | |
| Metabolism | Modern Acinetobacter baumannii clinical isolates replicate inside spacious vacuoles and egress from macrophages. | Sycz G, Di Venanzio G, Distel JS, Sartorio MG, Le NH, Scott NE, Beatty WL, Feldman MF. | PLoS Pathog | 10.1371/journal.ppat.1009802 | 2021 | |
| Steroid Derivatives as Potential Antimicrobial Agents Against Staphylococcus aureus Planktonic Cells. | Vollaro A, Esposito A, Antonaki E, Iula VD, D'Alonzo D, Guaragna A, De Gregorio E. | Microorganisms | 10.3390/microorganisms8040468 | 2020 | | |
| Pathogenicity | Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report. | Garcia Casallas JC, Robayo-Amortegui H, Corredor-Rozo Z, Carrasco-Marquez AM, Escobar-Perez J. | J Med Case Rep | 10.1186/s13256-019-2062-3 | 2019 | |
| Metabolism | Identification of Novel Acinetobacter baumannii Type VI Secretion System Antibacterial Effector and Immunity Pairs. | Fitzsimons TC, Lewis JM, Wright A, Kleifeld O, Schittenhelm RB, Powell D, Harper M, Boyce JD. | Infect Immun | 10.1128/iai.00297-18 | 2018 | |
| Update on Multidrug Resistance Efflux Pumps in Acinetobacter spp. | Kornelsen V, Kumar A. | Antimicrob Agents Chemother | 10.1128/aac.00514-21 | 2021 | | |
| Enhancing outer membrane permeability of tetracycline antibiotics in P. aeruginosa using TOB-CIP conjugates. | Dhiman S, Ramirez D, Arora R, Arthur G, Schweizer F. | RSC Med Chem | 10.1039/d4md00329b | 2024 | | |
| Analysis of the role of the LH92_11085 gene of a biofilm hyper-producing Acinetobacter baumannii strain on biofilm formation and attachment to eukaryotic cells. | Alvarez-Fraga L, Perez A, Rumbo-Feal S, Merino M, Vallejo JA, Ohneck EJ, Edelmann RE, Beceiro A, Vazquez-Ucha JC, Valle J, Actis LA, Bou G, Poza M. | Virulence | 10.1080/21505594.2016.1145335 | 2016 | | |
| Pathogenicity | Addition of ethylamines to the phenols of bithionol and synthetic retinoids does not elicit activity in gram-negative bacteria. | Cheng AV, Schrank CL, Escobar IE, Mylonakis E, Wuest WM. | Bioorg Med Chem Lett | 10.1016/j.bmcl.2020.127099 | 2020 | |
| Pathogenicity | The Mechanisms of Disease Caused by Acinetobacter baumannii. | Morris FC, Dexter C, Kostoulias X, Uddin MI, Peleg AY. | Front Microbiol | 10.3389/fmicb.2019.01601 | 2019 | |
| A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism. | Trebosc V, Gartenmann S, Royet K, Manfredi P, Totzl M, Schellhorn B, Pieren M, Tigges M, Lociuro S, Sennhenn PC, Gitzinger M, Bumann D, Kemmer C. | Antimicrob Agents Chemother | 10.1128/aac.01275-16 | 2016 | | |
| Genetics | Comparative genomic analysis and multi-drug resistance differences of Acinetobacter baumannii in Chongqing, China. | Pu L, Jian Z, Pan F, Geng Y, He M, Liao P. | Infect Drug Resist | 10.2147/idr.s216745 | 2019 | |
| Genetics | Genetic Configuration of Genomic Resistance Islands in Acinetobacter baumannii Clinical Isolates From Egypt. | Hamed SM, Hussein AFA, Al-Agamy MH, Radwan HH, Zafer MM. | Front Microbiol | 10.3389/fmicb.2022.878912 | 2022 | |
| Metabolism | AbaM Regulates Quorum Sensing, Biofilm Formation, and Virulence in Acinetobacter baumannii. | Lopez-Martin M, Dubern JF, Alexander MR, Williams P. | J Bacteriol | 10.1128/jb.00635-20 | 2021 | |
| Crosstalk Between Type VI Secretion System and Mobile Genetic Elements. | Penil-Celis A, Garcillan-Barcia MP. | Front Mol Biosci | 10.3389/fmolb.2019.00126 | 2019 | | |
| Genetics | DNA-triplex Forming Purine Repeat Containing Genes in Acinetobacter baumannii and Their Association with Infection and Adaptation. | Singh HN, Rajeswari MR. | Front Cell Infect Microbiol | 10.3389/fcimb.2017.00250 | 2017 | |
| Pathogenicity | Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology. | Kostoulias X, Murray GL, Cerqueira GM, Kong JB, Bantun F, Mylonakis E, Khoo CA, Peleg AY. | Antimicrob Agents Chemother | 10.1128/aac.01540-15 | 2016 | |
| Biological Control of Acinetobacter baumannii: In Vitro and In Vivo Activity, Limitations, and Combination Therapies. | Havenga B, Reyneke B, Waso-Reyneke M, Ndlovu T, Khan S, Khan W. | Microorganisms | 10.3390/microorganisms10051052 | 2022 | | |
| Preserving Vascular Integrity Protects Mice against Multidrug-Resistant Gram-Negative Bacterial Infection. | Gebremariam T, Zhang L, Alkhazraji S, Gu Y, Youssef EG, Tong Z, Kish-Trier E, Bajji A, de Araujo CV, Rich B, French SW, Li DY, Mueller AL, Odelberg SJ, Zhu W, Ibrahim AS. | Antimicrob Agents Chemother | 10.1128/aac.00303-20 | 2020 | | |
| Involvement of the Histone-Like Nucleoid Structuring Protein (H-NS) in Acinetobacter baumannii's Natural Transformation. | Le C, Pimentel C, Tuttobene MR, Subils T, Escalante J, Nishimura B, Arriaga S, Rodgers D, Bonomo RA, Sieira R, Tolmasky ME, Ramirez MS. | Pathogens | 10.3390/pathogens10091083 | 2021 | | |
| Pathogenicity | Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models. | Parra Millan R, Jimenez Mejias ME, Sanchez Encinales V, Ayerbe Algaba R, Gutierrez Valencia A, Pachon Ibanez ME, Diaz C, Perez Del Palacio J, Lopez Cortes LF, Pachon J, Smani Y. | Antimicrob Agents Chemother | 10.1128/aac.02708-15 | 2016 | |
| Pathogenicity | Differential roles of antimicrobials in the acquisition of drug resistance through activation of the SOS response in Acinetobacter baumannii. | Jara LM, Cortes P, Bou G, Barbe J, Aranda J. | Antimicrob Agents Chemother | 10.1128/aac.04918-14 | 2015 | |
| Pathogenicity | The Response of Acinetobacter baumannii to Hydrogen Sulfide Reveals Two Independent Persulfide-Sensing Systems and a Connection to Biofilm Regulation. | Walsh BJC, Wang J, Edmonds KA, Palmer LD, Zhang Y, Trinidad JC, Skaar EP, Giedroc DP. | mBio | 10.1128/mbio.01254-20 | 2020 | |
| Genetics | Gut Microbiota and Neurovascular Patterns in Amnestic Mild Cognitive Impairment. | Kazen AB, Umfleet LG, Aboulalazm FA, Cohen AD, Terhune S, Mason L, Obarski S, Franczak M, Kindel TL, Wang Y, Kirby JR. | Brain Sci | 10.3390/brainsci15060538 | 2025 | |
| Cross-protection and cross-feeding between Klebsiella pneumoniae and Acinetobacter baumannii promotes their co-existence. | Semenec L, Cain AK, Dawson CJ, Liu Q, Dinh H, Lott H, Penesyan A, Maharjan R, Short FL, Hassan KA, Paulsen IT. | Nat Commun | 10.1038/s41467-023-36252-2 | 2023 | | |
| Pathogenicity | Parallel Evolution of Tobramycin Resistance across Species and Environments. | Scribner MR, Santos-Lopez A, Marshall CW, Deitrick C, Cooper VS. | mBio | 10.1128/mbio.00932-20 | 2020 | |
| High-Throughput Discovery of Synthetic Siderophores for Trojan Horse Antibiotics. | Weber BS, Ritchie NE, Hilker S, Chan DCK, Peukert C, Deisinger JP, Ives R, Ardal C, Burrows LL, Bronstrup M, Magolan J, Raivio TL, Brown ED. | ACS Infect Dis | 10.1021/acsinfecdis.4c00359 | 2024 | | |
| Pathogenicity | Antimicrobial Activity of Gallium Compounds on ESKAPE Pathogens. | Hijazi S, Visaggio D, Pirolo M, Frangipani E, Bernstein L, Visca P. | Front Cell Infect Microbiol | 10.3389/fcimb.2018.00316 | 2018 | |
| Phylogeny | Genome diversity of domesticated Acinetobacter baumannii ATCC 19606T strains. | Artuso I, Lucidi M, Visaggio D, Capecchi G, Lugli GA, Ventura M, Visca P. | Microb Genom | 10.1099/mgen.0.000749 | 2022 | |
| First identification of multidrug-resistant Acinetobacter bereziniae isolates harboring bla NDM-1 from hospitals in South China. | Mo XM, Pan Q, Seifert H, Xing XW, Yuan J, Zhou ZY, Luo XY, Liu HM, Xie YL, Yang LQ, Hong XB, Higgins PG, Wong NK. | Heliyon | 10.1016/j.heliyon.2022.e12365 | 2023 | | |
| Whole-Genome Sequence Analysis of the Naturally Competent Acinetobacter baumannii Clinical Isolate A118 | Traglia GM, Chua K, Centron D, Tolmasky ME, Ramirez MS. | Genome biology and evolution. | 2014 | | ||
| Semisynthetic blasticidin S ester derivatives show enhanced antibiotic activity. | Gannett C, Banks P, Chuong C, Weger-Lucarelli J, Mevers E, Lowell AN. | RSC Med Chem | 10.1039/d2md00412g | 2023 | | |
| Pathogenicity | Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc. | Magallon J, Chiem K, Tran T, Ramirez MS, Jimenez V, Tolmasky ME. | PLoS One | 10.1371/journal.pone.0217602 | 2019 | |
| An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1. | Marr CM, MacDonald U, Trivedi G, Chakravorty S, Russo TA. | Front Microbiol | 10.3389/fmicb.2020.595798 | 2020 | | |
| Genetics | Crucial Role of the Accessory Genome in the Evolutionary Trajectory of Acinetobacter baumannii Global Clone 1. | Alvarez VE, Quiroga MP, Galan AV, Vilacoba E, Quiroga C, Ramirez MS, Centron D. | Front Microbiol | 10.3389/fmicb.2020.00342 | 2020 | |
| An Optimized Synthetic-Bioinformatic Natural Product Antibiotic Sterilizes Multidrug-Resistant Acinetobacter baumannii-Infected Wounds. | Vila-Farres X, Chu J, Ternei MA, Lemetre C, Park S, Perlin DS, Brady SF. | mSphere | 10.1128/msphere.00528-17 | 2018 | | |
| Metabolism | Formylglycine-Generating Enzyme-Like Proteins Constitute a Novel Family of Widespread Type VI Secretion System Immunity Proteins. | Lopez J, Le NH, Moon KH, Salomon D, Bosis E, Feldman MF. | J Bacteriol | 10.1128/jb.00281-21 | 2021 | |
| Enzymology | A New Class of Cell Wall-Recycling l,d-Carboxypeptidase Determines beta-Lactam Susceptibility and Morphogenesis in Acinetobacter baumannii. | Dai Y, Pinedo V, Tang AY, Cava F, Geisinger E. | mBio | 10.1128/mbio.02786-21 | 2021 | |
| Integrated Co-functional Network Analysis on the Resistance and Virulence Features in Acinetobacter baumannii. | Xie R, Shao N, Zheng J. | Front Microbiol | 10.3389/fmicb.2020.598380 | 2020 | | |
| Molecular characteristics of carbapenem-resistant Acinetobacter spp. from clinical infection samples and fecal survey samples in Southern China. | Li S, Duan X, Peng Y, Rui Y. | BMC Infect Dis | 10.1186/s12879-019-4423-3 | 2019 | | |
| Structural Modification of Lipopolysaccharide Conferred by mcr-1 in Gram-Negative ESKAPE Pathogens. | Liu YY, Chandler CE, Leung LM, McElheny CL, Mettus RT, Shanks RMQ, Liu JH, Goodlett DR, Ernst RK, Doi Y. | Antimicrob Agents Chemother | 10.1128/aac.00580-17 | 2017 | | |
| Antimicrobial Resistance: Two-Component Regulatory Systems and Multidrug Efflux Pumps. | De Gaetano GV, Lentini G, Fama A, Coppolino F, Beninati C. | Antibiotics (Basel) | 10.3390/antibiotics12060965 | 2023 | | |
| Acinetobacter baumannii Kills Fungi via a Type VI DNase Effector. | Luo J, Chu X, Jie J, Sun Y, Guan Q, Li D, Luo ZQ, Song L. | mBio | 10.1128/mbio.03420-22 | 2023 | | |
| Streptomyces sp. Strain PBR11, a Forest-Derived Soil Actinomycetia with Antimicrobial Potential. | Mazumdar R, Dutta PP, Saikia J, Borah JC, Thakur D. | Microbiol Spectr | 10.1128/spectrum.03489-22 | 2023 | | |
| Pathogenicity | Mutasynthetic Production and Antimicrobial Characterization of Darobactin Analogs. | Bohringer N, Green R, Liu Y, Mettal U, Marner M, Modaresi SM, Jakob RP, Wuisan ZG, Maier T, Iinishi A, Hiller S, Lewis K, Schaberle TF. | Microbiol Spectr | 10.1128/spectrum.01535-21 | 2021 | |
| Enzymology | Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii. | Baginska N, Pichlak A, Gorski A, Jonczyk-Matysiak E. | Virol Sin | 10.1007/s12250-019-00125-0 | 2019 | |
| Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2. | Peng SY, You RI, Lai MJ, Lin NT, Chen LK, Chang KC. | Sci Rep | 10.1038/s41598-017-11832-7 | 2017 | | |
| Genetics | Pangenome of Acinetobacter baumannii uncovers two groups of genomes, one of them with genes involved in CRISPR/Cas defence systems associated with the absence of plasmids and exclusive genes for biofilm formation. | Mangas EL, Rubio A, Alvarez-Marin R, Labrador-Herrera G, Pachon J, Pachon-Ibanez ME, Divina F, Perez-Pulido AJ. | Microb Genom | 10.1099/mgen.0.000309 | 2019 | |
| Metabolism | Protein determinants of dissemination and host specificity of metallo-beta-lactamases. | Lopez C, Ayala JA, Bonomo RA, Gonzalez LJ, Vila AJ. | Nat Commun | 10.1038/s41467-019-11615-w | 2019 | |
| The convergent total synthesis and antibacterial profile of the natural product streptothricin F. | Dowgiallo MG, Miller BC, Kassu M, Smith KP, Fetigan AD, Guo JJ, Kirby JE, Manetsch R. | Chem Sci | 10.1039/d1sc06445b | 2022 | | |
| Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia. | Bruhn KW, Pantapalangkoor P, Nielsen T, Tan B, Junus J, Hujer KM, Wright MS, Bonomo RA, Adams MD, Chen W, Spellberg B. | J Infect Dis | 10.1093/infdis/jiu593 | 2015 | | |
| Overexpression of BIT33_RS14560 Enhances the Biofilm Formation and Virulence of Acinetobacter baumannii. | Yang R, Lai B, Liao K, Liu B, Huang L, Li S, Gu J, Lin Z, Chen Y, Wang S, Qiu Y, Deng J, Chen S, Zhuo C, Zhou Y. | Front Microbiol | 10.3389/fmicb.2022.867770 | 2022 | | |
| Genes Involved in the Biosynthesis and Transport of Acinetobactin in Acinetobacter baumannii. | Hasan T, Choi CH, Oh MH. | Genomics Inform | 10.5808/gi.2015.13.1.2 | 2015 | | |
| Characteristics and diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with drug-resistant clinical isolates of Acinetobacter baumannii. | Salehi B, Ghalavand Z, Yadegar A, Eslami G. | Antimicrob Resist Infect Control | 10.1186/s13756-021-00924-9 | 2021 | | |
| Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. | Eze EC, Chenia HY, El Zowalaty ME. | Infect Drug Resist | 10.2147/idr.s169894 | 2018 | | |
| Phylogeny | Microevolution in the major outer membrane protein OmpA of Acinetobacter baumannii. | Viale AM, Evans BA. | Microb Genom | 10.1099/mgen.0.000381 | 2020 | |
| Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1. | Luna BM, Ulhaq A, Yan J, Pantapalangkoor P, Nielsen TB, Davies BW, Actis LA, Spellberg B. | mSphere | 10.1128/msphere.00140-17 | 2017 | | |
| Metabolism | Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. | Hamidian M, Nigro SJ. | Microb Genom | 10.1099/mgen.0.000306 | 2019 | |
| Expeditious synthesis and preliminary antimicrobial activity of deflazacort and its precursors. | Esposito A, De Gregorio E, De Fenza M, D'Alonzo D, Satawani A, Guaragna A. | RSC Adv | 10.1039/c9ra03673c | 2019 | | |
| Axiom Microbiome Array, the next generation microarray for high-throughput pathogen and microbiome analysis. | Thissen JB, Be NA, McLoughlin K, Gardner S, Rack PG, Shapero MH, Rowland RRR, Slezak T, Jaing CJ. | PLoS One | 10.1371/journal.pone.0212045 | 2019 | | |
| Location, Location, Location: Establishing Design Principles for New Antibacterials from Ferric Siderophore Transport Systems. | Luo VC, Peczuh MW. | Molecules | 10.3390/molecules29163889 | 2024 | | |
| The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections. | Garcia-Patino MG, Garcia-Contreras R, Licona-Limon P. | Front Immunol | 10.3389/fimmu.2017.00441 | 2017 | | |
| Evaluating Antioxidant Performance, Biosafety, and Antimicrobial Efficacy of Houttuynia cordata Extract and Microwave-Assisted Synthesis of Biogenic Silver Nano-Antibiotics. | Moorthy K, Chang KC, Huang HC, Wu WJ, Chiang CK. | Antioxidants (Basel) | 10.3390/antiox13010032 | 2023 | | |
| Phylogeny | Molecular epidemiology and antimicrobial resistance features of Acinetobacter baumannii clinical isolates from Pakistan. | Karah N, Khalid F, Wai SN, Uhlin BE, Ahmad I. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-019-0344-7 | 2020 | |
| Genome Sequence of Acinetobacter baumannii Strain D36, an Antibiotic-Resistant Isolate from Lineage 2 of Global Clone 1. | Hamidian M, Hawkey J, Holt KE, Hall RM. | Genome Announc | 10.1128/genomea.01478-15 | 2015 | | |
| Metabolism | Wza gene knockout decreases Acinetobacter baumannii virulence and affects Wzy-dependent capsular polysaccharide synthesis. | Niu T, Guo L, Luo Q, Zhou K, Yu W, Chen Y, Huang C, Xiao Y. | Virulence | 10.1080/21505594.2019.1700659 | 2020 | |
| Metabolism | Combating virulence of Gram-negative bacilli by OmpA inhibition. | Vila-Farres X, Parra-Millan R, Sanchez-Encinales V, Varese M, Ayerbe-Algaba R, Bayo N, Guardiola S, Pachon-Ibanez ME, Kotev M, Garcia J, Teixido M, Vila J, Pachon J, Giralt E, Smani Y. | Sci Rep | 10.1038/s41598-017-14972-y | 2017 | |
| Pathogenicity | Serum Albumin and Ca2+ Are Natural Competence Inducers in the Human Pathogen Acinetobacter baumannii. | Traglia GM, Quinn B, Schramm ST, Soler-Bistue A, Ramirez MS. | Antimicrob Agents Chemother | 10.1128/aac.00529-16 | 2016 | |
| Identification and structure-activity relationships for a series of N, N-disubstituted 2-aminobenzothiazoles as potent inhibitors of S. aureus. | Cao F, Kinthada R, Boehm T, D' Cunha N, Leus IV, Orth C, Zgurskaya HI, Walker JK. | Bioorg Med Chem Lett | 10.1016/j.bmcl.2023.129301 | 2023 | | |
| Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens. | Tran TB, Wang J, Doi Y, Velkov T, Bergen PJ, Li J. | Front Microbiol | 10.3389/fmicb.2018.00721 | 2018 | | |
| Heteroaryl-Ethylenes as New Lead Compounds in the Fight against High Priority Bacterial Strains. | Bongiorno D, Musso N, Bonacci PG, Bivona DA, Massimino M, Stracquadanio S, Bonaccorso C, Fortuna CG, Stefani S. | Antibiotics (Basel) | 10.3390/antibiotics10091034 | 2021 | | |
| Genome sequence analysis of an extensively drug-resistant Acinetobacter baumannii indigo-pigmented strain depicts evidence of increase genome plasticity. | Traglia G, Chiem K, Quinn B, Fernandez JS, Montana S, Almuzara M, Mussi MA, Tolmasky ME, Iriarte A, Centron D, Ramirez MS. | Sci Rep | 10.1038/s41598-018-35377-5 | 2018 | | |
| Metabolism | Homeoviscous Adaptation of the Acinetobacter baumannii Outer Membrane: Alteration of Lipooligosaccharide Structure during Cold Stress. | Herrera CM, Voss BJ, Trent MS. | mBio | 10.1128/mbio.01295-21 | 2021 | |
| Surface-Related Features and Virulence Among Acinetobacter baumannii Clinical Isolates Belonging to International Clones I and II. | Skerniskyte J, Krasauskas R, Pechoux C, Kulakauskas S, Armalyte J, Suziedeliene E. | Front Microbiol | 10.3389/fmicb.2018.03116 | 2018 | | |
| Pathogenicity | In Vitro and In Vivo Assessment of the Efficacy of Bromoageliferin, an Alkaloid Isolated from the Sponge Agelas dilatata, against Pseudomonas aeruginosa. | Pech-Puch D, Perez-Povedano M, Martinez-Guitian M, Lasarte-Monterrubio C, Vazquez-Ucha JC, Bou G, Rodriguez J, Beceiro A, Jimenez C. | Mar Drugs | 10.3390/md18060326 | 2020 | |
| Draft Genome Sequence of JVAP01T, the Type Strain of the Novel Species Acinetobacter dijkshoorniae. | Fernandez-Orth D, Cosgaya C, Telli M, Mosqueda N, Mari-Almirall M, Roca I, Vila J. | Genome Announc | 10.1128/genomea.01480-16 | 2017 | | |
| Pathogenicity | Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii. | Smani Y, Fabrega A, Roca I, Sanchez-Encinales V, Vila J, Pachon J. | Antimicrob Agents Chemother | 10.1128/aac.02101-13 | 2014 | |
| Conjugation to Native and Nonnative Triscatecholate Siderophores Enhances Delivery and Antibacterial Activity of a beta-Lactam to Gram-Negative Bacterial Pathogens. | Motz RN, Guo C, Sargun A, Walker GT, Sassone-Corsi M, Raffatellu M, Nolan EM. | J Am Chem Soc | 10.1021/jacs.3c14490 | 2024 | | |
| First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt. | Abdulzahra AT, Khalil MAF, Elkhatib WF. | New Microbes New Infect | 10.1016/j.nmni.2018.08.007 | 2018 | | |
| Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme. | Lopez M, Mayer C, Fernandez-Garcia L, Blasco L, Muras A, Ruiz FM, Bou G, Otero A, Tomas M, GEIH-GEMARA (SEIMC). | PLoS One | 10.1371/journal.pone.0174454 | 2017 | | |
| Metabolism | The Acinetobacter baumannii disinfectant resistance protein, AmvA, is a spermidine and spermine efflux pump. | Short FL, Liu Q, Shah B, Clift HE, Naidu V, Li L, Prity FT, Mabbutt BC, Hassan KA, Paulsen IT. | Commun Biol | 10.1038/s42003-021-02629-6 | 2021 | |
| Evolved resistance to a novel cationic peptide antibiotic requires high mutation supply. | Santos-Lopez A, Fritz MJ, Lombardo JB, Burr AHP, Heinrich VA, Marshall CW, Cooper VS. | Evol Med Public Health | 10.1093/emph/eoac022 | 2022 | | |
| Draft Genome Sequence of the Biofilm-Hyperproducing Acinetobacter baumannii Clinical Strain MAR002. | Alvarez-Fraga L, Lopez M, Merino M, Rumbo-Feal S, Tomas M, Bou G, Poza M. | Genome Announc | 10.1128/genomea.00824-15 | 2015 | | |
| Pathogenicity | AB569, a non-toxic combination of acidified nitrite and EDTA, is effective at killing the notorious Iraq/Afghanistan combat wound pathogens, multi-drug resistant Acinetobacter baumannii and Acinetobacter spp. | Bogue AL, Panmanee W, McDaniel CT, Mortensen JE, Kamau E, Actis LA, Johannigman JA, Schurr MJ, Satish L, Kotagiri N, Hassett DJ. | PLoS One | 10.1371/journal.pone.0247513 | 2021 | |
| Pathogenicity | The Landscape of Phenotypic and Transcriptional Responses to Ciprofloxacin in Acinetobacter baumannii: Acquired Resistance Alleles Modulate Drug-Induced SOS Response and Prophage Replication. | Geisinger E, Vargas-Cuebas G, Mortman NJ, Syal S, Dai Y, Wainwright EL, Lazinski D, Wood S, Zhu Z, Anthony J, van Opijnen T, Isberg RR. | mBio | 10.1128/mbio.01127-19 | 2019 | |
| Pathogenicity | Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel beta-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii. | McLeod SM, Shapiro AB, Moussa SH, Johnstone M, McLaughlin RE, de Jonge BLM, Miller AA. | Antimicrob Agents Chemother | 10.1128/aac.01576-17 | 2018 | |
| Metabolism | Acinetobacter baumannii OxyR Regulates the Transcriptional Response to Hydrogen Peroxide. | Juttukonda LJ, Green ER, Lonergan ZR, Heffern MC, Chang CJ, Skaar EP. | Infect Immun | 10.1128/iai.00413-18 | 2019 | |
| Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii. | Eijkelkamp BA, Stroeher UH, Hassan KA, Paulsen IT, Brown MH. | BMC Genomics | 10.1186/1471-2164-15-1020 | 2014 | | |
| Metabolism | The Secrets of Acinetobacter Secretion. | Weber BS, Kinsella RL, Harding CM, Feldman MF. | Trends Microbiol | 10.1016/j.tim.2017.01.005 | 2017 | |
| In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii. | Yang YS, Lee Y, Tseng KC, Huang WC, Chuang MF, Kuo SC, Lauderdale TL, Chen TL. | Antimicrob Agents Chemother | 10.1128/aac.02994-15 | 2016 | | |
| CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in Acinetobacter baumannii. | Wang Y, Wang Z, Ji Q. | STAR Protoc | 10.1016/j.xpro.2020.100025 | 2020 | | |
| Comparative analysis of the pathogenicity between multidrug-resistant Acinetobacter baumannii clinical isolates: isolation of highly pathogenic multidrug-resistant A. baumannii and experimental therapeutics with fourth-generation cephalosporin cefozopran. | Nishida S, Ono Y. | Infect Drug Resist | 10.2147/idr.s166154 | 2018 | | |
| Effects of Lipidation on a Proline-Rich Antibacterial Peptide. | Armas F, Di Stasi A, Mardirossian M, Romani AA, Benincasa M, Scocchi M. | Int J Mol Sci | 10.3390/ijms22157959 | 2021 | | |
| Metabolism | Heme uptake and utilization by hypervirulent Acinetobacter baumannii LAC-4 is dependent on a canonical heme oxygenase (abHemO). | Giardina BJ, Shahzad S, Huang W, Wilks A. | Arch Biochem Biophys | 10.1016/j.abb.2019.108066 | 2019 | |
| Pathogenicity | Evolutionary pathways to antibiotic resistance are dependent upon environmental structure and bacterial lifestyle. | Santos-Lopez A, Marshall CW, Scribner MR, Snyder DJ, Cooper VS. | Elife | 10.7554/elife.47612 | 2019 | |
| Repurposed Antimicrobial Combination Therapy: Tobramycin-Ciprofloxacin Hybrid Augments Activity of the Anticancer Drug Mitomycin C Against Multidrug-Resistant Gram-Negative Bacteria. | Domalaon R, Ammeter D, Brizuela M, Gorityala BK, Zhanel GG, Schweizer F. | Front Microbiol | 10.3389/fmicb.2019.01556 | 2019 | | |
| Interbacterial Transfer of Carbapenem Resistance and Large Antibiotic Resistance Islands by Natural Transformation in Pathogenic Acinetobacter. | Godeux AS, Svedholm E, Barreto S, Potron A, Venner S, Charpentier X, Laaberki MH. | mBio | 10.1128/mbio.02631-21 | 2022 | | |
| Phylogeny | MALDI-TOF MS Is an Effective Technique To Classify Specific Microbiota. | Chen L, Gao W, Tan X, Han Y, Jiao F, Feng B, Xie J, Li B, Zhao H, Tu H, Yu S, Wang L. | Microbiol Spectr | 10.1128/spectrum.00307-23 | 2023 | |
| Pathogenicity | Marine Organisms from the Yucatan Peninsula (Mexico) as a Potential Natural Source of Antibacterial Compounds. | Pech-Puch D, Perez-Povedano M, Gomez P, Martinez-Guitian M, Lasarte-Monterrubio C, Vazquez-Ucha JC, Novoa-Olmedo ML, Guillen-Hernandez S, Villegas-Hernandez H, Bou G, Rodriguez J, Beceiro A, Jimenez C. | Mar Drugs | 10.3390/md18070369 | 2020 | |
| Hydrogen-peroxide generating electrochemical bandage is active in vitro against mono- and dual-species biofilms. | Raval YS, Mohamed A, Flurin L, Mandrekar JN, Greenwood Quaintance KE, Beyenal H, Patel R. | Biofilm | 10.1016/j.bioflm.2021.100055 | 2021 | | |
| New Shuttle Vectors for Real-Time Gene Expression Analysis in Multidrug-Resistant Acinetobacter Species: In Vitro and In Vivo Responses to Environmental Stressors. | Lucidi M, Visaggio D, Prencipe E, Imperi F, Rampioni G, Cincotti G, Leoni L, Visca P. | Appl Environ Microbiol | 10.1128/aem.01334-19 | 2019 | | |
| Toll-Like Receptor 9 Contributes to Defense against Acinetobacter baumannii Infection. | Noto MJ, Boyd KL, Burns WJ, Varga MG, Peek RM, Skaar EP. | Infect Immun | 10.1128/iai.00410-15 | 2015 | | |
| A Genomic Approach To Identify Klebsiella pneumoniae and Acinetobacter baumannii Strains with Enhanced Competitive Fitness in the Lungs during Multistrain Pneumonia. | Agard MJ, Ozer EA, Morris AR, Piseaux R, Hauser AR. | Infect Immun | 10.1128/iai.00871-18 | 2019 | | |
| Metabolism | Distinctive Roles of Two Acinetobactin Isomers in Challenging Host Nutritional Immunity. | Kim M, Kim DY, Song WY, Park SE, Harrison SA, Chazin WJ, Oh MH, Kim HJ. | mBio | 10.1128/mbio.02248-21 | 2021 | |
| Metabolism | Human pleural fluid triggers global changes in the transcriptional landscape of Acinetobacter baumannii as an adaptive response to stress. | Martinez J, Fernandez JS, Liu C, Hoard A, Mendoza A, Nakanouchi J, Rodman N, Courville R, Tuttobene MR, Lopez C, Gonzalez LJ, Shahrestani P, Papp-Wallace KM, Vila AJ, Tolmasky ME, Bonomo RA, Sieira R, Ramirez MS. | Sci Rep | 10.1038/s41598-019-53847-2 | 2019 | |
| Metabolism | The Role of the Two-Component System BaeSR in Disposing Chemicals through Regulating Transporter Systems in Acinetobacter baumannii. | Lin MF, Lin YY, Lan CY. | PLoS One | 10.1371/journal.pone.0132843 | 2015 | |
| Metabolism | Characterization of RelA in Acinetobacter baumannii. | Perez-Varela M, Tierney ARP, Kim JS, Vazquez-Torres A, Rather P. | J Bacteriol | 10.1128/jb.00045-20 | 2020 | |
| Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance. | Abdi SN, Ghotaslou R, Ganbarov K, Mobed A, Tanomand A, Yousefi M, Asgharzadeh M, Kafil HS. | Infect Drug Resist | 10.2147/idr.s228089 | 2020 | | |
| Enzymology | A New Micromonospora Strain with Antibiotic Activity Isolated from the Microbiome of a Mid-Atlantic Deep-Sea Sponge. | Back CR, Stennett HL, Williams SE, Wang L, Ojeda Gomez J, Abdulle OM, Duffy T, Neal C, Mantell J, Jepson MA, Hendry KR, Powell D, Stach JEM, Essex-Lopresti AE, Willis CL, Curnow P, Race PR. | Mar Drugs | 10.3390/md19020105 | 2021 | |
| Pathogenicity | The tet39 Determinant and the msrE-mphE Genes in Acinetobacter Plasmids Are Each Part of Discrete Modules Flanked by Inversely Oriented pdif (XerC-XerD) Sites. | Blackwell GA, Hall RM. | Antimicrob Agents Chemother | 10.1128/aac.00780-17 | 2017 | |
| Ethnobotany, Phytochemistry, and Biological Activities of the Genus Cordyline. | Tematio Fouedjou R, Tsakem B, Siwe-Noundou X, Dongmo Fogang HP, Tiombou Donkia A, Kemvoufo Ponou B, Poka M, Demana PH, Teponno RB, Azefack Tapondjou L. | Biomolecules | 10.3390/biom13121783 | 2023 | | |
| Multidrug Resistant Acinetobacter Isolates Release Resistance Determinants Through Contact-Dependent Killing and Bacteriophage Lysis. | Crippen CS, Jr MJR, Sanchez S, Szymanski CM. | Front Microbiol | 10.3389/fmicb.2020.01918 | 2020 | | |
| Phylogeny | Phase-Variable Control of Multiple Phenotypes in Acinetobacter baumannii Strain AB5075. | Tipton KA, Dimitrova D, Rather PN. | J Bacteriol | 10.1128/jb.00188-15 | 2015 | |
| Draft Genome Sequence of Klebsiella pneumoniae Carbapenemase-Producing Acinetobacter baumannii Strain M3AC9-7, Isolated from Puerto Rico. | Martinez T, Ropelewski AJ, Gonzalez-Mendez R, Vazquez GJ, Robledo IE. | Genome Announc | 10.1128/genomea.00274-15 | 2015 | | |
| Antimicrobial Diterpene Alkaloids from an Agelas citrina Sponge Collected in the Yucatán Peninsula. | Pech-Puch D, Forero AM, Fuentes-Monteverde JC, Lasarte-Monterrubio C, Martinez-Guitian M, Gonzalez-Salas C, Guillen-Hernandez S, Villegas-Hernandez H, Beceiro A, Griesinger C, Rodriguez J, Jimenez C. | Mar Drugs | 10.3390/md20050298 | 2022 | | |
| Confronting Tigecycline-Resistant Acinetobacter baumannii via Immunization Against Conserved Resistance Determinants. | Chiang MH, Yang YS, Sun JR, Wang YC, Kuo SC, Lee YT, Chuang YP, Chen TL. | Front Microbiol | 10.3389/fmicb.2020.00536 | 2020 | | |
| Pathogenicity | In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria. | Ito A, Sato T, Ota M, Takemura M, Nishikawa T, Toba S, Kohira N, Miyagawa S, Ishibashi N, Matsumoto S, Nakamura R, Tsuji M, Yamano Y. | Antimicrob Agents Chemother | 10.1128/aac.01454-17 | 2018 | |
| Pathogenicity | Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens. | Dillon N, Holland M, Tsunemoto H, Hancock B, Cornax I, Pogliano J, Sakoulas G, Nizet V. | EBioMedicine | 10.1016/j.ebiom.2019.07.041 | 2019 | |
| Genetics | Lunaemycins, New Cyclic Hexapeptide Antibiotics from the Cave Moonmilk-Dweller Streptomyces lunaelactis MM109T. | Martinet L, Naome A, Rezende LCD, Tellatin D, Pignon B, Docquier JD, Sannio F, Baiwir D, Mazzucchelli G, Frederich M, Rigali S. | Int J Mol Sci | 10.3390/ijms24021114 | 2023 | |
| Metabolism | Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria. | Krishnamoorthy G, Leus IV, Weeks JW, Wolloscheck D, Rybenkov VV, Zgurskaya HI. | mBio | 10.1128/mbio.01172-17 | 2017 | |
| Repurposing of Ciclopirox to Overcome the Limitations of Zidovudine (Azidothymidine) against Multidrug-Resistant Gram-Negative Bacteria. | Cho H, Kim KS. | Pharmaceutics | 10.3390/pharmaceutics14030552 | 2022 | | |
| Legume Plant Peptides as Sources of Novel Antimicrobial Molecules Against Human Pathogens. | Lima RM, Lima RM, Rathod BB, Tiricz H, Howan DHO, Al Bouni MA, Jenei S, Timar E, Endre G, Toth GK, Kondorosi E. | Front Mol Biosci | 10.3389/fmolb.2022.870460 | 2022 | | |
| Metabolism | A Slam-dependent hemophore contributes to heme acquisition in the bacterial pathogen Acinetobacter baumannii. | Bateman TJ, Shah M, Ho TP, Shin HE, Pan C, Harris G, Fegan JE, Islam EA, Ahn SK, Hooda Y, Gray-Owen SD, Chen W, Moraes TF. | Nat Commun | 10.1038/s41467-021-26545-9 | 2021 | |
| Simple Method for Markerless Gene Deletion in Multidrug-Resistant Acinetobacter baumannii. | Oh MH, Lee JC, Kim J, Choi CH, Han K. | Appl Environ Microbiol | 10.1128/aem.03975-14 | 2015 | | |
| Evaluation of Parameters for High Efficiency Transformation of Acinetobacter baumannii. | Yildirim S, Thompson MG, Jacobs AC, Zurawski DV, Kirkup BC. | Sci Rep | 10.1038/srep22110 | 2016 | | |
| New Antimicrobial Bioactivity against Multidrug-Resistant Gram-Positive Bacteria of Kinase Inhibitor IMD0354. | Escobar IE, White A, Kim W, Mylonakis E. | Antibiotics (Basel) | 10.3390/antibiotics9100665 | 2020 | | |
| Comparative genome analysis reveals niche-specific genome expansion in Acinetobacter baumannii strains. | Yakkala H, Samantarrai D, Gribskov M, Siddavattam D. | PLoS One | 10.1371/journal.pone.0218204 | 2019 | | |
| Sanguinarine synergistically potentiates aminoglycoside-mediated bacterial killing. | Lu C, Zhang N, Kou S, Gao L, Peng B, Dai Y, Zheng J. | Microb Biotechnol | 10.1111/1751-7915.14017 | 2022 | | |
| Spatiotemporal dynamics of multidrug resistant bacteria on intensive care unit surfaces. | D'Souza AW, Potter RF, Wallace M, Shupe A, Patel S, Sun X, Gul D, Kwon JH, Andleeb S, Burnham CD, Dantas G. | Nat Commun | 10.1038/s41467-019-12563-1 | 2019 | | |
| Gram-Negative Bacteria Holding Together in a Biofilm: The Acinetobacter baumannii Way. | Pompilio A, Scribano D, Sarshar M, Di Bonaventura G, Palamara AT, Ambrosi C. | Microorganisms | 10.3390/microorganisms9071353 | 2021 | | |
| Protein Aggregation is Associated with Acinetobacter baumannii Desiccation Tolerance. | Wang X, Cole CG, DuPai CD, Davies BW. | Microorganisms | 10.3390/microorganisms8030343 | 2020 | | |
| Natural history of Acinetobacter baumannii infection in mice. | Luna BM, Yan J, Reyna Z, Moon E, Nielsen TB, Reza H, Lu P, Bonomo R, Louie A, Drusano G, Bulitta J, She R, Spellberg B. | PLoS One | 10.1371/journal.pone.0219824 | 2019 | | |
| Complete Genome Sequence of the Multiresistant Acinetobacter baumannii Strain AbH12O-A2, Isolated during a Large Outbreak in Spain. | Merino M, Alvarez-Fraga L, Gomez MJ, Aransay AM, Lavin JL, Chaves F, Bou G, Poza M. | Genome Announc | 10.1128/genomea.01182-14 | 2014 | | |
| Pathogenicity | Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii. | Thandar M, Lood R, Winer BY, Deutsch DR, Euler CW, Fischetti VA. | Antimicrob Agents Chemother | 10.1128/aac.02972-15 | 2016 | |
| Insights into the Chemical Diversity of Selected Fungi from the Tza Itzá Cenote of the Yucatan Peninsula. | Fajardo-Hernandez CA, Khan FST, Flores-Bocanegra L, Prieto-Davo A, Wan B, Ma R, Qader M, Villanueva-Silva R, Martinez-Cardenas A, Lopez-Lobato MA, Hematian S, Franzblau SG, Raja HA, Garcia-Contreras R, Figueroa M. | ACS Omega | 10.1021/acsomega.2c00544 | 2022 | | |
| Acinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection. | Subashchandrabose S, Smith S, DeOrnellas V, Crepin S, Kole M, Zahdeh C, Mobley HL. | mSphere | 10.1128/msphere.00013-15 | 2016 | | |
| Metabolism | Genetic Dissection of the Type VI Secretion System in Acinetobacter and Identification of a Novel Peptidoglycan Hydrolase, TagX, Required for Its Biogenesis. | Weber BS, Hennon SW, Wright MS, Scott NE, de Berardinis V, Foster LJ, Ayala JA, Adams MD, Feldman MF. | mBio | 10.1128/mbio.01253-16 | 2016 | |
| Metabolism | Multi-metal Restriction by Calprotectin Impacts De Novo Flavin Biosynthesis in Acinetobacter baumannii. | Wang J, Lonergan ZR, Gonzalez-Gutierrez G, Nairn BL, Maxwell CN, Zhang Y, Andreini C, Karty JA, Chazin WJ, Trinidad JC, Skaar EP, Giedroc DP. | Cell Chem Biol | 10.1016/j.chembiol.2019.02.011 | 2019 | |
| Genetics | The genome sequence of Acinetobacter baumannii isolated from a septicemic patient in a local hospital in Malaysia. | Izwan I, Teh LK, Salleh MZ. | Genom Data | 10.1016/j.gdata.2015.08.028 | 2015 | |
| In vitro activity of hypochlorous acid generating electrochemical bandage against monospecies and dual-species bacterial biofilms. | Kletzer J, Raval YS, Mohamed A, Mandrekar JN, Greenwood-Quaintance KE, Beyenal H, Patel R. | J Appl Microbiol | 10.1093/jambio/lxad194 | 2023 | | |
| Identification and Functional Analysis of Cytokine-Like Protein CLEC-47 in Caenorhabditis elegans. | Pan W, Huang X, Guo Z, Nagarajan R, Mylonakis E. | mBio | 10.1128/mbio.02579-21 | 2021 | | |
| Antimicrobial potential of a ponericin-like peptide isolated from Bombyx mori L. hemolymph in response to Pseudomonas aeruginosa infection. | Nesa J, Jana SK, Sadat A, Biswas K, Kati A, Kaya O, Mondal R, Dam P, Thakur M, Kumar A, Hossain M, Lima LR, Rezende SB, Bhattacharjya D, Gangopadhyay D, Ghorai S, Altuntas S, Panda AK, Chakrabarti P, Swarnakar S, Chakraborty J, Yilmaz B, Macedo MLR, Franco OL, Cardoso MH, Mandal AK. | Sci Rep | 10.1038/s41598-022-19450-8 | 2022 | | |
| Metabolism | Acinetobacter: an emerging pathogen with a versatile secretome. | Elhosseiny NM, Attia AS. | Emerg Microbes Infect | 10.1038/s41426-018-0030-4 | 2018 | |
| Pathogenicity | Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii. | Penwell WF, Shapiro AB, Giacobbe RA, Gu RF, Gao N, Thresher J, McLaughlin RE, Huband MD, DeJonge BL, Ehmann DE, Miller AA. | Antimicrob Agents Chemother | 10.1128/aac.04808-14 | 2015 | |
| Genetics | A genome-wide association study identifies a horizontally transferred bacterial surface adhesin gene associated with antimicrobial resistant strains. | Suzuki M, Shibayama K, Yahara K. | Sci Rep | 10.1038/srep37811 | 2016 | |
| Genetics | The complete genome and phenome of a community-acquired Acinetobacter baumannii. | Farrugia DN, Elbourne LD, Hassan KA, Eijkelkamp BA, Tetu SG, Brown MH, Shah BS, Peleg AY, Mabbutt BC, Paulsen IT. | PLoS One | 10.1371/journal.pone.0058628 | 2013 | |
| Terpenoids from Marine Sources: A Promising Avenue for New Antimicrobial Drugs. | Liu X, Xin J, Sun Y, Zhao F, Niu C, Liu S. | Mar Drugs | 10.3390/md22080347 | 2024 | | |
| Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii. | Da Silva GJ, Domingues S. | Antibiotics (Basel) | 10.3390/antibiotics6040028 | 2017 | | |
| Metabolism | Design of live attenuated bacterial vaccines based on D-glutamate auxotrophy. | Cabral MP, Garcia P, Beceiro A, Rumbo C, Perez A, Moscoso M, Bou G. | Nat Commun | 10.1038/ncomms15480 | 2017 | |
| Genetics | Characterization of Extremely Drug-Resistant and Hypervirulent Acinetobacter baumannii AB030. | Singh M, De Silva PM, Al-Saadi Y, Switala J, Loewen PC, Hausner G, Chen W, Hernandez I, Castillo-Ramirez S, Kumar A. | Antibiotics (Basel) | 10.3390/antibiotics9060328 | 2020 | |
| Metabolism | Desiccation tolerance in Acinetobacter baumannii is mediated by the two-component response regulator BfmR. | Farrow JM, Wells G, Pesci EC. | PLoS One | 10.1371/journal.pone.0205638 | 2018 | |
| Pathogenicity | Identification of antibiotic resistance genes in the multidrug-resistant Acinetobacter baumannii strain, MDR-SHH02, using whole-genome sequencing. | Wang H, Wang J, Yu P, Ge P, Jiang Y, Xu R, Chen R, Liu X. | Int J Mol Med | 10.3892/ijmm.2016.2844 | 2017 | |
| Genetics | Comparative Analysis and Data Provenance for 1,113 Bacterial Genome Assemblies. | Yarmosh DA, Lopera JG, Puthuveetil NP, Combs PF, Reese AL, Tabron C, Pierola AE, Duncan J, Greenfield SR, Marlow R, King S, Riojas MA, Bagnoli J, Benton B, Jacobs JL. | mSphere | 10.1128/msphere.00077-22 | 2022 | |
| Light Modulates Important Pathogenic Determinants and Virulence in ESKAPE Pathogens Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus. | Tuttobene MR, Perez JF, Pavesi ES, Perez Mora B, Biancotti D, Cribb P, Altilio M, Muller GL, Gramajo H, Tamagno G, Ramirez MS, Diacovich L, Mussi MA. | J Bacteriol | 10.1128/jb.00566-20 | 2021 | | |
| Intra Strain Variation of the Effects of Gram-Negative ESKAPE Pathogens on Intestinal Colonization, Host Viability, and Host Response in the Model Organism Caenorhabditis elegans. | Scott E, Holden-Dye L, O'Connor V, Wand ME. | Front Microbiol | 10.3389/fmicb.2019.03113 | 2019 | | |
| A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against Acinetobacter baumannii Infection. | Du X, Xue J, Jiang M, Lin S, Huang Y, Deng K, Shu L, Xu H, Li Z, Yao J, Chen S, Shen Z, Feng G. | Int J Nanomedicine | 10.2147/ijn.s296527 | 2021 | | |
| In vitro and in vivo Virulence Potential of the Emergent Species of the Acinetobacter baumannii (Ab) Group. | Cosgaya C, Ratia C, Mari-Almirall M, Rubio L, Higgins PG, Seifert H, Roca I, Vila J. | Front Microbiol | 10.3389/fmicb.2019.02429 | 2019 | | |
| Pathogenicity | In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii-calcoaceticus Complex Isolates Collected Globally in 2016 and 2017. | McLeod SM, Moussa SH, Hackel MA, Miller AA. | Antimicrob Agents Chemother | 10.1128/aac.02534-19 | 2020 | |
| Pathogenicity | Acinetobacter baumannii Biofilm Formation in Human Serum and Disruption by Gallium. | Runci F, Bonchi C, Frangipani E, Visaggio D, Visca P. | Antimicrob Agents Chemother | 10.1128/aac.01563-16 | 2017 | |
| Phylogeny | Offline Next Generation Metagenomics Sequence Analysis Using MinION Detection Software (MINDS). | Deshpande SV, Reed TM, Sullivan RF, Kerkhof LJ, Beigel KM, Wade MM. | Genes (Basel) | 10.3390/genes10080578 | 2019 | |
| Antimicrobial activity, cytotoxicity and chemical analysis of lemongrass essential oil (Cymbopogon flexuosus) and pure citral. | Adukwu EC, Bowles M, Edwards-Jones V, Bone H. | Appl Microbiol Biotechnol | 10.1007/s00253-016-7807-y | 2016 | | |
| Metabolism | CsrA Supports both Environmental Persistence and Host-Associated Growth of Acinetobacter baumannii. | Farrow JM, Wells G, Palethorpe S, Adams MD, Pesci EC. | Infect Immun | 10.1128/iai.00259-20 | 2020 | |
| Pathogenicity | Studies on Aminoglycoside Susceptibility Identify a Novel Function of KsgA To Secure Translational Fidelity during Antibiotic Stress. | Zou J, Zhang W, Zhang H, Zhang XD, Peng B, Zheng J. | Antimicrob Agents Chemother | 10.1128/aac.00853-18 | 2018 | |
| Targeting Superoxide dismutase confers enhanced Reactive Oxygen Species mediated eradication of Polymyxin B induced Acinetobacter baumannii persisters. | Dubey V, Gupta R, Pathania R. | Antimicrob Agents Chemother | 10.1128/aac.02180-20 | 2023 | | |
| Pathogenicity | The roles of history, chance, and natural selection in the evolution of antibiotic resistance. | Santos-Lopez A, Marshall CW, Haas AL, Turner C, Rasero J, Cooper VS. | Elife | 10.7554/elife.70676 | 2021 | |
| Design and Evaluation of Novel Polymyxin Fluorescent Probes. | Yun B, Roberts KD, Thompson PE, Nation RL, Velkov T, Li J. | Sensors (Basel) | 10.3390/s17112598 | 2017 | | |
| Metabolism | Multidrug-Resistant Acinetobacter baumannii Chloramphenicol Resistance Requires an Inner Membrane Permease. | Karalewitz AP, Miller SI. | Antimicrob Agents Chemother | 10.1128/aac.00513-18 | 2018 | |
| Metabolism | Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis. | Bhuiyan MS, Ellett F, Murray GL, Kostoulias X, Cerqueira GM, Schulze KE, Mahamad Maifiah MH, Li J, Creek DJ, Lieschke GJ, Peleg AY. | Proc Natl Acad Sci U S A | 10.1073/pnas.1523116113 | 2016 | |
| Metabolism | RNA-Mediated cis Regulation in Acinetobacter baumannii Modulates Stress-Induced Phenotypic Variation. | Ching C, Gozzi K, Heinemann B, Chai Y, Godoy VG. | J Bacteriol | 10.1128/jb.00799-16 | 2017 | |
| Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach. | Barbarossa A, Rosato A, Corbo F, Clodoveo ML, Fracchiolla G, Carrieri A, Carocci A. | Antibiotics (Basel) | 10.3390/antibiotics11060816 | 2022 | | |
| Transcriptome | TSS-EMOTE, a refined protocol for a more complete and less biased global mapping of transcription start sites in bacterial pathogens. | Prados J, Linder P, Redder P. | BMC Genomics | 10.1186/s12864-016-3211-3 | 2016 | |
| Iron and Acinetobacter baumannii Biofilm Formation. | Gentile V, Frangipani E, Bonchi C, Minandri F, Runci F, Visca P. | Pathogens | 10.3390/pathogens3030704 | 2014 | | |
| Small protein A and phospholipase D immunization serves a protective role in a mouse pneumonia model of Acinetobacter baumannii infection. | Li H, Tan H, Hu Y, Pan P, Su X, Hu C. | Mol Med Rep | 10.3892/mmr.2017.6688 | 2017 | | |
| Enzymology | Fomite-fingerpad transfer efficiency (pick-up and deposit) of Acinetobacter baumannii-with and without a latex glove. | Greene C, Vadlamudi G, Eisenberg M, Foxman B, Koopman J, Xi C. | Am J Infect Control | 10.1016/j.ajic.2015.05.008 | 2015 | |
| Metabolism | The Mutation of Conservative Asp268 Residue in the Peptidoglycan-Associated Domain of the OmpA Protein Affects Multiple Acinetobacter baumannii Virulence Characteristics. | Skerniskyte J, Karazijaite E, Deschamps J, Krasauskas R, Briandet R, Suziedeliene E. | Molecules | 10.3390/molecules24101972 | 2019 | |
| Guiding the Way: Traditional Medicinal Chemistry Inspiration for Rational Gram-Negative Drug Design. | Stoorza AM, Duerfeldt AS. | J Med Chem | 10.1021/acs.jmedchem.3c01831 | 2024 | | |
| Metabolism | Structural Basis for Enhancement of Carbapenemase Activity in the OXA-51 Family of Class D beta-Lactamases. | Smith CA, Antunes NT, Stewart NK, Frase H, Toth M, Kantardjieff KA, Vakulenko S. | ACS Chem Biol | 10.1021/acschembio.5b00090 | 2015 | |
| The Phenylacetic Acid Catabolic Pathway Regulates Antibiotic and Oxidative Stress Responses in Acinetobacter. | Hooppaw AJ, McGuffey JC, Di Venanzio G, Ortiz-Marquez JC, Weber BS, Lightly TJ, van Opijnen T, Scott NE, Cardona ST, Feldman MF. | mBio | 10.1128/mbio.01863-21 | 2022 | | |
| Metabolism | Structural comparison of Acinetobacter baumannii beta-ketoacyl-acyl carrier protein reductases in fatty acid and aryl polyene biosynthesis. | Lee WC, Choi S, Jang A, Son K, Kim Y. | Sci Rep | 10.1038/s41598-021-86997-3 | 2021 | |
| UmuDAb: An Error-Prone Polymerase Accessory Homolog Whose N-Terminal Domain Is Required for Repression of DNA Damage Inducible Gene Expression in Acinetobacter baylyi. | Witkowski TA, Grice AN, Stinnett DB, Wells WK, Peterson MA, Hare JM. | PLoS One | 10.1371/journal.pone.0152013 | 2016 | | |
| Metabolism | Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond. | Weber BS, Harding CM, Feldman MF. | J Bacteriol | 10.1128/jb.00906-15 | 2015 | |
| Exploring Structure-Activity Relationships of Niclosamide-Based Colistin Potentiators in Colistin-Resistant Gram-Negative Bacteria. | Berry L, Neale Q, Arora R, Ramirez D, Brizuela M, Domalaon R, Arthur G, Schweizer F. | Antibiotics (Basel) | 10.3390/antibiotics13010043 | 2024 | | |
| Development of multiplex cross displacement amplification combined with lateral flow biosensor assay for detection of virulent shigella sonnei. | Wang Y, He Z, Ablimit P, Ji S, Jin D. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.1012105 | 2022 | | |
| Role of bacterial efflux pumps in antibiotic resistance, virulence, and strategies to discover novel efflux pump inhibitors. | Gaurav A, Bakht P, Saini M, Pandey S, Pathania R. | Microbiology (Reading) | 10.1099/mic.0.001333 | 2023 | | |
| Evolutionarily stable gene clusters shed light on the common grounds of pathogenicity in the Acinetobacter calcoaceticus-baumannii complex. | Djahanschiri B, Di Venanzio G, Distel JS, Breisch J, Dieckmann MA, Goesmann A, Averhoff B, Gottig S, Wilharm G, Feldman MF, Ebersberger I. | PLoS Genet | 10.1371/journal.pgen.1010020 | 2022 | | |
| Pathogenicity | Effect of calcium on the interaction of Acinetobacter baumannii with human respiratory epithelial cells. | Chen Y, Shao T, Fang S, Pan P, Jiang J, Cheng T, Wan H, Yu D. | BMC Microbiol | 10.1186/s12866-019-1643-z | 2019 | |
| Restoring and Enhancing the Potency of Existing Antibiotics against Drug-Resistant Gram-Negative Bacteria through the Development of Potent Small-Molecule Adjuvants. | Yu B, Roy Choudhury M, Yang X, Benoit SL, Womack E, Van Mouwerik Lyles K, Acharya A, Kumar A, Yang C, Pavlova A, Zhu M, Yuan Z, Gumbart JC, Boykin DW, Maier RJ, Eichenbaum Z, Wang B. | ACS Infect Dis | 10.1021/acsinfecdis.2c00121 | 2022 | | |
| Phylogeny | Whole-Genome Sequencing Elucidates Epidemiology of Nosocomial Clusters of Acinetobacter baumannii. | Willems S, Kampmeier S, Bletz S, Kossow A, Kock R, Kipp F, Mellmann A. | J Clin Microbiol | 10.1128/jcm.00721-16 | 2016 | |
| Comparative Genomics of Acinetobacter baumannii Clinical Strains From Brazil Reveals Polyclonal Dissemination and Selective Exchange of Mobile Genetic Elements Associated With Resistance Genes. | Leal NC, Campos TL, Rezende AM, Docena C, Mendes-Marques CL, de Sa Cavalcanti FL, Wallau GL, Rocha IV, Cavalcanti CLB, Veras DL, Alves LR, Andrade-Figueiredo M, de Barros MPS, de Almeida AMP, de Morais MMC, Leal-Balbino TC, Xavier DE, de-Melo-Neto OP. | Front Microbiol | 10.3389/fmicb.2020.01176 | 2020 | | |
| A novel family of integrases associated with prophages and genomic islands integrated within the tRNA-dihydrouridine synthase A (dusA) gene. | Farrugia DN, Elbourne LD, Mabbutt BC, Paulsen IT. | Nucleic Acids Res | 10.1093/nar/gkv337 | 2015 | | |
| Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity. | Richards AM, Abu Kwaik Y, Lamont RJ. | Mol Oral Microbiol | 10.1111/omi.12072 | 2015 | | |
| Metabolism | Bioengineering of bacterial pathogens for noninvasive imaging and in vivo evaluation of therapeutics. | Rajamani S, Kuszpit K, Scarff JM, Lundh L, Khan M, Brown J, Stafford R, Cazares LH, Panchal RG, Bocan T. | Sci Rep | 10.1038/s41598-018-30806-x | 2018 | |
| Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii. | Huang W, Yao Y, Wang S, Xia Y, Yang X, Long Q, Sun W, Liu C, Li Y, Chu X, Bai H, Yao Y, Ma Y. | Sci Rep | 10.1038/srep20724 | 2016 | | |
| Pathogenicity | Curcumin alleviates persistence of Acinetobacter baumannii against colistin. | Kaur A, Sharma P, Capalash N. | Sci Rep | 10.1038/s41598-018-29291-z | 2018 | |
| Competence for Natural Transformation Is Common among Clinical Strains of Resistant Acinetobacter spp. | Domingues S, Rosario N, Candido A, Neto D, Nielsen KM, Da Silva GJ. | Microorganisms | 10.3390/microorganisms7020030 | 2019 | | |
| Regulation of the physiology and virulence of Ralstonia solanacearum by the second messenger 2',3'-cyclic guanosine monophosphate. | Li X, Yin W, Lin JD, Zhang Y, Guo Q, Wang G, Chen X, Cui B, Wang M, Chen M, Li P, He YW, Qian W, Luo H, Zhang LH, Liu XW, Song S, Deng Y. | Nat Commun | 10.1038/s41467-023-43461-2 | 2023 | | |
| Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine. | Gellings PS, Wilkins AA, Morici LA. | Pathogens | 10.3390/pathogens9121066 | 2020 | | |
| Effect of Temperature on Metronidazole Resistance in Helicobacter pylori. | Gong M, Han Y, Wang X, Tao H, Meng F, Hou B, Sun BB, Wang G. | Front Microbiol | 10.3389/fmicb.2021.681911 | 2021 | | |
| Enzymology | Iron-Regulated Phospholipase C Activity Contributes to the Cytolytic Activity and Virulence of Acinetobacter baumannii. | Fiester SE, Arivett BA, Schmidt RE, Beckett AC, Ticak T, Carrier MV, Ghosh R, Ohneck EJ, Metz ML, Sellin Jeffries MK, Actis LA. | PLoS One | 10.1371/journal.pone.0167068 | 2016 | |
| Genetics | Essential Gene Clusters Involved in Copper Tolerance Identified in Acinetobacter baumannii Clinical and Environmental Isolates. | Thummeepak R, Pooalai R, Harrison C, Gannon L, Thanwisai A, Chantratita N, Millard AD, Sitthisak S. | Pathogens | 10.3390/pathogens9010060 | 2020 | |
| Proteome | Unraveling the molecular dynamics of Pseudomonas aeruginosa biofilms at the air-liquid interface. | Sung K, Park M, Chon J, Kweon O, Khan S. | Future Microbiol | 10.2217/fmb-2023-0234 | 2024 | |
| Joint Transcriptional Control of Virulence and Resistance to Antibiotic and Environmental Stress in Acinetobacter baumannii. | Gebhardt MJ, Gallagher LA, Jacobson RK, Usacheva EA, Peterson LR, Zurawski DV, Shuman HA. | mBio | 10.1128/mbio.01660-15 | 2015 | | |
| The Delivery of the Novel Drug 'Halicin' Using Electrospun Fibers for the Treatment of Pressure Ulcer against Pathogenic Bacteria. | Aburayan WS, Booq RY, BinSaleh NS, Alfassam HA, Bakr AA, Bukhary HA, Alyamani EJ, Tawfik EA. | Pharmaceutics | 10.3390/pharmaceutics12121189 | 2020 | | |
| Metabolism | Structural and functional analysis of the Acinetobacter baumannii BlsA photoreceptor and regulatory protein. | Wood CR, Squire MS, Finley NL, Page RC, Actis LA. | PLoS One | 10.1371/journal.pone.0220918 | 2019 | |
| Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms. | Alves de Lima E Silva A, Rio-Tinto A. | Interdiscip Perspect Infect Dis | 10.1155/2024/9109041 | 2024 | | |
| Advances in Small Molecule Inhibitors Targeting the Bacterial Lipoprotein Transport System (Lol) in Gram-Negative Bacteria. | Song S, Shim SY. | Chem Asian J | 10.1002/asia.202500350 | 2025 | | |
| A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin. | Heo HY, Zou G, Baek S, Kim JS, Mylonakis E, Ausubel FM, Gao H, Kim W. | Adv Sci (Weinh) | 10.1002/advs.202306112 | 2024 | | |
| New Provisional Function of OmpA from Acinetobacter sp. Strain SA01 Based on Environmental Challenges. | Shahryari S, Talaee M, Haghbeen K, Adrian L, Vali H, Shahbani Zahiri H, Noghabi KA. | mSystems | 10.1128/msystems.01175-20 | 2021 | | |
| Pathogenicity | Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data. | Oikonomou O, Sarrou S, Papagiannitsis CC, Georgiadou S, Mantzarlis K, Zakynthinos E, Dalekos GN, Petinaki E. | BMC Infect Dis | 10.1186/s12879-015-1297-x | 2015 | |
| Pathogenicity | Antimicrobial Constituents from Machaerium Pers.: Inhibitory Activities and Synergism of Machaeriols and Machaeridiols against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus faecium, and Permeabilized Gram-Negative Pathogens. | Muhammad I, Jacob MR, Ibrahim MA, Raman V, Kumarihamy M, Wang M, Al-Adhami T, Hind C, Clifford M, Martin B, Zhao J, Sutton JM, Rahman KM. | Molecules | 10.3390/molecules25246000 | 2020 | |
| Enzymology | Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide. | Jenei S, Tiricz H, Szolomajer J, Timar E, Klement E, Al Bouni MA, Lima RM, Lima RM, Kata D, Harmati M, Buzas K, Foldesi I, Toth GK, Endre G, Kondorosi E. | Front Microbiol | 10.3389/fmicb.2020.00270 | 2020 | |
| Pathogenicity | In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii. | de Leseleuc L, Harris G, KuoLee R, Chen W. | Antimicrob Agents Chemother | 10.1128/aac.00778-12 | 2012 | |
| In Vitro Antimicrobial Activity of the Decontaminant HybenX® Compared to Chlorhexidine and Sodium Hypochlorite against Common Bacterial and Yeast Pathogens. | Antonelli A, Giovannini L, Baccani I, Giuliani V, Pace R, Rossolini GM. | Antibiotics (Basel) | 10.3390/antibiotics8040188 | 2019 | | |
| DNA uptake by the nosocomial pathogen Acinetobacter baumannii occurs during movement along wet surfaces. | Wilharm G, Piesker J, Laue M, Skiebe E. | J Bacteriol | 10.1128/jb.00754-13 | 2013 | | |
| Pathogenicity | Susceptibility of colistin-resistant pathogens to predatory bacteria. | Dharani S, Kim DH, Shanks RMQ, Doi Y, Kadouri DE. | Res Microbiol | 10.1016/j.resmic.2017.09.001 | 2018 | |
| Genetics | New eight genes identified at the clinical multidrug-resistant Acinetobacter baumannii DMS06669 strain in a Vietnam hospital. | Si-Tuan N, Ngoc HM, Hang PTT, Nguyen C, Van PH, Huong NT. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-017-0250-9 | 2017 | |
| Multiple Strategies for the Application of Medicinal Plant-Derived Bioactive Compounds in Controlling Microbial Biofilm and Virulence Properties. | Mulat M, Banicod RJS, Tabassum N, Javaid A, Karthikeyan A, Jeong GJ, Kim YM, Jung WK, Khan F. | Antibiotics (Basel) | 10.3390/antibiotics14060555 | 2025 | | |
| Pathogenicity | In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment. | Kim Y, Bae IK, Jeong SH, Yong D, Lee K. | Yonsei Med J | 10.3349/ymj.2015.56.4.928 | 2015 | |
| Pathogenicity | A gamma-lactam siderophore antibiotic effective against multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter spp. | Goldberg JA, Kumar V, Spencer EJ, Hoyer D, Marshall SH, Hujer AM, Hujer KM, Bethel CR, Papp-Wallace KM, Perez F, Jacobs MR, van Duin D, Kreiswirth BN, van den Akker F, Plummer MS, Bonomo RA. | Eur J Med Chem | 10.1016/j.ejmech.2021.113436 | 2021 | |
| Pathogenicity | Interspecies DNA acquisition by a naturally competent Acinetobacter baumannii strain. | Traglia GM, Place K, Dotto C, Fernandez JS, Montana S, Bahiense CDS, Soler-Bistue A, Iriarte A, Perez F, Tolmasky ME, Bonomo RA, Melano RG, Ramirez MS. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2018.12.013 | 2019 | |
| Metabolism | The Acinetobacter baumannii Omp33-36 porin is a virulence factor that induces apoptosis and modulates autophagy in human cells. | Rumbo C, Tomas M, Fernandez Moreira E, Soares NC, Carvajal M, Santillana E, Beceiro A, Romero A, Bou G. | Infect Immun | 10.1128/iai.02034-14 | 2014 | |
| Enzymology | Screen Printed Based Impedimetric Immunosensor for Rapid Detection of Escherichia coli in Drinking Water. | Cimafonte M, Fulgione A, Gaglione R, Papaianni M, Capparelli R, Arciello A, Bolletti Censi S, Borriello G, Velotta R, Della Ventura B. | Sensors (Basel) | 10.3390/s20010274 | 2020 | |
| Regulation of the aceI multidrug efflux pump gene in Acinetobacter baumannii. | Liu Q, Hassan KA, Ashwood HE, Gamage HKAH, Li L, Mabbutt BC, Paulsen IT. | J Antimicrob Chemother | 10.1093/jac/dky034 | 2018 | | |
| Enzymology | Identification of NDM-1 in a Putatively Novel Acinetobacter Species ("NB14") Closely Related to Acinetobacter pittii. | Espinal P, Mosqueda N, Telli M, van der Reijden T, Rolo D, Rolo D, Fernandez-Orth D, Dijkshoorn L, Roca I, Vila J. | Antimicrob Agents Chemother | 10.1128/aac.01455-15 | 2015 | |
| Metabolism | The Tip of the VgrG Spike Is Essential to Functional Type VI Secretion System Assembly in Acinetobacter baumannii. | Lopez J, Ly PM, Feldman MF. | mBio | 10.1128/mbio.02761-19 | 2020 | |
| Assessment of the feed additive consisting of red carotenoid-rich Paracoccus carotinifaciens NITE SD 00017 for salmon and trout for the renewal of its authorisation (ENEOS Techno Materials Corporation). | EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Bampidis V, Azimonti G, Bastos ML, Christensen H, Durjava M, Dusemund B, Kouba M, Lopez-Alonso M, Lopez Puente S, Marcon F, Mayo B, Pechova A, Petkova M, Ramos F, Villa RE, Woutersen R, Bories G, Brantom P, Gropp J, Dioni A, Galobart J, Holczknecht O, Revez J, Vettori MV. | EFSA J | 10.2903/j.efsa.2024.8905 | 2024 | | |
| Pathogenicity | New Frontiers for Old Medications: Repurposing Approved Drugs Against Gram-Negative Bacterial Infections. | Aloni-Grinstein R, Mamroud E, Gal Y. | Microorganisms | 10.3390/microorganisms13092115 | 2025 | |
| Molecular Epidemiology of Emerging Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter pittii in Taiwan, 2010 to 2014. | Chen FJ, Huang WC, Liao YC, Wang HY, Lai JF, Kuo SC, Lauderdale TL, Sytwu HK. | Antimicrob Agents Chemother | 10.1128/aac.02007-18 | 2019 | | |
| Draft Genome Sequences of Multidrug-Resistant Acinetobacter sp. Strains from Colombian Hospitals. | Barreto-Hernandez E, Falquet L, Reguero MT, Mantilla JR, Valenzuela EM, Gonzalez E, Cepeda A, Escalante A. | Genome Announc | 10.1128/genomea.00868-13 | 2013 | | |
| Metabolism | The FhaB/FhaC two-partner secretion system is involved in adhesion of Acinetobacter baumannii AbH12O-A2 strain. | Perez A, Merino M, Rumbo-Feal S, Alvarez-Fraga L, Vallejo JA, Beceiro A, Ohneck EJ, Mateos J, Fernandez-Puente P, Actis LA, Poza M, Bou G. | Virulence | 10.1080/21505594.2016.1262313 | 2017 | |
| Enzymology | Carbapenem-resistance and pathogenicity of bovine Acinetobacter indicus-like isolates. | Klotz P, Gottig S, Leidner U, Semmler T, Scheufen S, Ewers C. | PLoS One | 10.1371/journal.pone.0171986 | 2017 | |
| Specific Interaction of Novel Friunavirus Phages Encoding Tailspike Depolymerases with Corresponding Acinetobacter baumannii Capsular Types. | Popova AV, Shneider MM, Arbatsky NP, Kasimova AA, Senchenkova SN, Shashkov AS, Dmitrenok AS, Chizhov AO, Mikhailova YV, Shagin DA, Sokolova OS, Timoshina OY, Kozlov RS, Miroshnikov KA, Knirel YA. | J Virol | 10.1128/jvi.01714-20 | 2021 | | |
| The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii. | Russo TA, Manohar A, Beanan JM, Olson R, MacDonald U, Graham J, Umland TC. | mSphere | 10.1128/msphere.00082-16 | 2016 | | |
| Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis. | Lin L, Tan B, Pantapalangkoor P, Ho T, Baquir B, Tomaras A, Montgomery JI, Reilly U, Barbacci EG, Hujer K, Bonomo RA, Fernandez L, Hancock RE, Adams MD, French SW, Buslon VS, Spellberg B. | mBio | 10.1128/mbio.00312-12 | 2012 | | |
| A niclosamide-tobramycin hybrid adjuvant potentiates cefiderocol against P. aeruginosa. | Berry L, Brizuela M, Jackson G, Schweizer F. | RSC Med Chem | 10.1039/d1md00206f | 2021 | | |
| Pathogenicity | Broad-spectrum suppression of bacterial pneumonia by aminoglycoside-propagated Acinetobacter baumannii. | Hood-Pishchany MI, Pham L, Wijers CD, Burns WJ, Boyd KL, Palmer LD, Skaar EP, Noto MJ. | PLoS Pathog | 10.1371/journal.ppat.1008374 | 2020 | |
| The HicAB System: Characteristics and Biological Roles of an Underappreciated Toxin-Antitoxin System. | Encina-Robles J, Perez-Villalobos V, Bustamante P. | Int J Mol Sci | 10.3390/ijms252212165 | 2024 | | |
| Homologs of the Acinetobacter baumannii AceI transporter represent a new family of bacterial multidrug efflux systems. | Hassan KA, Liu Q, Henderson PJ, Paulsen IT. | mBio | 10.1128/mbio.01982-14 | 2015 | | |
| Pathogenicity | Antibiotic resistance acquired through a DNA damage-inducible response in Acinetobacter baumannii. | Norton MD, Spilkia AJ, Godoy VG. | J Bacteriol | 10.1128/jb.02176-12 | 2013 | |
| Stress responses in the opportunistic pathogen Acinetobacter baumannii. | Fiester SE, Actis LA. | Future Microbiol | 10.2217/fmb.12.150 | 2013 | | |
| Protein N-terminal acylation: An emerging field in bacterial cell physiology. | Parks AR, Escalante-Semerena JC. | Curr Trends Microbiol | 10.31300/ctmb.16.2022.1-18 | 2022 | | |
| Whole-cell biosensing by siderophore-based molecular recognition and localized surface plasmon resonance. | Hu J, Ghosh M, Miller MJ, Bohn PW. | Anal Methods | 10.1039/c8ay02180e | 2019 | | |
| Acinetobacter baumannii in human body louse. | La Scola B, Raoult D. | Emerg Infect Dis | 10.3201/eid1009.040242 | 2004 | | |
| Bioactive Potential of Wild Plants from Gardunha Mountain: Phytochemical Characterization and Biological Activities. | Coimbra A, Gallardo E, Luis A, Gaspar PD, Ferreira S, Duarte AP. | Molecules | 10.3390/molecules30193876 | 2025 | | |
| Bioactive Compounds and Traditional Uses of Tripleurospermum disciforme (C.A.Mey.) Sch.Bip.: A Comprehensive Study on Its Therapeutic Potential. | Sheydaei P, Ferreira S, Almeida M, Coimbra A, Yousefbeyk F, Gallardo E, Breitenfeld L, Amaral ME, Duarte AP. | Molecules | 10.3390/molecules30183685 | 2025 | | |
| Screening of the Potential Bioactivities of Pennyroyal (Mentha pulegium L.) Essential Oil. | Luis A, Domingues F. | Antibiotics (Basel) | 10.3390/antibiotics10101266 | 2021 | | |
| Ayahuasca Beverages: Phytochemical Analysis and Biological Properties. | Goncalves J, Luis A, Gradillas A, Garcia A, Restolho J, Fernandez N, Domingues F, Gallardo E, Duarte AP. | Antibiotics (Basel) | 10.3390/antibiotics9110731 | 2020 | | |
| Anti-Inflammatory and Antimicrobial Activities of Portuguese Prunus avium L. (Sweet Cherry) By-Products Extracts. | Nunes AR, Flores-Felix JD, Goncalves AC, Falcao A, Alves G, Silva LR. | Nutrients | 10.3390/nu14214576 | 2022 | | |
| Pathogenicity | The effect of PAMAM dendrimers on the antibacterial activity of antibiotics with different water solubility. | Winnicka K, Wroblewska M, Wieczorek P, Sacha PT, Tryniszewska EA. | Molecules | 10.3390/molecules18078607 | 2013 | |
| Essential Oil from Coriandrum sativum: A review on Its Phytochemistry and Biological Activity. | Al-Khayri JM, Banadka A, Nandhini M, Nagella P, Al-Mssallem MQ, Alessa FM. | Molecules | 10.3390/molecules28020696 | 2023 | | |
| Antimicrobial Activity of Some Essential Oils-Present Status and Future Perspectives. | Chouhan S, Sharma K, Guleria S. | Medicines (Basel) | 10.3390/medicines4030058 | 2017 | | |
| Essential Oils and Their Components as Modulators of Antibiotic Activity against Gram-Negative Bacteria. | Aelenei P, Miron A, Trifan A, Bujor A, Gille E, Aprotosoaie AC. | Medicines (Basel) | 10.3390/medicines3030019 | 2016 | | |
| Chemical Profiling and Evaluation of Antioxidant and Anti-Microbial Properties of Selected Commercial Essential Oils: A Comparative Study. | Luis A, Duarte AP, Pereira L, Domingues F. | Medicines (Basel) | 10.3390/medicines4020036 | 2017 | | |
| Pathogenicity | Enhanced antibacterial effect of the novel T4-like bacteriophage KARL-1 in combination with antibiotics against multi-drug resistant Acinetobacter baumannii. | Jansen M, Wahida A, Latz S, Kruttgen A, Hafner H, Buhl EM, Ritter K, Horz HP. | Sci Rep | 10.1038/s41598-018-32344-y | 2018 | |
| Plasmid DNA fingerprinting of Acinetobacter species other than Acinetobacter baumannii. | Seifert H, Schulze A, Baginski R, Pulverer G. | J Clin Microbiol | 10.1128/jcm.32.1.82-86.1994 | 1994 | | |
| Phylogeny | Acinetobacter baumannii serotyping for delineation of outbreaks of nosocomial cross-infection. | Traub WH. | J Clin Microbiol | 10.1128/jcm.27.12.2713-2716.1989 | 1989 | |
| In-vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance. | Findlay J, Poirel L, Bouvier M, Nordmann P | J Glob Antimicrob Resist | 10.1016/j.jgar.2022.05.011 | 2022 | | |
| Pathogenicity | Eradication of drug-resistant Acinetobacter baumannii by cell-penetrating peptide fused endolysin. | Lim J, Jang J, Myung H, Song M | J Microbiol | 10.1007/s12275-022-2107-y | 2022 | |
| 6-Bromo-2-naphthol from Silene armeria extract sensitizes Acinetobacter baumannii strains to polymyxin. | Kang M, Kim W, Lee J, Jung HS, Jeon CO, Park W | Sci Rep | 10.1038/s41598-022-11995-y | 2022 | | |
| Pathogenicity | Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens. | Lim J, Hong J, Jung Y, Ha J, Kim H, Myung H, Song M | J Microbiol Biotechnol | 10.4014/jmb.2205.05009 | 2022 | |
| Metabolism | The Influence of Blue Light and the BlsA Photoreceptor on the Oxidative Stress Resistance Mechanisms of Acinetobacter baumannii. | Squire MS, Townsend HA, Actis LA | Front Cell Infect Microbiol | 10.3389/fcimb.2022.856953 | 2022 | |
| Metabolism | Effect of Hcp Iron Ion Regulation on the Interaction Between Acinetobacter baumannii With Human Pulmonary Alveolar Epithelial Cells and Biofilm Formation. | Pan P, Wang X, Chen Y, Chen Q, Yang Y, Wei C, Cheng T, Wan H, Yu D | Front Cell Infect Microbiol | 10.3389/fcimb.2022.761604 | 2022 | |
| Metabolism | iTRAQ-Based Quantitative Proteomic Analysis of Acinetobacter baumannii under Hypoxia and Normoxia Reveals the Role of OmpW as a Virulence Factor. | Gil-Marques ML, Pachon J, Smani Y | Microbiol Spectr | 10.1128/spectrum.02328-21 | 2022 | |
| Pathogenicity | Fighting Acinetobacter baumannii infections with the acylase PvdQ. | Vogel J, Jansen L, Setroikromo R, Cavallo FM, van Dijl JM, Quax WJ | Microbes Infect | 10.1016/j.micinf.2022.104951 | 2022 | |
| Stress | Tobramycin Stress Induced Differential Gene Expression in Acinetobacter baumannii. | Kashyap S, Sharma P, Capalash N | Curr Microbiol | 10.1007/s00284-022-02788-7 | 2022 | |
| Atorvastatin does not display an antimicrobial activity on its own nor potentiates the activity of other antibiotics against Acinetobacter baumannii ATCC17978 or A. baumannii AB030. | Kornelsen V, Unger M, Kumar A | Access Microbiol | 10.1099/acmi.0.000288 | 2021 | | |
| DksA Modulates Antimicrobial Susceptibility of Acinetobacter baumannii. | Kim N, Son JH, Kim K, Kim HJ, Shin M, Lee JC | Antibiotics (Basel) | 10.3390/antibiotics10121472 | 2021 | | |
| Enzymology | Sporadic Dissemination of tet(X3) and tet(X6) Mediated by Highly Diverse Plasmidomes among Livestock-Associated Acinetobacter. | Cheng YY, Liu Y, Chen Y, Huang FM, Chen RC, Xiao YH, Zhou K | Microbiol Spectr | 10.1128/Spectrum.01141-21 | 2021 | |
| Pathogenicity | Therapeutic Effects of Inhibitor of ompA Expression against Carbapenem-Resistant Acinetobacter baumannii Strains. | Na SH, Jeon H, Oh MH, Kim YJ, Chu M, Lee IY, Lee JC | Int J Mol Sci | 10.3390/ijms222212257 | 2021 | |
| Pathogenicity | Benzalkonium chloride antagonises aminoglycoside antibiotics and promotes evolution of resistance. | Short FL, Lee V, Mamun R, Malmberg R, Li L, Espinosa MI, Venkatesan K, Paulsen IT | EBioMedicine | 10.1016/j.ebiom.2021.103653 | 2021 | |
| Metabolism | Global regulator DksA modulates virulence of Acinetobacter baumannii. | Kim N, Son JH, Kim K, Kim HJ, Kim YJ, Shin M, Lee JC | Virulence | 10.1080/21505594.2021.1995253 | 2021 | |
| In-Depth Analysis of the Role of the Acinetobactin Cluster in the Virulence of Acinetobacter baumannii. | Conde-Perez K, Vazquez-Ucha JC, Alvarez-Fraga L, Ageitos L, Rumbo-Feal S, Martinez-Guitian M, Trigo-Tasende N, Rodriguez J, Bou G, Jimenez C, Beceiro A, Poza M | Front Microbiol | 10.3389/fmicb.2021.752070 | 2021 | | |
| Phosphorylation of Extracellular Proteins in Acinetobacter baumannii in Sessile Mode of Growth. | Massier S, Robin B, Megroz M, Wright A, Harper M, Hayes B, Cosette P, Broutin I, Boyce JD, De E, Hardouin J | Front Microbiol | 10.3389/fmicb.2021.738780 | 2021 | | |
| Medical Evaluation of the Antimicrobial Activity of Rose Oil on Some Standard Bacteria Strains and Clinical Isolates. | Demirel S | Altern Ther Health Med | AT6887 | 2021 | | |
| Metabolism | Killing of Gram-negative and Gram-positive bacteria by a bifunctional cell wall-targeting T6SS effector. | Le NH, Pinedo V, Lopez J, Cava F, Feldman MF | Proc Natl Acad Sci U S A | 10.1073/pnas.2106555118 | 2021 | |
| Assessment of Antibiofilm Potencies of Nervonic and Oleic Acid against Acinetobacter baumannii Using In Vitro and Computational Approaches. | Khadke SK, Lee JH, Kim YG, Raj V, Lee J | Biomedicines | 10.3390/biomedicines9091133 | 2021 | | |
| Mechanism Underlying the Role of LuxR Family Transcriptional Regulator abaR in Biofilm Formation by Acinetobacter baumannii. | Sun X, Xiang J | Curr Microbiol | 10.1007/s00284-021-02654-y | 2021 | | |
| Genetics | Identification of Two Variants of Acinetobacter baumannii Strain ATCC 17978 with Distinct Genotypes and Phenotypes. | Wijers CDM, Pham L, Menon S, Boyd KL, Noel HR, Skaar EP, Gaddy JA, Palmer LD, Noto MJ | Infect Immun | 10.1128/IAI.00454-21 | 2021 | |
| Pathogenicity | Screening of small molecules attenuating biofilm formation of Acinetobacter baumannii by inhibition of ompA promoter activity. | Na SH, Jeon H, Oh MH, Kim YJ, Lee JC | J Microbiol | 10.1007/s12275-021-1394-z | 2021 | |
| Stress | The gigA/gigB Genes Regulate the Growth, Stress Response, and Virulence of Acinetobacter baumannii ATCC 17978 Strain. | Zhou H, Gebhardt MJ, Czyz DM, Yao Y, Shuman HA | Front Microbiol | 10.3389/fmicb.2021.723949 | 2021 | |
| Proteome | An integrated strategy for the construction of a species-specific glycan library for mass spectrometry-based intact glycopeptide analyses. | Meng X, Li L, Wang X | Talanta | 10.1016/j.talanta.2021.122626 | 2021 | |
| BonA from Acinetobacter baumannii Forms a Divisome-Localized Decamer That Supports Outer Envelope Function. | Grinter R, Morris FC, Dunstan RA, Leung PM, Kropp A, Belousoff M, Gunasinghe SD, Scott NE, Beckham S, Peleg AY, Greening C, Li J, Heinz E, Lithgow T | mBio | 10.1128/mBio.01480-21 | 2021 | | |
| Biotechnology | Carboxy-Terminal Processing Protease Controls Production of Outer Membrane Vesicles and Biofilm in Acinetobacter baumannii. | Roy R, You RI, Chang CH, Yang CY, Lin NT | Microorganisms | 10.3390/microorganisms9061336 | 2021 | |
| Metabolism | Essential Gene Analysis in Acinetobacter baumannii by High-Density Transposon Mutagenesis and CRISPR Interference. | Bai J, Dai Y, Farinha A, Tang AY, Syal S, Vargas-Cuebas G, van Opijnen T, Isberg RR, Geisinger E | J Bacteriol | 10.1128/JB.00565-20 | 2021 | |
| Metabolism | Dissemination of novel Tn7 family transposons carrying genes for synthesis and uptake of fimsbactin siderophores among Acinetobacter baumannii isolates. | Hamidian M, Hall RM | Microb Genom | 10.1099/mgen.0.000548 | 2021 | |
| AOA-2 Derivatives as Outer Membrane Protein A Inhibitors for Treatment of Gram-Negative Bacilli Infections. | Ayerbe-Algaba R, Bayo N, Verdu E, Parra-Millan R, Seco J, Teixido M, Pachon J, Giralt E, Smani Y | Front Microbiol | 10.3389/fmicb.2021.634323 | 2021 | | |
| Pathogenicity | d-mannose-sensitive pilus of Acinetobacter baumannii is linked to biofilm formation and adherence onto respiratory tract epithelial cells. | Chen CL, Dudek A, Liang YH, Janapatla RP, Lee HY, Hsu L, Kuo HY, Chiu CH | J Microbiol Immunol Infect | 10.1016/j.jmii.2021.01.008 | 2021 | |
| Pathogenicity | Transferable Acinetobacter baumannii plasmid pDETAB2 encodes OXA-58 and NDM-1 and represents a new class of antibiotic resistance plasmids. | Liu H, Moran RA, Chen Y, Doughty EL, Hua X, Jiang Y, Xu Q, Zhang L, Blair JMA, McNally A, van Schaik W, Yu Y | J Antimicrob Chemother | 10.1093/jac/dkab005 | 2021 | |
| Metabolism | The role of Zur-regulated lipoprotein A in bacterial morphology, antimicrobial susceptibility, and production of outer membrane vesicles in Acinetobacter baumannii. | Kim N, Kim HJ, Oh MH, Kim SY, Kim MH, Son JH, Kim SI, Shin M, Lee YC, Lee JC | BMC Microbiol | 10.1186/s12866-020-02083-0 | 2021 | |
| Pathogenicity | Genomic and phenotypic analyses of multidrug-resistant Acinetobacter baumannii NCCP 16007 isolated from a patient with a urinary tract infection. | Kim M, Park J, Park W | Virulence | 10.1080/21505594.2020.1867421 | 2021 | |
| Pathogenicity | Global Transcriptomic Analysis During Murine Pneumonia Infection Reveals New Virulence Factors in Acinetobacter baumannii. | Martinez-Guitian M, Vazquez-Ucha JC, Alvarez-Fraga L, Conde-Perez K, Vallejo JA, Perina A, Bou G, Poza M, Beceiro A | J Infect Dis | 10.1093/infdis/jiaa522 | 2021 | |
| Metabolism | Peptidoglycan editing provides immunity to Acinetobacter baumannii during bacterial warfare. | Le NH, Peters K, Espaillat A, Sheldon JR, Gray J, Di Venanzio G, Lopez J, Djahanschiri B, Mueller EA, Hennon SW, Levin PA, Ebersberger I, Skaar EP, Cava F, Vollmer W, Feldman MF | Sci Adv | 10.1126/sciadv.abb5614 | 2020 | |
| Phenotypic Variation and Carbapenem Resistance Potential in OXA-499-Producing Acinetobacter pittii. | Zhang L, Fu Y, Han X, Xu Q, Weng S, Yan B, Liu L, Hua X, Chen Y, Yu Y | Front Microbiol | 10.3389/fmicb.2020.01134 | 2020 | | |
| Biotechnology | Characterization of biofilm production in different strains of Acinetobacter baumannii and the effects of chemical compounds on biofilm formation. | Lin MF, Lin YY, Lan CY | PeerJ | 10.7717/peerj.9020 | 2020 | |
| Discovery of a Novel Hypervirulent Acinetobacter baumannii Strain in a Case of Community-Acquired Pneumonia. | Zhou H, Larkin PMK, Huang J, Yao Y, Zhu B, Yang Q, Hua X, Zhou J, Yang S, Yu Y | Infect Drug Resist | 10.2147/IDR.S244044 | 2020 | | |
| Mutation of the Carboxy-Terminal Processing Protease in Acinetobacter baumannii Affects Motility, Leads to Loss of Membrane Integrity, and Reduces Virulence. | Roy R, You RI, Lin MD, Lin NT | Pathogens | 10.3390/pathogens9050322 | 2020 | | |
| Pathogenicity | Role of PstS in the Pathogenesis of Acinetobacter baumannii Under Microaerobiosis and Normoxia. | Gil-Marques ML, Labrador Herrera G, Miro Canturri A, Pachon J, Smani Y, Pachon-Ibanez ME | J Infect Dis | 10.1093/infdis/jiaa201 | 2020 | |
| Metabolism | A response regulator protein with antar domain, AvnR, in Acinetobacter baumannii ATCC 17978 impacts its virulence and amino acid metabolism. | De Silva PM, Patidar R, Graham CI, Brassinga AKC, Kumar A | Microbiology (Reading) | 10.1099/mic.0.000913 | 2020 | |
| Metabolism | Direct interaction between RecA and a CheW-like protein is required for surface-associated motility, chemotaxis and the full virulence of Acinetobacter baumannii strain ATCC 17978. | Corral J, Perez-Varela M, Barbe J, Aranda J | Virulence | 10.1080/21505594.2020.1748923 | 2020 | |
| Metabolism | Role of ppGpp-regulated efflux genes in Acinetobacter baumannii. | Jung HW, Kim K, Islam MM, Lee JC, Shin M | J Antimicrob Chemother | 10.1093/jac/dkaa014 | 2020 | |
| Metabolism | [Influence of abaR gene knockout on growth metabolism and biofilm formation of Acinetobacter baumannii]. | Guo HN, Chen Z, Xiang J | Zhonghua Shao Shang Za Zhi | 10.3760/cma.j.issn.1009-2587.2020.01.006 | 2020 | |
| COL(R) Acinetobacter baumannii sRNA Signatures: Computational Comparative Identification and Biological Targets. | Cafiso V, Stracquadanio S, Lo Verde F, Dovere V, Zega A, Pigola G, Aranda J, Stefani S | Front Microbiol | 10.3389/fmicb.2019.03075 | 2020 | | |
| Pathogenicity | Effects of different resistance mechanisms on antimicrobial resistance in Acinetobacter baumannii: a strategic system for screening and activity testing of new antibiotics. | Tsai YK, Liou CH, Lin JC, Fung CP, Chang FY, Siu LK | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2020.105918 | 2020 | |
| Metabolism | Zur-regulated lipoprotein A contributes to the fitness of Acinetobacter baumannii. | Lee EK, Choi CH, Oh MH | J Microbiol | 10.1007/s12275-020-9531-7 | 2020 | |
| Metabolism | The sensor kinase BfmS controls production of outer membrane vesicles in Acinetobacter baumannii. | Kim SY, Kim MH, Kim SI, Son JH, Kim S, Lee YC, Shin M, Oh MH, Lee JC | BMC Microbiol | 10.1186/s12866-019-1679-0 | 2019 | |
| Enzymology | AdeB efflux pump gene knockdown by mRNA mediated peptide nucleic acid in multidrug resistance Acinetobacter baumannii. | Abdi SN, Ghotaslou R, Asgharzadeh M, Mehramouz B, Hasani A, Baghi HB, Tanomand A, Narenji H, Yousefi B, Gholizadeh P, Yousefi M, Bastami M, Ganbarov K, Samadi Kafil H | Microb Pathog | 10.1016/j.micpath.2019.103825 | 2019 | |
| Metabolism | A corepressor participates in LexA-independent regulation of error-prone polymerases in Acinetobacter. | Peterson MA, Grice AN, Hare JM | Microbiology (Reading) | 10.1099/mic.0.000866 | 2020 | |
| Pathogenicity | Imaging of bioluminescent Acinetobacter baumannii in a mouse pneumonia model. | Na SH, Oh MH, Jeon H, Lee YK, Lee B, Shin M, Lee JC | Microb Pathog | 10.1016/j.micpath.2019.103784 | 2019 | |
| Pathogenicity | Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by peptide-PNA conjugates and synergy with colistin. | Martinez-Guitian M, Vazquez-Ucha JC, Alvarez-Fraga L, Conde-Perez K, Bou G, Poza M, Beceiro A | J Antimicrob Chemother | 10.1093/jac/dkz409 | 2020 | |
| Metabolism | Involvement of HisF in the Persistence of Acinetobacter baumannii During a Pneumonia Infection. | Martinez-Guitian M, Vazquez-Ucha JC, Alvarez-Fraga L, Conde-Perez K, Lasarte-Monterrubio C, Vallejo JA, Bou G, Poza M, Beceiro A | Front Cell Infect Microbiol | 10.3389/fcimb.2019.00310 | 2019 | |
| Metabolism | Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii. | Vazquez-Ucha JC, Martinez-Guitian M, Maneiro M, Conde-Perez K, Alvarez-Fraga L, Torrens G, Oliver A, Buynak JD, Bonomo RA, Bou G, Gonzalez-Bello C, Poza M, Beceiro A | Antimicrob Agents Chemother | 10.1128/AAC.01092-19 | 2019 | |
| Metabolism | Quorum and Light Signals Modulate Acetoin/Butanediol Catabolism in Acinetobacter spp. | Tuttobene MR, Fernandez-Garcia L, Blasco L, Cribb P, Ambroa A, Muller GL, Fernandez-Cuenca F, Bleriot I, Rodriguez RE, Barbosa BGV, Lopez-Rojas R, Trastoy R, Lopez M, Bou G, Tomas M, Mussi MA | Front Microbiol | 10.3389/fmicb.2019.01376 | 2019 | |
| Intercellular Transfer of Chromosomal Antimicrobial Resistance Genes between Acinetobacter baumannii Strains Mediated by Prophages. | Wachino JI, Jin W, Kimura K, Arakawa Y | Antimicrob Agents Chemother | 10.1128/AAC.00334-19 | 2019 | | |
| Phylogeny | Computational Prediction of sRNA in Acinetobacter baumannii. | Arya S, Dubey V, Sen D, Sharma A, Pathania R | Methods Mol Biol | 10.1007/978-1-4939-9118-1_27 | 2019 | |
| Genetics | MITE Aba12 , a Novel Mobile Miniature Inverted-Repeat Transposable Element Identified in Acinetobacter baumannii ATCC 17978 and Its Prevalence across the Moraxellaceae Family. | Adams FG, Brown MH | mSphere | 10.1128/mSphereDirect.00028-19 | 2019 | |
| Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy. | Cafiso V, Stracquadanio S, Lo Verde F, Gabriele G, Mezzatesta ML, Caio C, Pigola G, Ferro A, Stefani S | Front Microbiol | 10.3389/fmicb.2018.03195 | 2019 | | |
| Pathogenicity | Roles of Efflux Pumps from Different Superfamilies in the Surface-Associated Motility and Virulence of Acinetobacter baumannii ATCC 17978. | Perez-Varela M, Corral J, Aranda J, Barbe J | Antimicrob Agents Chemother | 10.1128/AAC.02190-18 | 2019 | |
| Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by A. baumannii. | Fernandez-Garcia L, Ambroa A, Blasco L, Bleriot I, Lopez M, Alvarez-Marin R, Fernandez-Cuenca F, Martinez-Martinez L, Vila J, Rodriguez-Bano J, Garnacho-Montero J, Cisneros JM, Pascual A, Pachon J, Bou G, Smani Y, Tomas M | Front Microbiol | 10.3389/fmicb.2018.03105 | 2018 | | |
| Metabolism | Comparative proteomics analyses of Acinetobacter baumannii strains ATCC 17978 and AB5075 reveal the differential role of type II secretion system secretomes in lung colonization and ciprofloxacin resistance. | Elhosseiny NM, Elhezawy NB, Attia AS | Microb Pathog | 10.1016/j.micpath.2018.12.039 | 2018 | |
| Pathogenicity | Anti-persister activity of squalamine against Acinetobacter baumannii. | Nicol M, Mlouka MAB, Berthe T, Di Martino P, Jouenne T, Brunel JM, De E | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2018.11.004 | 2018 | |
| Pathogenicity | Distinct role of outer membrane protein A in the intrinsic resistance of Acinetobacter baumannii and Acinetobacter nosocomialis. | Kwon HI, Kim S, Oh MH, Shin M, Lee JC | Infect Genet Evol | 10.1016/j.meegid.2018.10.022 | 2018 | |
| Enzymology | Multiple Quorum Quenching Enzymes Are Active in the Nosocomial Pathogen Acinetobacter baumannii ATCC17978. | Mayer C, Muras A, Romero M, Lopez M, Tomas M, Otero A | Front Cell Infect Microbiol | 10.3389/fcimb.2018.00310 | 2018 | |
| Pathogenicity | Peptidoglycan recycling contributes to intrinsic resistance to fosfomycin in Acinetobacter baumannii. | Gil-Marques ML, Moreno-Martinez P, Costas C, Pachon J, Blazquez J, McConnell MJ | J Antimicrob Chemother | 10.1093/jac/dky289 | 2018 | |
| Integrase-Controlled Excision of Metal-Resistance Genomic Islands in Acinetobacter baumannii. | Al-Jabri Z, Zamudio R, Horvath-Papp E, Ralph JD, Al-Muharrami Z, Rajakumar K, Oggioni MR | Genes (Basel) | 10.3390/genes9070366 | 2018 | | |
| Transcriptome | The primary transcriptome, small RNAs and regulation of antimicrobial resistance in Acinetobacter baumannii ATCC 17978. | Kroger C, MacKenzie KD, Alshabib EY, Kirzinger MWB, Suchan DM, Chao TC, Akulova V, Miranda-CasoLuengo AA, Monzon VA, Conway T, Sivasankaran SK, Hinton JCD, Hokamp K, Cameron ADS | Nucleic Acids Res | 10.1093/nar/gky603 | 2018 | |
| Metabolism | Recombinant production of A1S_0222 from Acinetobacter baumannii ATCC 17978 and confirmation of its DNA-(adenine N6)-methyltransferase activity. | Blaschke U, Suwono B, Zafari S, Ebersberger I, Skiebe E, Jeffries CM, Svergun DI, Wilharm G | Protein Expr Purif | 10.1016/j.pep.2018.06.009 | 2018 | |
| Pathogenicity | A Light-Regulated Type I Pilus Contributes to Acinetobacter baumannii Biofilm, Motility, and Virulence Functions. | Wood CR, Ohneck EJ, Edelmann RE, Actis LA | Infect Immun | 10.1128/IAI.00442-18 | 2018 | |
| Trans-Cinnamaldehyde and Eugenol Increase Acinetobacter baumannii Sensitivity to Beta-Lactam Antibiotics. | Karumathil DP, Nair MS, Gaffney J, Kollanoor-Johny A, Venkitanarayanan K | Front Microbiol | 10.3389/fmicb.2018.01011 | 2018 | | |
| Transcriptome | Resistance to pentamidine is mediated by AdeAB, regulated by AdeRS, and influenced by growth conditions in Acinetobacter baumannii ATCC 17978. | Adams FG, Stroeher UH, Hassan KA, Marri S, Brown MH | PLoS One | 10.1371/journal.pone.0197412 | 2018 | |
| Metabolism | Substrate Specificities and Efflux Efficiencies of RND Efflux Pumps of Acinetobacter baumannii. | Leus IV, Weeks JW, Bonifay V, Smith L, Richardson S, Zgurskaya HI | J Bacteriol | 10.1128/JB.00049-18 | 2018 | |
| Pathogenicity | Relationship between Tolerance and Persistence Mechanisms in Acinetobacter baumannii Strains with AbkAB Toxin-Antitoxin System. | Fernandez-Garcia L, Fernandez-Cuenca F, Blasco L, Lopez-Rojas R, Ambroa A, Lopez M, Pascual A, Bou G, Tomas M | Antimicrob Agents Chemother | 10.1128/AAC.00250-18 | 2018 | |
| Metabolism | Pneumonia infection in mice reveals the involvement of the feoA gene in the pathogenesis of Acinetobacter baumannii. | Alvarez-Fraga L, Vazquez-Ucha JC, Martinez-Guitian M, Vallejo JA, Bou G, Beceiro A, Poza M | Virulence | 10.1080/21505594.2017.1420451 | 2018 | |
| Pathogenicity | Unsaturated Fatty Acids Affect Quorum Sensing Communication System and Inhibit Motility and Biofilm Formation of Acinetobacter baumannii. | Nicol M, Alexandre S, Luizet JB, Skogman M, Jouenne T, Salcedo SP, De E | Int J Mol Sci | 10.3390/ijms19010214 | 2018 | |
| Functional Characterization of Acinetobacter baumannii Lacking the RNA Chaperone Hfq. | Kuo HY, Chao HH, Liao PC, Hsu L, Chang KC, Tung CH, Chen CH, Liou ML | Front Microbiol | 10.3389/fmicb.2017.02068 | 2017 | | |
| Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin. | Masadeh MM, Alzoubi KH, Al-Azzam SI, Al-Buhairan AM | Clin Pharmacol | 10.2147/CPAA.S148448 | 2017 | | |
| Acinetobacter baumannii Virulence Traits: A Comparative Study of a Novel Sequence Type with Other Italian Endemic International Clones. | Ambrosi C, Scribano D, Aleandri M, Zagaglia C, Di Francesco L, Putignani L, Palamara AT | Front Microbiol | 10.3389/fmicb.2017.01977 | 2017 | | |
| Pathogenicity | Effect of Incubation Temperature on Antibiotic Resistance and Virulence Factors of Acinetobacter baumannii ATCC 17978. | De Silva PM, Chong P, Fernando DM, Westmacott G, Kumar A | Antimicrob Agents Chemother | 10.1128/AAC.01514-17 | 2017 | |
| Pathogenicity | Outer membrane protein A contributes to antimicrobial resistance of Acinetobacter baumannii through the OmpA-like domain. | Kwon HI, Kim S, Oh MH, Na SH, Kim YJ, Jeon YH, Lee JC | J Antimicrob Chemother | 10.1093/jac/dkx257 | 2017 | |
| Metabolism | Effect of Sodium Chloride on Surface-Associated Motility of Acinetobacter baumannii and the Role of AdeRS Two-Component System. | De Silva PM, Kumar A | J Membr Biol | 10.1007/s00232-017-9985-7 | 2017 | |
| Pathogenicity | Global assessment of small RNAs reveals a non-coding transcript involved in biofilm formation and attachment in Acinetobacter baumannii ATCC 17978. | Alvarez-Fraga L, Rumbo-Feal S, Perez A, Gomez MJ, Gayoso C, Vallejo JA, Ohneck EJ, Valle J, Actis LA, Beceiro A, Bou G, Poza M | PLoS One | 10.1371/journal.pone.0182084 | 2017 | |
| Pathogenicity | Osmotic Compounds Enhance Antibiotic Efficacy against Acinetobacter baumannii Biofilm Communities. | Falghoush A, Beyenal H, Besser TE, Omsland A, Call DR | Appl Environ Microbiol | 10.1128/AEM.01297-17 | 2017 | |
| Metabolism | A1S_2811, a CheA/Y-like hybrid two-component regulator from Acinetobacter baumannii ATCC17978, is involved in surface motility and biofilm formation in this bacterium. | Chen R, Lv R, Xiao L, Wang M, Du Z, Tan Y, Cui Y, Yan Y, Luo Y, Yang R, Song Y | Microbiologyopen | 10.1002/mbo3.510 | 2017 | |
| Pathogenicity | Response to Bile Salts in Clinical Strains of Acinetobacter baumannii Lacking the AdeABC Efflux Pump: Virulence Associated with Quorum Sensing. | Lopez M, Blasco L, Gato E, Perez A, Fernandez-Garcia L, Martinez-Martinez L, Fernandez-Cuenca F, Rodriguez-Bano J, Pascual A, Bou G, Tomas M | Front Cell Infect Microbiol | 10.3389/fcimb.2017.00143 | 2017 | |
| Pathogenicity | Mutations in the beta-Subunit of the RNA Polymerase Impair the Surface-Associated Motility and Virulence of Acinetobacter baumannii. | Perez-Varela M, Corral J, Vallejo JA, Rumbo-Feal S, Bou G, Aranda J, Barbe J | Infect Immun | 10.1128/IAI.00327-17 | 2017 | |
| Metabolism | Disruption of tetR type regulator adeN by mobile genetic element confers elevated virulence in Acinetobacter baumannii. | Saranathan R, Pagal S, Sawant AR, Tomar A, Madhangi M, Sah S, Satti A, Arunkumar KP, Prashanth K | Virulence | 10.1080/21505594.2017.1322240 | 2017 | |
| Pathogenicity | [Influences of abaR gene on biofilm formation of Acinetobacter baumannii]. | Guo HN, Xiang J | Zhonghua Shao Shang Za Zhi | 10.3760/cma.j.issn.1009-2587.2017.04.003 | 2017 | |
| Pathogenicity | Contribution of the A. baumannii A1S_0114 Gene to the Interaction with Eukaryotic Cells and Virulence. | Rumbo-Feal S, Perez A, Ramelot TA, Alvarez-Fraga L, Vallejo JA, Beceiro A, Ohneck EJ, Arivett BA, Merino M, Fiester SE, Kennedy MA, Actis LA, Bou G, Poza M | Front Cell Infect Microbiol | 10.3389/fcimb.2017.00108 | 2017 | |
| Pathogenicity | Zinc stress induces copper depletion in Acinetobacter baumannii. | Hassan KA, Pederick VG, Elbourne LD, Paulsen IT, Paton JC, McDevitt CA, Eijkelkamp BA | BMC Microbiol | 10.1186/s12866-017-0965-y | 2017 | |
| Phylogeny | Characterisation and genome sequence of the lytic Acinetobacter baumannii bacteriophage vB_AbaS_Loki. | Turner D, Wand ME, Briers Y, Lavigne R, Sutton JM, Reynolds DM | PLoS One | 10.1371/journal.pone.0172303 | 2017 | |
| Genetics | Multi-omics approach to study global changes in a triclosan-resistant mutant strain of Acinetobacter baumannii ATCC 17978. | Fernando DM, Chong P, Singh M, Spicer V, Unger M, Loewen PC, Westmacott G, Kumar A | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2016.10.014 | 2016 | |
| Phylogeny | Isolation and Characterization of Acinetobacter baumannii Recovered from Campylobacter Selective Medium. | Fernando DM, Khan IU, Patidar R, Lapen DR, Talbot G, Topp E, Kumar A | Front Microbiol | 10.3389/fmicb.2016.01871 | 2016 | |
| Pathogenicity | Antimicrobial activity of novel 4H-4-oxoquinolizine compounds against extensively drug-resistant Acinetobacter baumannii strains. | Na SH, Jeon H, Kim YJ, Kwon HI, Selasi GN, Nicholas A, Yun CS, Lee SH, Lee JC | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2016.10.008 | 2016 | |
| The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii. | Mu X, Wang N, Li X, Shi K, Zhou Z, Yu Y, Hua X | Front Microbiol | 10.3389/fmicb.2016.01715 | 2016 | | |
| Metabolism | The secretome of Acinetobacter baumannii ATCC 17978 type II secretion system reveals a novel plasmid encoded phospholipase that could be implicated in lung colonization. | Elhosseiny NM, El-Tayeb OM, Yassin AS, Lory S, Attia AS | Int J Med Microbiol | 10.1016/j.ijmm.2016.09.006 | 2016 | |
| Pathogenicity | Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces. | Greene C, Wu J, Rickard AH, Xi C | Lett Appl Microbiol | 10.1111/lam.12627 | 2016 | |
| Pathogenicity | Design of an anti-adhesive surface by a pilicide strategy. | Reffuveille F, Nicol M, De E, Thebault P | Colloids Surf B Biointerfaces | 10.1016/j.colsurfb.2016.07.037 | 2016 | |
| Phenotype | Characterization of a highly virulent and antimicrobial-resistant Acinetobacter baumannii strain isolated from diseased chicks in China. | Liu D, Liu ZS, Hu P, Hui Q, Fu BQ, Lu SY, Li YS, Zou DY, Li ZH, Yan DM, Ding YX, Zhang YY, Zhou Y, Liu NN, Ren HL | Microbiol Immunol | 10.1111/1348-0421.12400 | 2016 | |
| Metabolism | Proteomic characterization of Nalpha- and Nepsilon-acetylation in Acinetobacter baumannii. | Kentache T, Jouenne T, De E, Hardouin J | J Proteomics | 10.1016/j.jprot.2016.05.021 | 2016 | |
| Metabolism | Mutations Decreasing Intrinsic beta-Lactam Resistance Are Linked to Cell Division in the Nosocomial Pathogen Acinetobacter baumannii. | Knight D, Dimitrova DD, Rudin SD, Bonomo RA, Rather PN | Antimicrob Agents Chemother | 10.1128/AAC.00361-16 | 2016 | |
| Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents. | Masadeh MM, Alzoubi KH, Al-Azzam SI, Khabour OF, Al-Buhairan AM | Pathogens | 10.3390/pathogens5010028 | 2016 | | |
| Metabolism | Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness. | Johnson TL, Waack U, Smith S, Mobley H, Sandkvist M | J Bacteriol | 10.1128/JB.00622-15 | 2015 | |
| Metabolism | Rapid and sensitive detection of carbapenemase activity in Acinetobacter baumannii using superficially porous liquid chromatography-tandem mass spectrometry. | Lin HR, Hu A, Lai MJ, Chiang CW, Liao CC, Chang KC | J Microbiol Immunol Infect | 10.1016/j.jmii.2015.08.001 | 2015 | |
| Genetics | Structure of the neutral capsular polysaccharide of Acinetobacter baumannii NIPH146 that carries the KL37 capsule gene cluster. | Arbatsky NP, Shneider MM, Kenyon JJ, Shashkov AS, Popova AV, Miroshnikov KA, Volozhantsev NV, Knirel YA | Carbohydr Res | 10.1016/j.carres.2015.05.003 | 2015 | |
| Pathogenicity | Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance. | Lin MF, Lin YY, Tu CC, Lan CY | J Microbiol Immunol Infect | 10.1016/j.jmii.2015.04.004 | 2015 | |
| Metabolism | Identification of genes essential for pellicle formation in Acinetobacter baumannii. | Giles SK, Stroeher UH, Eijkelkamp BA, Brown MH | BMC Microbiol | 10.1186/s12866-015-0440-6 | 2015 | |
| Enzymology | Therapeutic efficacy of lysophosphatidylcholine in severe infections caused by Acinetobacter baumannii. | Smani Y, Dominguez-Herrera J, Ibanez-Martinez J, Pachon J | Antimicrob Agents Chemother | 10.1128/AAC.04986-14 | 2015 | |
| Metabolism | Transcriptome profiling in imipenem-selected Acinetobacter baumannii. | Chang KC, Kuo HY, Tang CY, Chang CW, Lu CW, Liu CC, Lin HR, Chen KH, Liou ML | BMC Genomics | 10.1186/1471-2164-15-815 | 2014 | |
| Genetics | Whole-genome sequence analysis of the naturally competent Acinetobacter baumannii clinical isolate A118. | Traglia GM, Chua K, Centron D, Tolmasky ME, Ramirez MS | Genome Biol Evol | 10.1093/gbe/evu176 | 2014 | |
| Pathogenicity | Triclosan can select for an AdeIJK-overexpressing mutant of Acinetobacter baumannii ATCC 17978 that displays reduced susceptibility to multiple antibiotics. | Fernando DM, Xu W, Loewen PC, Zhanel GG, Kumar A | Antimicrob Agents Chemother | 10.1128/AAC.03074-14 | 2014 | |
| Pathogenicity | Impact of Acinetobacter baumannii superoxide dismutase on motility, virulence, oxidative stress resistance and susceptibility to antibiotics. | Heindorf M, Kadari M, Heider C, Skiebe E, Wilharm G | PLoS One | 10.1371/journal.pone.0101033 | 2014 | |
| Metabolism | Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung. | Wang N, Ozer EA, Mandel MJ, Hauser AR | mBio | 10.1128/mBio.01163-14 | 2014 | |
| Metabolism | Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility. | Lin MF, Lin YY, Yeh HW, Lan CY | BMC Microbiol | 10.1186/1471-2180-14-119 | 2014 | |
| Pathogenicity | Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system. | Mosqueda N, Gato E, Roca I, Lopez M, de Alegria CR, Fernandez Cuenca F, Martinez-Martinez L, Pachon J, Cisneros JM, Rodriguez-Bano J, Pascual A, Vila J, Bou G, Tomas M | J Antimicrob Chemother | 10.1093/jac/dku179 | 2014 | |
| Genetics | Insertion sequence transposition determines imipenem resistance in Acinetobacter baumannii. | Kuo HY, Chang KC, Liu CC, Tang CY, Peng JH, Lu CW, Tu CC, Liou ML | Microb Drug Resist | 10.1089/mdr.2014.0004 | 2014 | |
| Pathogenicity | Prophage induction and differential RecA and UmuDAb transcriptome regulation in the DNA damage responses of Acinetobacter baumannii and Acinetobacter baylyi. | Hare JM, Ferrell JC, Witkowski TA, Grice AN | PLoS One | 10.1371/journal.pone.0093861 | 2014 | |
| Proteome | Ser/Thr/Tyr phosphoproteome characterization of Acinetobacter baumannii: comparison between a reference strain and a highly invasive multidrug-resistant clinical isolate. | Soares NC, Spat P, Mendez JA, Nakedi K, Aranda J, Bou G | J Proteomics | 10.1016/j.jprot.2014.03.009 | 2014 | |
| Pathogenicity | Virstatin inhibits biofilm formation and motility of Acinetobacter baumannii. | Nait Chabane Y, Mlouka MB, Alexandre S, Nicol M, Marti S, Pestel-Caron M, Vila J, Jouenne T, De E | BMC Microbiol | 10.1186/1471-2180-14-62 | 2014 | |
| Enzymology | Characterization of blaOXA-143 variants in Acinetobacter baumannii and Acinetobacter pittii. | Zander E, Bonnin RA, Seifert H, Higgins PG | Antimicrob Agents Chemother | 10.1128/AAC.02618-13 | 2014 | |
| Pathogenicity | Effect of chlorine exposure on the survival and antibiotic gene expression of multidrug resistant Acinetobacter baumannii in water. | Karumathil DP, Yin HB, Kollanoor-Johny A, Venkitanarayanan K | Int J Environ Res Public Health | 10.3390/ijerph110201844 | 2014 | |
| Genetics | Proteogenomic characterization of antimicrobial resistance in extensively drug-resistant Acinetobacter baumannii DU202. | Lee SY, Yun SH, Lee YG, Choi CW, Leem SH, Park EC, Kim GH, Lee JC, Kim SI | J Antimicrob Chemother | 10.1093/jac/dku008 | 2014 | |
| Enzymology | Class D beta-lactamases: are they all carbapenemases? | Antunes NT, Lamoureaux TL, Toth M, Stewart NK, Frase H, Vakulenko SB | Antimicrob Agents Chemother | 10.1128/AAC.02522-13 | 2014 | |
| Pathogenicity | Serum resistance, gallium nitrate tolerance and extrapulmonary dissemination are linked to heme consumption in a bacteremic strain of Acinetobacter baumannii. | de Leseleuc L, Harris G, KuoLee R, Xu HH, Chen W | Int J Med Microbiol | 10.1016/j.ijmm.2013.12.002 | 2013 | |
| Pathogenicity | Role of Acinetobacter baumannii UmuD homologs in antibiotic resistance acquired through DNA damage-induced mutagenesis. | Aranda J, Lopez M, Leiva E, Magan A, Adler B, Bou G, Barbe J | Antimicrob Agents Chemother | 10.1128/AAC.02346-13 | 2013 | |
| Transcriptome | Whole transcriptome analysis of Acinetobacter baumannii assessed by RNA-sequencing reveals different mRNA expression profiles in biofilm compared to planktonic cells. | Rumbo-Feal S, Gomez MJ, Gayoso C, Alvarez-Fraga L, Cabral MP, Aransay AM, Rodriguez-Ezpeleta N, Fullaondo A, Valle J, Tomas M, Bou G, Poza M | PLoS One | 10.1371/journal.pone.0072968 | 2013 | |
| Pathogenicity | Contribution of efflux pumps, porins, and beta-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. | Rumbo C, Gato E, Lopez M, Ruiz de Alegria C, Fernandez-Cuenca F, Martinez-Martinez L, Vila J, Pachon J, Cisneros JM, Rodriguez-Bano J, Pascual A, Bou G, Tomas M | Antimicrob Agents Chemother | 10.1128/AAC.00730-13 | 2013 | |
| Pathogenicity | Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii. | Smani Y, Dominguez-Herrera J, Pachon J | J Infect Dis | 10.1093/infdis/jit386 | 2013 | |
| Enzymology | Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978. | Lai MJ, Soo PC, Lin NT, Hu A, Chen YJ, Chen LK, Chang KC | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2013.04.022 | 2013 | |
| Metabolism | H-NS plays a role in expression of Acinetobacter baumannii virulence features. | Eijkelkamp BA, Stroeher UH, Hassan KA, Elbourne LD, Paulsen IT, Brown MH | Infect Immun | 10.1128/IAI.00065-13 | 2013 | |
| Metabolism | A systematic quantitative proteomic examination of multidrug resistance in Acinetobacter baumannii. | Chopra S, Ramkissoon K, Anderson DC | J Proteomics | 10.1016/j.jprot.2013.03.008 | 2013 | |
| Metabolism | Structure and biosynthesis of fimsbactins A-F, siderophores from Acinetobacter baumannii and Acinetobacter baylyi. | Proschak A, Lubuta P, Grun P, Lohr F, Wilharm G, De Berardinis V, Bode HB | Chembiochem | 10.1002/cbic.201200764 | 2013 | |
| Enzymology | OXA-235, a novel class D beta-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. | Higgins PG, Perez-Llarena FJ, Zander E, Fernandez A, Bou G, Seifert H | Antimicrob Agents Chemother | 10.1128/AAC.02413-12 | 2013 | |
| Metabolism | Effect of ethanol on differential protein production and expression of potential virulence functions in the opportunistic pathogen Acinetobacter baumannii. | Nwugo CC, Arivett BA, Zimbler DL, Gaddy JA, Richards AM, Actis LA | PLoS One | 10.1371/journal.pone.0051936 | 2012 | |
| Enzymology | Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility. | Zander E, Chmielarczyk A, Heczko P, Seifert H, Higgins PG | J Antimicrob Chemother | 10.1093/jac/dks382 | 2012 | |
| Metabolism | Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. | Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litran T | Infect Immun | 10.1128/IAI.06096-11 | 2012 | |
| Metabolism | Nuclear translocation of Acinetobacter baumannii transposase induces DNA methylation of CpG regions in the promoters of E-cadherin gene. | Moon DC, Choi CH, Lee SM, Lee JH, Kim SI, Kim DS, Lee JC | PLoS One | 10.1371/journal.pone.0038974 | 2012 | |
| Metabolism | Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation. | Iwashkiw JA, Seper A, Weber BS, Scott NE, Vinogradov E, Stratilo C, Reiz B, Cordwell SJ, Whittal R, Schild S, Feldman MF | PLoS Pathog | 10.1371/journal.ppat.1002758 | 2012 | |
| Metabolism | Deciphering the function of the outer membrane protein OprD homologue of Acinetobacter baumannii. | Catel-Ferreira M, Nehme R, Molle V, Aranda J, Bouffartigues E, Chevalier S, Bou G, Jouenne T, De E | Antimicrob Agents Chemother | 10.1128/AAC.06022-11 | 2012 | |
| Metabolism | Surface-associated motility, a common trait of clinical isolates of Acinetobacter baumannii, depends on 1,3-diaminopropane. | Skiebe E, de Berardinis V, Morczinek P, Kerrinnes T, Faber F, Lepka D, Hammer B, Zimmermann O, Ziesing S, Wichelhaus TA, Hunfeld KP, Borgmann S, Grobner S, Higgins PG, Seifert H, Busse HJ, Witte W, Pfeifer Y, Wilharm G | Int J Med Microbiol | 10.1016/j.ijmm.2012.03.003 | 2012 | |
| Metabolism | Screening of nuclear targeting proteins in Acinetobacter baumannii based on nuclear localization signals. | Moon DC, Gurung M, Lee JH, Lee YS, Choi CW, Kim SI, Lee JC | Res Microbiol | 10.1016/j.resmic.2012.02.001 | 2012 | |
| Metabolism | Characterization of the Acinetobacter baumannii growth phase-dependent and serum responsive transcriptomes. | Jacobs AC, Sayood K, Olmsted SB, Blanchard CE, Hinrichs S, Russell D, Dunman PM | FEMS Immunol Med Microbiol | 10.1111/j.1574-695X.2011.00926.x | 2012 | |
| Pathogenicity | Analysis of genes encoding penicillin-binding proteins in clinical isolates of Acinetobacter baumannii. | Cayo R, Rodriguez MC, Espinal P, Fernandez-Cuenca F, Ocampo-Sosa AA, Pascual A, Ayala JA, Vila J, Martinez-Martinez L | Antimicrob Agents Chemother | 10.1128/AAC.00459-11 | 2011 | |
| Metabolism | The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. | Arroyo LA, Herrera CM, Fernandez L, Hankins JV, Trent MS, Hancock RE | Antimicrob Agents Chemother | 10.1128/AAC.00256-11 | 2011 | |
| Metabolism | Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii. | Rumbo C, Fernandez-Moreira E, Merino M, Poza M, Mendez JA, Soares NC, Mosquera A, Chaves F, Bou G | Antimicrob Agents Chemother | 10.1128/AAC.00929-10 | 2011 | |
| Metabolism | Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions. | Eijkelkamp BA, Hassan KA, Paulsen IT, Brown MH | BMC Genomics | 10.1186/1471-2164-12-126 | 2011 | |
| Pathogenicity | Molecular cloning and functional characterization of two novel membrane fusion proteins in conferring antimicrobial resistance in Acinetobacter baumannii. | Srinivasan VB, Rajamohan G, Pancholi P, Marcon M, Gebreyes WA | J Antimicrob Chemother | 10.1093/jac/dkq469 | 2011 | |
| Pathogenicity | The opportunistic human pathogen Acinetobacter baumannii senses and responds to light. | Mussi MA, Gaddy JA, Cabruja M, Arivett BA, Viale AM, Rasia R, Actis LA | J Bacteriol | 10.1128/JB.00917-10 | 2010 | |
| Pathogenicity | Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii. | Chopra S, Torres-Ortiz M, Hokama L, Madrid P, Tanga M, Mortelmans K, Kodukula K, Galande AK | J Antimicrob Chemother | 10.1093/jac/dkq353 | 2010 | |
| Metabolism | Associating growth-phase-related changes in the proteome of Acinetobacter baumannii with increased resistance to oxidative stress. | Soares NC, Cabral MP, Gayoso C, Mallo S, Rodriguez-Velo P, Fernandez-Moreira E, Bou G | J Proteome Res | 10.1021/pr901116r | 2010 | |
| Metabolism | 2-DE analysis indicates that Acinetobacter baumannii displays a robust and versatile metabolism. | Soares NC, Cabral MP, Parreira JR, Gayoso C, Barba MJ, Bou G | Proteome Sci | 10.1186/1477-5956-7-37 | 2009 | |
| Genetics | Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. | Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR, Bonomo RA | Antimicrob Agents Chemother | 10.1128/AAC.00284-09 | 2009 | |
| Pathogenicity | ATPase genes of diverse multidrug-resistant Acinetobacter baumannii isolates frequently harbour integrated DNA. | Shaikh F, Spence RP, Levi K, Ou HY, Deng Z, Towner KJ, Rajakumar K | J Antimicrob Chemother | 10.1093/jac/dkn481 | 2008 | |
| Genetics | Variable number tandem repeat loci providing discrimination within widespread genotypes of Acinetobacter baumannii. | Turton JF, Matos J, Kaufmann ME, Pitt TL | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-008-0659-3 | 2008 | |
| Genetics | Amplification of a single-locus variable-number direct repeats with restriction fragment length polymorphism (DR-PCR/RFLP) for genetic typing of Acinetobacter baumannii strains. | Nowak-Zaleska A, Krawczyk B, Kotlowski R, Mikucka A, Gospodarek E | Pol J Microbiol | 2008 | | |
| Pathogenicity | Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. | Iacono M, Villa L, Fortini D, Bordoni R, Imperi F, Bonnal RJ, Sicheritz-Ponten T, De Bellis G, Visca P, Cassone A, Carattoli A | Antimicrob Agents Chemother | 10.1128/AAC.01643-07 | 2008 | |
| Ketoprofen, piroxicam and indomethacin-suppressed quorum sensing and virulence factors in Acinetobacter baumannii. | Elshaer SL, Shaldam MA, Shaaban MI | J Appl Microbiol | 10.1111/jam.15609 | 2022 | | |
| Subinhibitory Concentrations of Clinically-Relevant Antimicrobials Affect Resistance-Nodulation-Division Family Promoter Activity in Acinetobacter baumannii. | Prieto Martin Gil S, Tajuelo A, Lopez-Siles M, McConnell MJ | Front Microbiol | 10.3389/fmicb.2021.780201 | 2021 | | |
| Metabolism | Comparison of the Acinetobacter baumannii Reference Strains ATCC 17978 and ATCC 19606 in Antimicrobial Resistance Mediated by the AdeABC Efflux Pump. | Lucassen K, Gerson S, Xanthopoulou K, Wille J, Wille T, Seifert H, Higgins PG | Antimicrob Agents Chemother | 10.1128/AAC.00570-21 | 2021 | |
| Genetics | Two Acinetobacter baumannii Isolates Obtained From a Fatal Necrotizing Fasciitis Infection Display Distinct Genomic and Phenotypic Characteristics in Comparison to Type Strains. | Grier JT, Arivett BA, Ramirez MS, Chosed RJ, Bigner JA, Ohneck EJ, Metz ML, Wood CR, Arce S, Tartaro A, Relich RF, Actis LA, Fiester SE | Front Cell Infect Microbiol | 10.3389/fcimb.2021.635673 | 2021 | |
| Regulation of tert-Butyl Hydroperoxide Resistance by Chromosomal OhrR in A. baumannii ATCC 19606. | Chen SJ, Shu HY, Lin GH | Microorganisms | 10.3390/microorganisms9030629 | 2021 | | |
| Genetics | Complete genome sequence and genome-scale metabolic modelling of Acinetobacter baumannii type strain ATCC 19606. | Zhu Y, Lu J, Zhao J, Zhang X, Yu HH, Velkov T, Li J | Int J Med Microbiol | 10.1016/j.ijmm.2020.151412 | 2020 | |
| Pathogenicity | Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii. | Gerson S, Lucassen K, Wille J, Nodari CS, Stefanik D, Nowak J, Wille T, Betts JW, Roca I, Vila J, Cisneros JM, Seifert H, Higgins PG | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2019.105862 | 2019 | |
| Metabolic Responses to Polymyxin Treatment in Acinetobacter baumannii ATCC 19606: Integrating Transcriptomics and Metabolomics with Genome-Scale Metabolic Modeling. | Zhu Y, Zhao J, Maifiah MHM, Velkov T, Schreiber F, Li J | mSystems | 10.1128/mSystems.00157-18 | 2019 | | |
| Pathogenicity | Subinhibitory Concentrations of Trimethoprim and Sulfamethoxazole Prevent Biofilm Formation by Acinetobacter baumannii through Inhibition of Csu Pilus Expression. | Moon KH, Weber BS, Feldman MF | Antimicrob Agents Chemother | 10.1128/AAC.00778-17 | 2017 | |
| Enzymology | Effects of Saline, an Ambient Acidic Environment, and Sodium Salicylate on OXA-Mediated Carbapenem Resistance in Acinetobacter baumannii. | Zander E, Seifert H, Higgins PG | Antimicrob Agents Chemother | 10.1128/AAC.03010-15 | 2016 | |
| Pathogenicity | Differential Role of the T6SS in Acinetobacter baumannii Virulence. | Repizo GD, Gagne S, Foucault-Grunenwald ML, Borges V, Charpentier X, Limansky AS, Gomes JP, Viale AM, Salcedo SP | PLoS One | 10.1371/journal.pone.0138265 | 2015 | |
| Optimisation of the Caenorhabditis elegans model for studying the pathogenesis of opportunistic Acinetobacter baumannii. | Vallejo JA, Beceiro A, Rumbo-Feal S, Rodriguez-Palero MJ, Russo TA, Bou G | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2015.05.021 | 2015 | | |
| Enzymology | CpaA a novel protease from Acinetobacter baumannii clinical isolates deregulates blood coagulation. | Tilley D, Law R, Warren S, Samis JA, Kumar A | FEMS Microbiol Lett | 10.1111/1574-6968.12496 | 2014 | |
| Pathogenicity | Synergistic activity of coriander oil and conventional antibiotics against Acinetobacter baumannii. | Duarte A, Ferreira S, Silva F, Domingues FC | Phytomedicine | 10.1016/j.phymed.2011.11.010 | 2012 | |
| Pathogenicity | Establishment of a novel target-based real-time quantitative PCR method for Acinetobacter baumannii detection. | Zhang L, Ding G, Wei L, Pan X, Mei L, Zhang Y, Lu Y | Diagn Mol Pathol | 10.1097/PDM.0b013e31821bbb1e | 2011 | |
| Pathogenicity | Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii. | Kuo HY, Chang KC, Kuo JW, Yueh HW, Liou ML | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2011.08.016 | 2011 | |
| Metabolism | Complementary Regulation of BfmRS Two-Component and AbaIR Quorum Sensing Systems to Express Virulence-Associated Genes in Acinetobacter baumannii. | Kim HJ, Kim NY, Ko SY, Park SY, Oh MH, Shin MS, Lee YC, Lee JC | Int J Mol Sci | 10.3390/ijms232113136 | 2022 | |
| Co-evolutionary adaptations of Acinetobacter baumannii and a clinical carbapenemase-encoding plasmid during carbapenem exposure. | Zhang L, Fu Y, Zhang L, Xu Q, Yang Y, He J, Leptihn S, Loh B, Moran RA, van Schaik W, Toleman MA, Chen Q, Liu L, Yu Y, Hua X | Evol Appl | 10.1111/eva.13441 | 2022 | | |
| Metabolism | 3-indoleacetonitrile attenuates biofilm formation and enhances sensitivity to imipenem in Acinetobacter baumannii. | Kashyap S, Sidhu H, Sharma P, Capalash N | Pathog Dis | 10.1093/femspd/ftac029 | 2022 | |
| Polyphosphate Kinase Is Required for the Processes of Virulence and Persistence in Acinetobacter baumannii. | Lv H, Zhou Y, Liu B, Guan J, Zhang P, Deng X, Li D, Wang J | Microbiol Spectr | 10.1128/spectrum.01230-22 | 2022 | | |
| Histamine Produced by Gram-Negative Bacteria Impairs Neutrophil's Antimicrobial Response by Engaging the Histamine 2 Receptor. | Dib K, El Banna A, Radulescu C, Lopez Campos G, Sheehan G, Kavanagh K | J Innate Immun | 10.1159/000525536 | 2022 | | |
| Recombinant AcnB, NrdR and RibD of Acinetobacter baumannii and their potential interaction with DNA adenine methyltransferase AamA. | Weber K, Doellinger J, Jeffries CM, Wilharm G | Protein Expr Purif | 10.1016/j.pep.2022.106134 | 2022 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive132687.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License